[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_c0b23fcf-82f7-4397-81f0-d93f25981fc0":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:c0b23fcf-82f7-4397-81f0-d93f25981fc0,\"}":101},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":37,"indexDatabases":61,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},"c0b23fcf-82f7-4397-81f0-d93f25981fc0","2023-12-05T06:20:36.347+00:00","2025-11-21T09:53:40.902+00:00",[],"Pharmacology-Therapeutics",{"issn":12,"title":14},{"VOID":13},"01637258",{"EN":15},"Pharmacology & Therapeutics","PUBLISHER","PENDING",null,0,[21,29],{"id":22,"createTime":23,"updateTime":24,"relativeEntities":25,"label":26,"description":28,"parentId":18,"standard":18,"scholarHubFieldId":18},"8b51d244-613f-4ff9-b308-d32de7c33ed9","2023-05-29T10:24:08.511+00:00","2023-11-21T07:37:03.796+00:00",[],{"EN":27},"Pharmacology",{},{"id":30,"createTime":31,"updateTime":32,"relativeEntities":33,"label":34,"description":36,"parentId":18,"standard":18,"scholarHubFieldId":18},"8d3ee16d-8f93-4e34-b94e-cd3a00dde338","2023-05-29T10:24:36.755+00:00","2023-11-21T05:10:53.773+00:00",[],{"EN":35},"Pharmacology (medical)",{},[38,50],{"id":39,"createTime":40,"updateTime":41,"relativeEntities":42,"slug":43,"properties":44,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":48,"url":18,"parentIds":49,"statistic":18},"18aff490-2422-46f1-a98d-c061dab6256d","2023-05-29T10:24:02.566+00:00","2025-11-21T10:07:49.466+00:00",[],"Elsevier-Inc-",{"title":45},{"EN":46},"Elsevier Inc.","AFFILIATION",10,[],{"id":51,"createTime":52,"updateTime":53,"relativeEntities":54,"slug":55,"properties":56,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":59,"url":18,"parentIds":60,"statistic":18},"4255270c-c84d-4cec-8432-a117a0ce9d06","2023-05-29T12:06:34.002+00:00","2024-02-23T03:04:34.507+00:00",[],"PERGAMON-ELSEVIER-SCIENCE-LTD",{"title":57},{"EN":58},"PERGAMON-ELSEVIER SCIENCE LTD",13,[],[62,82],{"id":63,"indexDatabase":64,"url":76,"indexYears":77,"academicFieldIds":78,"indexDatabaseRanking":81},"fd0c7f8b-622e-4d53-a6fc-3c765c8caaa9",{"id":65,"createTime":66,"updateTime":67,"relativeEntities":68,"label":69,"description":71,"key":73,"publicationTags":74,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":70,"VI":70},"Scopus - Elsevier",{"EN":70,"VI":72},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[75],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F21195","1976-1977,1979-1985,1987-2025",[79,80],"46eddd1f-e049-4237-8609-9d60083086ad","e39d1b91-b03d-48ed-87bb-ab5b714ad558","SCOPUS__Q1",{"id":83,"indexDatabase":84,"url":98,"indexYears":18,"academicFieldIds":99,"indexDatabaseRanking":18},"83766068-abc8-479c-975a-fe875cd4fb60",{"id":85,"createTime":86,"updateTime":87,"relativeEntities":88,"label":89,"description":91,"key":94,"publicationTags":95,"standard":18},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":90,"VI":90},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":92,"EN":93},"Cơ sở dữ liệu SCIE","SCIE database","scie",[96,97],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0163-7258",[100],"2b943d65-24a8-4546-9232-a1e32c12cb6c",{"meta":102,"data":104},{"total":103},"2153",[105,187,247,442,502,574,632,761,846,904],{"id":106,"createTime":107,"updateTime":108,"relativeEntities":109,"slug":110,"properties":111,"entityType":118,"verifyStatus":119,"verifyTime":108,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":121,"fullTextUrl":18,"authors":122,"publicationType":155,"publisherRelationship":156,"citationCount":18,"citationInfo":18,"publishDate":184,"publishYear":185,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"063b566b-d027-421e-8d06-676d143e777b","2024-01-16T01:51:46.934+00:00","2024-12-21T23:59:29.112+00:00",[],"Critical-assessment-of-how-to-study-addiction-and-its-treatment-Human-and-non-human-animal-models",{"references":112,"title":114,"doi":116},{"VOID":113},"Abrahamsen, 1995, Curve-shift analysis of self-stimulation in food-restricted rats: relationship between daily meal, plasma corticosterone and reward sensitization, Brain Res, 695, 186, 10.1016\u002F0006-8993(95)00764-H\nAcheson, 2000, Lesions and inactivation implicate dorsomedial hindbrain in MFB self-stimulation, Physiol Behav, 71, 159, 10.1016\u002FS0031-9384(00)00325-5\nAdams, 1976, Probing brain chemistry with electroanalytical techniques, Anal Chem, 48, 1126A, 10.1021\u002Fac50008a001\nAdams, 1978, In vivo electrochemical recording: a new neurophysiological technique, Trends Neurosci, 1, 160, 10.1016\u002F0166-2236(78)90098-X\nAddolorato, 2000, Ability of baclofen in reducing alcohol craving and intake: II. Preliminary clinical evidence, Alcohol Clin Exp Res, 24, 67\nAddolorato, 2002, Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study, Alcohol Alcohol, 37, 504, 10.1093\u002Falcalc\u002F37.5.504\nAllan, 1998, The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine, Psychopharmacol Bull, 34, 71\nAltshuler, 1980, Alternation of ethanol self-administration by naltrexone, Life Sci, 26, 679, 10.1016\u002F0024-3205(80)90257-X\nAmeisen, 2005, Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician, Alcohol Alcohol, 40, 147, 10.1093\u002Falcalc\u002Fagh130\nAmerican Psychiatric Association, 2000\nAndreoli, 2003, Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior, Neuropsychopharmacology, 28, 1272, 10.1038\u002Fsj.npp.1300183\nAndreoli, 2003, Effect of selective antagonism of dopamine D3 receptor by SB-277011-A on oral alcohol self-administration in mice, Eur Neuropsychopharmacol, 13, S17, 10.1016\u002FS0924-977X(03)90011-3\nAnnau, 1974, Electrical self-stimulation of single and multiple loci: long term observations, Physiol Behav, 13, 281, 10.1016\u002F0031-9384(74)90046-8\nAnthony, 1994, Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey, Exp Clin Psychopharmacol, 2, 244, 10.1037\u002F1064-1297.2.3.244\nArnold, 1997, A critique of fixed ratio and progressive ratio schedules used to examine the neural substrates of drug reinforcement, Pharmacol Biochem Behav, 57, 441, 10.1016\u002FS0091-3057(96)00445-5\nAshby, 1999, Implication of the GABAB receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine, Synapse, 31, 151, 10.1002\u002F(SICI)1098-2396(199902)31:2\u003C151::AID-SYN8>3.0.CO;2-W\nAshby, 2002, Systemic administration of 1R,4S-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats, Synapse, 44, 61, 10.1002\u002Fsyn.10052\nAshby, 2003, Acute administration of the selective D3 receptor antagonist SB-277011-A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats, Synapse, 48, 154, 10.1002\u002Fsyn.10188\nAssadi, 2003, Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581], BMC Psychiatry, 18, 16, 10.1186\u002F1471-244X-3-16\nAwad, 1993, Subjective response to neuroleptics in schizophrenia, Schizophr Bull, 19, 609, 10.1093\u002Fschbul\u002F19.3.609\nBaker, 1998, Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and condition place preference, Synapse, 30, 181, 10.1002\u002F(SICI)1098-2396(199810)30:2\u003C181::AID-SYN8>3.0.CO;2-8\nBardo, 1998, Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens, Crit Rev Neurobiol, 12, 37, 10.1615\u002FCritRevNeurobiol.v12.i1-2.30\nBartoletti, 2004, The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine, Behav Pharmacol, 15, 397, 10.1097\u002F00008877-200409000-00014\nBaseski, 2005, Capillary liquid chromatography with MS3 for the determination of enkephalins in microdialysis samples from the striatum of anesthetized and freely-moving rats, J Mass Spectrom, 40, 146, 10.1002\u002Fjms.733\nBauco, 2001, Effects of neurotensin receptor inactivation on brain stimulation reward in Fischer 344 and Lewis rats, Eur J Pharmacol, 432, 57, 10.1016\u002FS0014-2999(01)01466-2\nBeal, 2001, Experimental models of Parkinson's disease, Nat Rev Neurosci, 2, 325, 10.1038\u002F35072550\nBelmaker, 1977, Haloperidol in normals, Br J Psychiatry, 131, 222, 10.1192\u002Fbjp.131.2.222b\nBenveniste, 1989, Brain microdialysis, J Neurochem, 52, 1667, 10.1111\u002Fj.1471-4159.1989.tb07243.x\nBetarbet, 2002, Animal models of Parkinson's disease, Bioessays, 24, 308, 10.1002\u002Fbies.10067\nBindra, 1968, Neuropsychological interpretation of the effects of drive and incentive-motivation on general activity and instrumental behavior, Psychol Rev, 75, 1, 10.1037\u002Fh0025306\nBlum, 2001, Molecular pathways involved in the neurotaxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease, Prog Neurobiol, 65, 135, 10.1016\u002FS0301-0082(01)00003-X\nBolam, 1995, Microcircuitry of the neostriatum, 1\nBourne, 2003, Intracerebral microdialysis: 30 years as a tool for the neuroscientist, Clin Exp Pharmacol Physiol, 30, 16, 10.1046\u002Fj.1440-1681.2003.03789.x\nBouthenet, 1991, Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA, Brain Res, 564, 203, 10.1016\u002F0006-8993(91)91456-B\nBozarth, 1983, Opiate reward mechanisms mapped by intracranial self-administration, 331\n1987\nBozarth, 1987, Intracranial self-administration procedures for the assessment of drug reinforcement, 173\nBozarth, 1981, Heroin reward is dependent on a dopaminergic substrate, Life Sci, 29, 1881, 10.1016\u002F0024-3205(81)90519-1\nBozarth, 1984, Anatomically distinct opiate receptor fields mediate reward and physical dependence, Science, 224, 516, 10.1126\u002Fscience.6324347\nBrady, 1984, Testing Drugs for Physical Dependence Potential and Abuse Liability, vol. 52\nBrebner, 1999, The GABAB agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure, Neuropharmacology, 38, 1797, 10.1016\u002FS0028-3908(99)00094-5\nBrebner, 2000, Intra-VTA baclofen attenuates cocaine self-administration on a progressive raio schedule of reinforcement, Pharmacol Biochem Behav, 66, 857, 10.1016\u002FS0091-3057(00)00286-0\nBrebner, 2000, Effects of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules, Psychopharmacology, 148, 314, 10.1007\u002Fs002130050056\nBrebner, 2002, The GABAB antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat, Psychopharmacology, 160, 49, 10.1007\u002Fs00213-001-0952-7\nBrebner, 2002, A potential role for GABAB agonists in the treatment of psychostimulant addiction, Alcohol Alcohol, 37, 478, 10.1093\u002Falcalc\u002F37.5.478\nBrebner, 2005, Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates, Psychopharmacology, 177, 409, 10.1007\u002Fs00213-004-1968-6\nBreiter, 1999, Functional magnetic resonance imaging of brain reward circuitry in the human, Ann N Y Acad Sci, 877, 523, 10.1111\u002Fj.1749-6632.1999.tb09287.x\nBressan, 2000, Striatal D2 blockade and depression in schizophrenia—SPET findings, Biol Psychiatry, 47, 128S, 10.1016\u002FS0006-3223(00)00689-2\nBressan, 2002, Typical antipsychotic drugs—D2 receptor occupancy and depressive symptoms in schizophrenia, Schizophr Res, 56, 31, 10.1016\u002FS0920-9964(01)00185-2\nBroadbent, 1999, Differential effects of GABAA and GABAB agonists on sensitization to the locomotor stimulant effects of ethanol in BDA\u002F2 J mice, Psychopharmacology, 141, 197, 10.1007\u002Fs002130050825\nBrodie, 2003, Treating cocaine addiction: from preclinical to clinical trial experience with γ-vinyl GABA, Synapse, 50, 261, 10.1002\u002Fsyn.10278\nBrodie, 2005, Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and\u002For cocaine addiction, Synapse, 55, 122, 10.1002\u002Fsyn.20097\nBuckett, 1981, The influence of a GABA transaminase inhibitor, γ-vinyl-GABA, on voluntary morphine consumption in the rat, Psychopharmacology, 75, 214, 10.1007\u002FBF00432191\nBuczek, 1999, Stress reinstates nicotine seeking but not sucrose solution seeking in rats, Psychopharmacology, 144, 183, 10.1007\u002Fs002130050992\nCaine, 1993, Modulation of cocaine self-administration in the rat through D-3 dopamine receptors, Science, 260, 1814, 10.1126\u002Fscience.8099761\nCampbell, 1985, A microcomputer-based method for physiologically-interpretable measurement of the rewarding efficacy of brain stimulation, Physiol Behav, 35, 395, 10.1016\u002F0031-9384(85)90315-4\nCampbell, 1999, Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats, Psychopharmacology, 143, 209, 10.1007\u002Fs002130050937\nCampos, 2003, The dopamine D3 receptor antagonist SB277011A antagonizes nicotine enhanced brain-stimulation reward in rat\nCampos, 2004, Blockade of dopamine D3 receptors by SB-277011A, NGB 2904 or BP 897 attenuates nicotine-enhanced brain stimulation reward in rat\nCapriles, 2003, A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats, Psychopharmacology, 168, 66, 10.1007\u002Fs00213-002-1283-z\nCarlezon, 1996, Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex, J Neurosci, 16, 3112, 10.1523\u002FJNEUROSCI.16-09-03112.1996\nCarr, 2002, Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms, Physiol Behav, 76, 353, 10.1016\u002FS0031-9384(02)00759-X\nChang, 1994, Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats, J Neurosci, 14, 1224, 10.1523\u002FJNEUROSCI.14-03-01224.1994\nChen, 1996, Systemic cocaine challenge after chronic cocaine treatment reveals sensitization of extracellular dopamine levels in nucleus accumbens but direct cocaine perfusion into nucleus accumbens does not: implications for the neural locus of cocaine sensitization, Life Sci [Pharmacol Lett], 14, P139, 10.1016\u002FS0024-3205(96)80014-2\nChester, 2002, GABAA receptor modulation of the rewarding and aversive effects of ethanol, Alcohol, 26, 131, 10.1016\u002FS0741-8329(02)00199-4\nChildress, 1999, Limbic activation during cue-induced cocaine craving, Am J Psychiatry, 156, 11, 10.1176\u002Fajp.156.1.11\nChristie, 1987, Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizing D[3H]aspartate and [3H]GABA, Neuroscience, 22, 425, 10.1016\u002F0306-4522(87)90345-9\nChrobak, 1993, Opioid and GABA modulation of accumbens-evoked ventral pallidal activity, J Neural Transm Gen Sect, 93, 123, 10.1007\u002FBF01245342\nChurch, 1987, Detecting behaviorally relevant changes in extracellular dopamine with microdialysis, Brain Res, 412, 397, 10.1016\u002F0006-8993(87)91150-4\nColombo, 2002, The GABAB receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats, Alcohol Alcohol, 37, 499, 10.1093\u002Falcalc\u002F37.5.499\nColombo, 2004, Role of GABAB receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics, Neurotox Res, 6, 403, 10.1007\u002FBF03033315\nComer, 2002, Intravenous buprenorphine self-administration by detoxified heroin abusers, J Pharmacol Exp Ther, 301, 266, 10.1124\u002Fjpet.301.1.266\nComer, 2002, Depot naltrexone: long-lasting antagonism of the effects of heroin in humans, Psychopharmacology, 159, 351, 10.1007\u002Fs002130100909\nCorbett, 1980, Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study, Brain Res, 185, 1, 10.1016\u002F0006-8993(80)90666-6\nCornish, 2000, Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction, J Neurosci, 20, RC89, 10.1523\u002FJNEUROSCI.20-15-j0006.2000\nCornish, 2001, Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens, J Addict Dis, 20, 43, 10.1300\u002FJ069v20n03_05\nCornish, 1997, Naltrexone pharmacotherapy for opioid dependent federal probationers, J Subst Abuse Treat, 14, 529, 10.1016\u002FS0740-5472(97)00020-2\nCorrigall, 2000, Response of nicotine self-administration in the rat to manipulations of μ-opioid and γ-aminobutyric acid receptors in the ventral tegmental area, Psychopharmacology, 149, 107, 10.1007\u002Fs002139900355\nCorrigall, 2001, GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat, Psychopharmacology, 158, 190, 10.1007\u002Fs002130100869\nCoulombe, 1987, Fitting intracranial self-stimulation data with growth models, Behav Neurosci, 101, 209, 10.1037\u002F0735-7044.101.2.209\nCousins, 2002, GABAB receptor agonists for the treatment of drug addiction: a review of recent findings, Drug Alcohol Depend, 65, 209, 10.1016\u002FS0376-8716(01)00163-6\nCraig, 1985, Measurement of mood and affect in schizophrenic patients, Am J Psychiatry, 142, 1272, 10.1176\u002Fajp.142.11.1272\nDackis, 2001, Cocaine dependence: a disease of the brain's reward centers, J Subst Abuse Treat, 21, 111, 10.1016\u002FS0740-5472(01)00192-1\nDackis, 2003, Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study, Drug Alcohol Depend, 70, 29, 10.1016\u002FS0376-8716(02)00335-6\nDavies, 2000, Analytical considerations for microdialysis sampling, Adv Drug Deliv Rev, 45, 169, 10.1016\u002FS0169-409X(00)00114-9\nDavis, 1974, Naloxone use to eliminate opiate-seeking behavior: need for extinction of conditioned reinforcement, Biological Psychiatry, 9, 181\nde Haan, 2000, Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone, Am J Psychiatry, 157, 1019, 10.1176\u002Fappi.ajp.157.6.1019\nde Haan, 2004, Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications, Can J Psychiatry, 49, 290, 10.1177\u002F070674370404900503\nDelgado, 1970, Telecommunication in brain research, vol. 5, 270\nDelgado, 1972, Dialytrode for long term intracerebral perfusion in awake monkeys, Arch Int Pharmacodyn Ther, 198, 9\nDe Vries, 1999, Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration, Psychopharmacology, 143, 254, 10.1007\u002Fs002130050944\nDewey, 1997, GABAergic attenuation of cocaine-induced dopamine release and locomotor activity, Synapse, 25, 393, 10.1002\u002F(SICI)1098-2396(199704)25:4\u003C393::AID-SYN11>3.0.CO;2-W\nDewey, 1998, A novel strategy for the treatment of cocaine addiction, Synapse, 30, 119, 10.1002\u002F(SICI)1098-2396(199810)30:2\u003C119::AID-SYN1>3.0.CO;2-F\nDewey, 1999, A pharmacologic strategy for the treatment of nicotine addiction, Synapse, 31, 76, 10.1002\u002F(SICI)1098-2396(199901)31:1\u003C76::AID-SYN10>3.0.CO;2-Y\nde Wit, 1981, Reinstatement of cocaine-reinforced responding in the rat, Psychopharmacology, 75, 134, 10.1007\u002FBF00432175\nde Wit, 1977, Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine, Can J Psychol, 31, 195, 10.1037\u002Fh0081662\ndeWit, 1989, Reinforcing and subjective effects of diazepam in non-drug abusing volunteers, Pharmacol Biochem Behav, 33, 205, 10.1016\u002F0091-3057(89)90451-6\nDi Chiara, 1998, A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use, J Psychopharmacol, 12, 54, 10.1177\u002F026988119801200108\nDi Chiara, 1999, Drug addiction as dopamine-dependent associative learning disorder, Eur J Pharmacol, 375, 13, 10.1016\u002FS0014-2999(99)00372-6\nDi Chiara, 1988, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc Natl Acad Sci U S A, 85, 5274, 10.1073\u002Fpnas.85.14.5274\nDi Ciano, 2003, The GABAB receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats, Neuropsychopharmacology, 28, 510, 10.1038\u002Fsj.npp.1300088\nDi Ciano, 2003, Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A, Neuropsychopharmacology, 28, 329, 10.1038\u002Fsj.npp.1300148\nDiaz, 2000, Dopamine D3 receptors expressed by all mesencephalic dopamine neurons, J Neurosci, 20, 8677, 10.1523\u002FJNEUROSCI.20-23-08677.2000\nDixon, 1991, Drug abuse in schizophrenic patients: clinical correlates and reasons for use, Am J Psychiatry, 148, 224, 10.1176\u002Fajp.148.2.224\nDobrovitsky, 2002, CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward, Neuropharmacology, 42, 626, 10.1016\u002FS0028-3908(02)00007-2\nEhrman, 1992, Conditioned tolerance in human opiate addicts, Psychopharmacology (Berl), 108, 218, 10.1007\u002FBF02245311\nEmerich, 1991, Neuroleptic dysphoria, Biol Psychiatry, 29, 201, 10.1016\u002F0006-3223(91)91281-U\nErb, 1996, Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods, Psychopharmacology, 128, 408, 10.1007\u002Fs002130050150\nErb, 1998, The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats, J Neurosci, 18, 5529, 10.1523\u002FJNEUROSCI.18-14-05529.1998\nErb, 2000, Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine-seeking, Neuropsychopharmacology, 23, 138, 10.1016\u002FS0893-133X(99)00158-X\nEsposito, 1987, Brain stimulation reward: measurement and mapping by psychophysical techniques and quantitative 2-[14C]deoxyglucose autoradiography, 421\nEttenberg, 1982, Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems, Psychopharmacologia, 78, 204, 10.1007\u002FBF00428151\nEveritt, 2001, Second order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking basis behaviour, Psychopharmacology, 153, 17, 10.1007\u002Fs002130000566\nEveritt, 2001, The neuropsychological basis of addictive behaviour, Brain Res Rev, 36, 129, 10.1016\u002FS0165-0173(01)00088-1\nFadda, 2003, Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat, Synapse, 50, 1, 10.1002\u002Fsyn.10238\nFattore, 2002, Baclofen antagonizes intravenous self-administration of nicotine in mice and rats, Alcohol Alcohol, 37, 495, 10.1093\u002Falcalc\u002F37.5.495\nFischman, 1982, Cocaine self-administration in humans, Fed Proc, 41, 241\nFischman, 1988, Human drug taking under controlled laboratory conditions, NIDA Res Monogr, 84, 196\nFlannery, 2004, Baclofen for alcohol dependence: a preliminary open-label study, Alcohol Clin Exp Res, 28, 1517, 10.1097\u002F01.ALC.0000141640.48924.14\nFoltin, 1992, Self-administration of cocaine by humans: choice between smoked and intravenous cocaine, J Pharmacol Exp Ther, 261, 841\nFrench, 1995, A comparison of the reinforcing efficacy of PCP, the PCP derivatives TCP and BTCP, and cocaine using a progressive ratio schedule in the rat, Behav Pharmacol, 6, 223, 10.1097\u002F00008877-199504000-00002\nGaddum, 1961, Push–pull cannulae, J Physiol, 155, P1\nGaddum, 1962, Substances released in nervous activity, 1\nGál, 2003, Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats, Brain Res Bull, 61, 595, 10.1016\u002FS0361-9230(03)00217-X\nGallistel, 1981, A portrait of the brain for self-stimulation, Psychol Rev, 88, 228, 10.1037\u002F0033-295X.88.3.228\nGarbutt, 2005, Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial, JAMA, 293, 1617, 10.1001\u002Fjama.293.13.1617\nGardner, 1971, An improved technique for determining brain reward thresholds in primates, Behav Res Meth Instrum, 3, 273, 10.3758\u002FBF03208404\nGardner, 2000, What we have learned about addiction from animal models of drug self-administration, Am J Addict, 9, 285, 10.1080\u002F105504900750047355\nGardner, 2002, Addictive potential of cannabinoids: the underlying neurobiology, Chem Phys Lipids, 121, 267, 10.1016\u002FS0009-3084(02)00162-7\nGardner, 2005, Brain-reward mechanisms, 48\nGardner, 1993, Overview of chemical sampling techniques, J Neurosci Methods, 48, 173, 10.1016\u002F0165-0270(93)90091-5\nGardner, 2002, Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats, Synapse, 46, 240, 10.1002\u002Fsyn.10138\nGeeraedts, 1990, Medial forebrain bundle of the rat: III. Cytoarchitecture of the rostral (telencephalic) part of the medial forebrain bundle bed nucleus, J Comp Neurol, 294, 507, 10.1002\u002Fcne.902940403\nGerasimov, 1999, Gamma-vinyl γ-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine\u002Fheroin (speedball) challenge, Eur J Pharmacol, 380, 1, 10.1016\u002FS0014-2999(99)00526-9\nGerasimov, 1999, Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine, Synapse, 34, 11, 10.1002\u002F(SICI)1098-2396(199910)34:1\u003C11::AID-SYN2>3.0.CO;2-5\nGerasimov, 2000, γ-Aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine, Eur J Pharmacol, 395, 129, 10.1016\u002FS0014-2999(00)00267-3\nGerasimov, 2001, GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine, Eur J Pharmacol, 414, 205, 10.1016\u002FS0014-2999(01)00800-7\nGerber, 1975, Drug-induced reinstatement of extinguished self-administration behavior in monkeys, Pharmacol Biochem Behav, 3, 1055, 10.1016\u002F0091-3057(75)90016-7\nGerfen, 1992, The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci, 15, 133, 10.1016\u002F0166-2236(92)90355-C\nGervin, 1999, Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology, Eur Psychiatry, 14, 405, 10.1016\u002FS0924-9338(99)00228-X\nGilbert, 2003, The dopamine D3 receptor antagonist SB277011A inhibits cocaine reinforcement under fixed ratio and progressive ratio schedules\nGilbert, 2005, Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors, Synapse, 57, 17, 10.1002\u002Fsyn.20152\nGlick, 1975, Changes in morphine self-administration and morphine dependence after lesions of the caudate nucleus in rats, Psychopharmacologia, 41, 219, 10.1007\u002FBF00428927\nGoeders, 1983, Cortical dopaminergic involvement in cocaine reinforcement, Science, 221, 773, 10.1126\u002Fscience.6879176\nGoeders, 1986, Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals, Pharmacol Biochem Behav, 25, 191, 10.1016\u002F0091-3057(86)90252-2\nGoeders, 1993, Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens, J Pharmacol Exp Ther, 265, 592\nGoeders, 1984, Self-administration of methionine enkephalin into the nucleus accumbens, Pharmacol Biochem Behav, 20, 451, 10.1016\u002F0091-3057(84)90284-3\nGoeders, 1986, Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex, Pharmacol Biochem Behav, 24, 1429, 10.1016\u002F0091-3057(86)90206-6\nGoldberg, 1973, Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey, J Pharmacol Exp Ther, 186, 18\nGoldberg, 1970, Conditioned morphine-induced abstinence changes: persistence in post morphine-dependent monkeys, J Exp Anal Behav, 14, 33, 10.1901\u002Fjeab.1970.14-33\nGoldberg, 1977, Behavior maintained under second-order schedules of intravenous morphine injection in squirrel and rhesus monkeys, Psychopharmacology, 51, 235, 10.1007\u002FBF00431630\nGoldberg, 1971, Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys, J Pharmacol Exp Ther, 179, 268\nGorelick, 2004, Agents in development for the management of cocaine abuse, Drugs, 64, 1547, 10.2165\u002F00003495-200464140-00004\nGracy, 2001, Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion, Neuropsychopharmacology, 24, 152, 10.1016\u002FS0893-133X(00)00186-X\nGraf Schimmelmann, 2004, Die initial dysphorische reaktion (IDR) auf die ersteinnahme von neuroleptika, Nervenarzt, 75, 36, 10.1007\u002Fs00115-003-1544-z\nGrant, 1996, Activation of memory circuits during cue-elicited cocaine craving, Proc Natl Acad of Sci U S A, 93, 12040, 10.1073\u002Fpnas.93.21.12040\nGraybiel, 1990, Neurotransmitters and neuromodulators in the basal ganglia, Trends Neurosci, 13, 244, 10.1016\u002F0166-2236(90)90104-I\nGriffiths, 1978, Experimental drug self-administration: generality across species and type of drug, NIDA Res Monogr, 20, 24\nGriffiths, 1979, Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo, J Pharmacol Exp Ther, 210, 301\nGriffiths, 1979, Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens, Adv Behav Pharmacol, 2, 163, 10.1016\u002FB978-0-12-004702-4.50010-2\nGrimm, 2000, Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of ability of relapse, Neuropsychopharmacology, 22, 473, 10.1016\u002FS0893-133X(99)00157-8\nGrundt, 2004, Novel dopamine D3 receptor ligands as tools for in vivo evaluation\nGutstein, 2001, Opioid analgesics, 569\nHaertzen, 1987, Addiction Research Center Inventory (ARCI): measurement of euphoria and other drug effects, 489\nHart, 2002, Effects of oral THC maintenance on smoked marijuana self-administration, Drug Alcohol Depend, 67, 301, 10.1016\u002FS0376-8716(02)00084-4\nHayes, 2004, The basolateral complex of the amygdala mediates the modulation of intracranial self-stimulation threshold by drug-associated cues, Eur J Neurosci, 20, 273, 10.1111\u002Fj.1460-9568.2004.03463.x\nHayes, 2003, Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat, Psychopharmacology, 168, 75, 10.1007\u002Fs00213-002-1328-3\nHeath, 1964, Pleasure response of human beings to direct stimulation of the brain: physiologic and psychodynamic considerations, 219\nHeidbreder, 2005, The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence, Brain Res Brain Res Rev, 49, 77, 10.1016\u002Fj.brainresrev.2004.12.033\nHeimer, 1991, Specificity of the projection patterns of accumbal core and shell in the rat, Neuroscience, 41, 89, 10.1016\u002F0306-4522(91)90202-Y\nHeit, 2003, Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients, J Pain Palliat Care Pharmacother, 17, 15, 10.1080\u002FJ354v17n01_03\nHenriksen, 1992, Properties of neurons recorded in the rodent nucleus accumbens, in vivo: relationship to behavioral state and heroin self-administration, Soc Neurosci Abstr, 18, 373\nHiroi, 1991, The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference, J Neurosci, 11, 2107, 10.1523\u002FJNEUROSCI.11-07-02107.1991\nHodos, 1961, Progressive ratio as a measure of reward strength, Science, 134, 943, 10.1126\u002Fscience.134.3483.943\nHoebel, 1969, Feeding and self-stimulation, Ann N Y Acad Sci, 157, 758, 10.1111\u002Fj.1749-6632.1969.tb12919.x\nHoebel, 1962, Hypothalamic control of feeding and self-stimulation, Science, 135, 375, 10.1126\u002Fscience.135.3501.375\nHoffmeister, 1975, Psychotropic drugs as negative reinforcers, Pharmacol Rev, 27, 419\nHoltzman, 2003, Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence, J Pharmacol Exp Ther, 304, 1033, 10.1124\u002Fjpet.102.044875\nHooks, 1994, Behavioral and neurochemical sensitization following cocaine self-administration, Psychopharmacology, 115, 265, 10.1007\u002FBF02244782\nHows, 2004, High-performance liquid chromatography\u002Ftandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples, J Neurosci Methods, 138, 123, 10.1016\u002Fj.jneumeth.2004.03.021\nHyman, 2001, Addiction and the brain: the neurobiology of compulsion and its persistence, Nat Rev Neurosci, 2, 695, 10.1038\u002F35094560\nIkemoto, 2003, Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies, J Neurosci, 23, 9305, 10.1523\u002FJNEUROSCI.23-28-09305.2003\nIkemoto, 1999, The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking, Brain Res Rev, 31, 6, 10.1016\u002FS0165-0173(99)00023-5\nIkemoto, 2004, Mapping of chemical trigger zones for reward, Neuropharmacology, 47, 190, 10.1016\u002Fj.neuropharm.2004.07.012\nIkemoto, 1997, Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward, J Neurosci, 17, 8580, 10.1523\u002FJNEUROSCI.17-21-08580.1997\nJanak, 2003, Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose, Alcohol, 30, 1, 10.1016\u002FS0741-8329(03)00068-5\nJarema, 2001, Subiektywna i obiektywna ocena schizofrenii lekami klasycznymi i atypowymi, Psychiatr Pol, 35, 5\nJarema, 2004, Porównanie subiektywnej i obiektywnej oceny leczenia olanzapin chorych na schizofreni, Psychiatr Pol, 38, 895\nJasinski, 2000, Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy, Clin Neuropharmacol, 23, 149, 10.1097\u002F00002826-200005000-00004\nJohnson, 2004, Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study, Alcohol Clin Exp Res, 28, 1137, 10.1097\u002F01.ALC.0000134533.96915.08\nJohnson, 1993, Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist, Neuropharmacology, 32, 1305, 10.1016\u002F0028-3908(93)90025-X\nJohnson, 1993, Neuroleptic dysphopria: in search of an animal model, Int J Neurosci, 70, 271, 10.3109\u002F00207459309000581\nJohnson, 1995, Reward shifts and motor responses following microinjections of opiate-specific agonists into either the core or shell of the nucleus accumbens, Psychopharmacology, 120, 195, 10.1007\u002FBF02246193\nJoseph, 2003, The interpretation of the measurement of nucleus accumbens dopamine by in vivo dialysis: the kick, the craving or the cognition?, Neurosci Biobehav Rev, 27, 527, 10.1016\u002Fj.neubiorev.2003.09.001\nJung, 1977, γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective inhibitor of GABA-T: effects on brain GABA metabolism in mice, J Neurochem, 29, 797, 10.1111\u002Fj.1471-4159.1977.tb10721.x\nKalivas, 2003, Brain circuitry and the reinstatement of cocaine-seeking behavior, Psychopharmacology, 168, 44, 10.1007\u002Fs00213-003-1393-2\nKalivas, 1990, Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists, J Pharmacol Exp Ther, 253, 858\nKalivas, 1993, GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area, Neuroscience, 57, 1047, 10.1016\u002F0306-4522(93)90048-K\nKampman, 2004, A pilot trial of topiramate for the treatment of cocaine dependence, Drug Alcohol Depend, 75, 233, 10.1016\u002Fj.drugalcdep.2004.03.008\nKandel, 1977, An investigation of nalorphine and perphenazine as negative reinforcers in an escape paradigm, Pharmacol Biochem Behav, 6, 61, 10.1016\u002F0091-3057(77)90160-5\nKatner, 1999, Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens, Alcohol Clin Exp Res, 23, 1751, 10.1111\u002Fj.1530-0277.1999.tb04070.x\nKatner, 1999, Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat, Neuropsychopharmacology, 20, 471, 10.1016\u002FS0893-133X(98)00084-0\nKawaguchi, 1995, Striatal interneurones: chemical physiological and morphological characterization, Trends Neurosci, 18, 527, 10.1016\u002F0166-2236(95)98374-8\nKillam, 1957, Further studies on the effects of centrally acting drugs on self-stimulation, J Pharmacol Exp Ther, 119, 157\nKing, 1995, Antipsychotic drug-induced dysphoria, Br J Psychiatry, 167, 480, 10.1192\u002Fbjp.167.4.480\nKissinger, 1990, Optimization of LC apparatus for determinations in neurochemistry with an emphasis on microdialysis samples, J Neurosci Methods, 34, 3, 10.1016\u002F0165-0270(90)90035-E\nKissinger, 1973, Voltammetry in brain tissue: a new neurophysiological measurement, Brain Res, 55, 209, 10.1016\u002F0006-8993(73)90503-9\nKiyatkin, 1999, Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats, Brain Res, 822, 88, 10.1016\u002FS0006-8993(99)01093-8\nKlitenick, 1992, Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study, J Neurosci, 12, 2623, 10.1523\u002FJNEUROSCI.12-07-02623.1992\nKoob, 1992, Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol Sci, 13, 177, 10.1016\u002F0165-6147(92)90060-J\nKoob, 2000, Neurobiology of addiction. Toward the development of new therapies, Ann N Y Acad Sci, 909, 170, 10.1111\u002Fj.1749-6632.2000.tb06682.x\nKoob, 1987, Positive reinforcement properties of drugs: search for neural substrates, 35\nKornetsky, 1985, Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria, NIDA Res Monogr, 62, 30\nKornetsky, 1979, Euphorigenic drugs: effects on the reward pathways of the brain, Fed Proc, 38, 2473\nKornetsky, 1991, The role the olfactory tubercle in the effects of cocaine, morphine, and brain-stimulation reward, Brain Res, 541, 75, 10.1016\u002F0006-8993(91)91076-D\nKushner, 1997, Gamma-vinyl-GABA attenuates cocaine-induced lowering of brain-stimulation reward thresholds, Psychopharmacology, 133, 383, 10.1007\u002Fs002130050418\nKushner, 1999, The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats, J Pharmacol Exp Ther, 290, 797\nLamb, 1991, The reinforcing and subjective effects of morphine in post-addicts: a dose–response study, J Pharmacol Exp Ther, 259, 1165\nLambert, 2003, Subjective well-being and initial dysphoric reaction under antipsychotic drugs—concepts, measurement and clinical relevance, Pharmacopsychiatry, 36, S181\nLeDoux, 1993, Emotional memory systems in the brain, Behav Brain Res, 58, 69, 10.1016\u002F0166-4328(93)90091-4\nLeDoux, 1997, How the brain processes emotional information, Ann N Y Acad Sci, 821, 259, 10.1111\u002Fj.1749-6632.1997.tb48285.x\nLeDoux, 2000, Emotional circuits in the brain, Annu Rev Neurosci, 23, 155, 10.1146\u002Fannurev.neuro.23.1.155\nLee, 1999, Cellular responses of nucleus accumbens neurons to opiate-seeking behavior: I. Sustained responding during heroin self-administration, Synapse, 33, 49, 10.1002\u002F(SICI)1098-2396(199907)33:1\u003C49::AID-SYN5>3.0.CO;2-O\nLee, 2004, Gamma-vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP), Synapse, 54, 183, 10.1002\u002Fsyn.20072\nLe Foll, 2002, Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice, Eur J Neurosci, 15, 2016, 10.1046\u002Fj.1460-9568.2002.02049.x\nLeite-Morris, 2004, GABAB receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization, J Pharmacol Exp Ther, 308, 667, 10.1124\u002Fjpet.103.058412\nLepore, 1992, Modelling drug kinetics with brain stimulation: dopamine antagonists increase self-stimulation, Pharmacol Biochem Behav, 41, 489, 10.1016\u002F0091-3057(92)90362-J\nLepore, 1996, Genetic differences in Δ9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate–frequency curve-shift electrical brain stimulation paradigm in three different rat strains, Life Sci [Pharmacol Lett], 58, PL365, 10.1016\u002F0024-3205(96)00237-8\nLevant, 1998, Differential distribution of D3 dopamine receptors in the brains of several mammalian species, Brain Res, 800, 269, 10.1016\u002FS0006-8993(98)00529-0\nLévesque, 1992, Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc Natl Acad Sci U S A, 89, 8155, 10.1073\u002Fpnas.89.17.8155\nLi, 2001, GABAB receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats, Life Sci, 70, 349, 10.1016\u002FS0024-3205(01)01397-2\nLile, 2004, Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans, Psychopharmacology, 171, 441, 10.1007\u002Fs00213-003-1598-4\nLin, 1996, Neonatal exposure to cocaine enhances the reward-potentiating properties of the drug in young adult animals, Behav Neurosci, 110, 791, 10.1037\u002F0735-7044.110.4.791\nLing, 1998, Baclofen as a cocaine anti-craving medication: a preliminary clinical study, Neuropsychopharmacology, 18, 403\nLu, 2000, Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats, NeuroReport, 11, 2373, 10.1097\u002F00001756-200008030-00008\nLyness, 1979, Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration, Pharmacol Biochem Behav, 11, 553, 10.1016\u002F0091-3057(79)90040-6\nMaidment, 1989, Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo, Neuroscience, 33, 549, 10.1016\u002F0306-4522(89)90407-7\nMaldonado, 2004, GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice, Psychopharmacology (Berl), 177, 130, 10.1007\u002Fs00213-004-1927-2\nMaldonado-Irizarry, 1996, Blockade of D-1 and D-2 dopamine receptors attenuates ‘relapse’ elicited by cocaine-associated environmental stimuli following prolonged extinction, Soc Neurosci Abstr, 22, 925\nManeuf, 1994, On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus, Exp Neurol, 125, 65, 10.1006\u002Fexnr.1994.1007\nMarcon, 2003, A new model to assess drug and cue-induced relapse to ethanol self-administration in mice, Behav Pharmacol, 14, S66\nMargules, 1962, Identical ‘feeding’ and ‘rewarding’ systems in the lateral hypothalamus of rats, Science, 135, 374, 10.1126\u002Fscience.135.3501.374\nMarkou, 1993, Animal models of drug craving, Psychopharmacology, 112, 163, 10.1007\u002FBF02244907\nMarkou, 2004, Role of γ-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation, Ann N Y Acad Sci, 1025, 491, 10.1196\u002Fannals.1316.061\nMartin, 2000, Effects of reward anticipation, reward presentation, and spatial parameters on the firing of single neurons recorded in the subiculum and nucleus accumbens of freely moving rats, Behav Brain Res, 116, 23, 10.1016\u002FS0166-4328(00)00249-7\nMattson, 1995, Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy, Acta Neurol Scand Suppl, 162, 27\nMcFarland, 1997, Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli, Psychopharmacology, 131, 86, 10.1007\u002Fs002130050269\nMcFarland, 2000, The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior, J Neurosci, 21, 8655, 10.1523\u002FJNEUROSCI.21-21-08655.2001\nMeil, 1996, Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse, Behav Pharmacol, 7, 754\nMeil, 1997, Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine, Behav Brain Res, 87, 139, 10.1016\u002FS0166-4328(96)02270-X\nMello, 1965, Operant drinking of alcohol on a rate-contingent ratio schedule of reinforcement, J Psychiatr Res, 3, 145, 10.1016\u002F0022-3956(65)90024-5\nMeredith, 1999, The synaptic framework for chemical signalling in nucleus accumbens, Ann N Y Acad Sci, 877, 140, 10.1111\u002Fj.1749-6632.1999.tb09266.x\nMeyer, 1979\nMiliaressis, 1986, The curve-shift paradigm in self-stimulation, Physiol Behav, 37, 85, 10.1016\u002F0031-9384(86)90388-4\nMogenson, 1980, From motivation to action: functional interface between the limbic system and the motor system, Prog Neurobiol, 14, 69, 10.1016\u002F0301-0082(80)90018-0\nMoore, 1979, Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems, Annu Rev Neurosci, 2, 113, 10.1146\u002Fannurev.ne.02.030179.000553\nMorgan, 1998, Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine, Synapse, 28, 60, 10.1002\u002F(SICI)1098-2396(199801)28:1\u003C60::AID-SYN7>3.0.CO;2-A\nMorgan, 2004, Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration, Neurosci Biobehav Rev, 27, 803, 10.1016\u002Fj.neubiorev.2003.11.004\nMueller, 2000, Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction, Behav Brain Res, 115, 39, 10.1016\u002FS0166-4328(00)00239-4\nMueller, 2002, Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference, Behav Brain Res, 136, 389, 10.1016\u002FS0166-4328(02)00297-8\nMuller, 1997, Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli, Behav Neurosci, 111, 683, 10.1037\u002F0735-7044.111.4.683\nMurray, 1996, Physiological measures of conduction velocity and refractory period for putative reward-relevant MFB axons arising in the rostral MFB, Physiol Behav, 59, 427, 10.1016\u002F0031-9384(95)02077-2\nMurray, 1996, Behavioral measures of conduction velocity and refractory period for reward-relevant axons in the anterior LH and VTA, Physiol Behav, 59, 643, 10.1016\u002F0031-9384(96)80249-6\nMurray, 1996, Attenuation of medial forebrain bundle reward by anterior lateral-hypothalamic lesions, Behav Brain Res, 75, 33, 10.1016\u002F0166-4328(96)00155-6\nNader, 1999, Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations, Behav Neurosci, 113, 891, 10.1037\u002F0735-7044.113.5.891\nNakajima, 1989, Subtypes of dopamine receptors involved in the mechanism of reinforcement, Neurosci Biobehav Rev, 13, 123, 10.1016\u002FS0149-7634(89)80020-X\nNakajima, 1993, Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation, Behav Neurosci, 107, 161, 10.1037\u002F0735-7044.107.1.161\nNazzaro, 1980, GABA antagonism lowers self-stimulation thresholds in the ventral tegmental area, Brain Res, 189, 279, 10.1016\u002F0006-8993(80)90029-3\nNazzaro, 1980, Naloxone blocks phencyclidine's dose-dependent effects on direct brain reward thresholds, 949\nNeisewander, 2004, Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior, Neuropsychopharmacology, 29, 1479, 10.1038\u002Fsj.npp.1300456\nNestler, 2004, Molecular mechanisms of drug addiction, Neuropharmacology, 47, 24, 10.1016\u002Fj.neuropharm.2004.06.031\nNewman, 2003, N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists, Bioorg Med Chem Lett, 13, 2179, 10.1016\u002FS0960-894X(03)00389-5\nO'Brien, 1975, Experimental analysis of conditioning factors in human narcotic addiction, Pharmacol Rev, 27, 535\nO'Brien, 1997, A range of research-based pharmacotherapies for addiction, Science, 278, 66, 10.1126\u002Fscience.278.5335.66\nO'Brien, 2001, Drug addiction and drug abuse, 621\nO'Brien, 2005, Anticraving medications for relapse prevention: a possible new class of psychoactive medications, Am J Psychiatry, 162, 1423, 10.1176\u002Fappi.ajp.162.8.1423\nO'Brien, 1975, Clinical experience with naltrexone, Am J Drug Alcohol Abuse, 2, 365, 10.3109\u002F00952997509005662\nO'Brien, 1977, Conditioned narcotic withdrawal in humans, Science, 195, 1000, 10.1126\u002Fscience.841320\nO'Brien, 1979, Unreinforced self-injections: effects on rituals and outcome in heroin addicts, NIDA Res Monogr, 27, 275\nO'Brien, 1984, Use of naltrexone to extinguish opioid-conditioned responses, J Clin Psychiatry, 45, 53\nO'Brien, 1986, Classical conditioning in human opioid dependence, 329\nOlds, 1959, Self-stimulation experiments and differentiated reward systems, 671\nOlds, 1979, Hypothalamic substrate for the positive reinforcing properties of morphine in the rat, Brain Res, 168, 351, 10.1016\u002F0006-8993(79)90175-6\nOlds, 1982, Reinforcing effects of morphine in the nucleus accumbens, Brain Res, 237, 429, 10.1016\u002F0006-8993(82)90454-1\nOlds, 1954, Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain, J Comp Physiol Psychol, 47, 419, 10.1037\u002Fh0058775\nOlds, 1963, Approach–avoidance analysis of rat diencephalon, J Comp Neurol, 120, 259, 10.1002\u002Fcne.901200206\nOlds, 1965, Drives, rewards and the brain, 329\nOlds, 1980, Self-administration of d-ala2-met-enkephalinamide at hypothalamic self stimulation sites, Brain Res, 194, 155, 10.1016\u002F0006-8993(80)91325-6\nO'Malley, 1992, Naltrexone and coping skills therapy for alcohol dependence: a controlled study, Arch Gen Psychiatry, 49, 881, 10.1001\u002Farchpsyc.1992.01820110045007\nPanagis, 2002, The effects of ventral tegmental administration of GABAA, GABAB, NMDA and AMPA receptor agonists on ventral pallidum self-stimulation, Behav Brain Res, 131, 115, 10.1016\u002FS0166-4328(01)00353-9\nPanagis, 1998, Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum, Psychopharmacology, 139, 222, 10.1007\u002Fs002130050708\nPappagallo, 1998, The concept of pseudotolerance, J Pharm Care Pain Symptom Control, 6, 95, 10.1300\u002FJ088v06n02_07\nPark, 2002, Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens, J Neurosci, 22, 2916, 10.1523\u002FJNEUROSCI.22-07-02916.2002\nParrot, 2003, Microdialysis monitoring of catecholamines and excitatory amino acids in the rat and mouse brain: recent developments based on capillary electrophoresis with laser-induced fluorescence detection—a mini-review, Cell Mol Neurobiol, 23, 793, 10.1023\u002FA:1025009221285\nParsons, 1996, Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement, J Neurochem, 67, 1078, 10.1046\u002Fj.1471-4159.1996.67031078.x\nPaterson, 2004, The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat, Psychopharmacology, 172, 179, 10.1007\u002Fs00213-003-1637-1\nPaterson, 2005, Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats, Neuropsychopharmacology, 30, 119, 10.1038\u002Fsj.npp.1300524\nPaul, 2001, Gamma-vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats, Synapse, 41, 219, 10.1002\u002Fsyn.1078\nPeng, 2004, Gamma-vinyl GABA, but not gabapentin, inhibits cocaine-triggered reinstatement of drug-seeking behavior in the rat\nPeoples, 2003, Differential changes in signal and background firing of accumbal neurons during cocaine self-administration, J Neurophysiol, 90, 993, 10.1152\u002Fjn.00849.2002\nPeoples, 1996, Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration, J Neurosci, 16, 3459, 10.1523\u002FJNEUROSCI.16-10-03459.1996\nPeoples, 1997, Operant behavior during sessions of intravenous cocaine infusion is necessary and sufficient for phasic firing of single nucleus accumbens neurons, Brain Res, 757, 280, 10.1016\u002FS0006-8993(97)00299-0\nPeoples, 1998, Tonic inhibition of single nucleus accumbens neurons in the rat: a predominant but not exclusive firing pattern induced by cocaine self-administration sessions, Neuroscience, 86, 13, 10.1016\u002FS0306-4522(98)00116-X\nPeoples, 1998, Phasic firing time locked to cocaine self-infusion and locomotion: dissociable firing patterns of single nucleus accumbens neurons in the rat, J Neurosci, 18, 7588, 10.1523\u002FJNEUROSCI.18-18-07588.1998\nPeoples, 1999, Phasic accumbal firing may contribute to the regulation of drug taking during intravenous cocaine self-administration sessions, Ann N Y Acad Sci, 877, 781, 10.1111\u002Fj.1749-6632.1999.tb09322.x\nPettit, 1989, Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis, Pharmacol Biochem Behav, 34, 899, 10.1016\u002F0091-3057(89)90291-8\nPettit, 1991, Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens, Brain Res, 539, 94, 10.1016\u002F0006-8993(91)90690-W\nPhillips, 1983, Strategies for studying the neurochemical substrates of drug reinforcement in rodents, Prog Neuropsychopharmacol Biol Psychiatry, 7, 585, 10.1016\u002F0278-5846(83)90029-5\nPhillips, 1992, Self-stimulation of the ventral tegmental area enhances dopamine release in the nucleus accumbens: a microdialysis study, Ann N Y Acad Sci, 654, 199, 10.1111\u002Fj.1749-6632.1992.tb25968.x\nPilla, 1999, Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist, Nature, 400, 371, 10.1038\u002F22560\nPost, 1976, Increasing effects of repetitive cocaine administration in the rat, Nature, 260, 731, 10.1038\u002F260731a0\nProsser, 1987, Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics, J Nerv Ment Dis, 175, 100, 10.1097\u002F00005053-198702000-00006\nRada, 1998, Dopamine release in the nucleus accumbens by hypothalamic stimulation-escape behavior, Brain Res, 782, 228, 10.1016\u002FS0006-8993(97)01283-3\nRamaekers, 1999, Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic, J Clin Psychopharmacol, 19, 209, 10.1097\u002F00004714-199906000-00003\nRanaldi, 2002, Baclofen decreases methamphetamine self-administration in rats, NeuroReport, 13, 1107, 10.1097\u002F00001756-200207020-00007\nRanaldi, 1994, Automating the generation and collection of rate–frequency functions in a curve-shift brain stimulation reward paradigm, J Neurosci Methods, 53, 163, 10.1016\u002F0165-0270(94)90174-0\nReavill, 2000, Pharmacological actions of a novel, high-affinity, and selective human dopamine D3 receptor antagonist, SB-277011-A, J Pharmacol Exp Ther, 294, 1154\nRichardson, 1996, Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy, J Neurosci Methods, 66, 1, 10.1016\u002F0165-0270(95)00153-0\nRivera, 2003, A novel dopamine D3 receptor antagonist (SB-277011-A) attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats\nRobarge, 2001, Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype, J Med Chem, 44, 3175, 10.1021\u002Fjm010146o\nRobbins, 2002, Limbic-striatal memory systems and drug addiction, Neurobiol Learn Mem, 78, 625, 10.1006\u002Fnlme.2002.4103\nRoberts, 1989, Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens, Pharmacol Biochem Behav, 32, 43, 10.1016\u002F0091-3057(89)90208-6\nRoberts, 1997, Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure, Psychopharmacology, 131, 271, 10.1007\u002Fs002130050293\nRoberts, 1993, Heroin self-administration in rats under a progressive ratio schedule of reinforcement, Psychopharmacology, 111, 215, 10.1007\u002FBF02245526\nRoberts, 2000, GABA modulation of cocaine self-administration, Ann N Y Acad Sci, 909, 155\nRoberts, 1982, Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area, Pharmacol Biochem Behav, 17, 901, 10.1016\u002F0091-3057(82)90469-5\nRoberts, 1987, Interpretation of lesion effects on stimulant self-administration, 87\nRoberts, 1977, On the role of ascending catecholamine systems in self-administration of cocaine, Pharmacol Biochem Behav, 6, 615, 10.1016\u002F0091-3057(77)90084-3\nRoberts, 1980, Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens, Pharmacol Biochem Behav, 12, 781, 10.1016\u002F0091-3057(80)90166-5\nRoberts, 1996, Baclofen attenuates the reinforcing effects of cocaine, Neuropsychopharmacology, 15, 417, 10.1016\u002F0893-133X(96)00002-4\nRoberts, 1996, Baclofen attenuates the reinforcing effects of cocaine in rats, Neuropsychopharmacology, 15, 417, 10.1016\u002F0893-133X(96)00002-4\nRobinson, 2003, Addiction, Annu Rev Psychol, 54, 25, 10.1146\u002Fannurev.psych.54.101601.145237\nRobinson, 2003, Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo, Clin Chem, 49, 1763, 10.1373\u002F49.10.1763\nRobledo, 1993, Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat, Behav Brain Res, 55, 159, 10.1016\u002F0166-4328(93)90112-4\nRomach, 1999, Attenuation of the euphoric effects of cocaine by the dopamine D1\u002FD5 antagonist ecopipam (SCH39166), Arch Gen Psychiatry, 56, 1101, 10.1001\u002Farchpsyc.56.12.1101\nRouttenberg, 1965, Effects of the availability of rewarding septal and hypothalamic stimulation on bar-pressing for food under conditions of deprivation, J Comp Physiol Psychol, 60, 158, 10.1037\u002Fh0022365\nRouttenberg, 1972, Self-stimulation in the frontal cortex of Rattus norvegicus, Behav Biol, 7, 567, 10.1016\u002FS0091-6773(72)80218-9\nRowlett, 2000, A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives, Psychopharmacology, 153, 1, 10.1007\u002Fs002130000610\nSachs, 1975, Mechanisms of action of 6-hydroxydopamine, Biochem Pharmacol, 24, 1, 10.1016\u002F0006-2952(75)90304-4\nSaigusa, 1999, High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty induced changes in behavior and release of accumbal dopamine, Neuroscience, 88, 1153, 10.1016\u002FS0306-4522(98)00275-9\nSanchez, 2001, Conditioned fear stimuli reinstate cocaine-induced conditioned place preference, Brain Res, 908, 86, 10.1016\u002FS0006-8993(01)02638-5\nSaul'skaya, 1990, The role of the hippocampal formation in controlling GABA release in the nucleus accumbens during an emotional conditioned response, Neurosci Behav Physiol, 29, 461, 10.1007\u002FBF02461086\nSchiefer, 2001, Evaluation of extensive visual field defects with computer-assisted kinetic perimetry, Klin Monatsbl Augenheilkd, 218, 13, 10.1055\u002Fs-2001-11255\nSchiffer, 2000, Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET\u002Fmicrodialysis study, Life Sci [Pharmacol Lett], 66, PL169, 10.1016\u002FS0024-3205(00)00432-X\nSchiffer, 2003, Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine, Psychopharmacology, 168, 339, 10.1007\u002Fs00213-003-1446-6\nSeeger, 1981, Amphetamine and morphine: additive effects on ICSS threshold, Soc Neurosci Abstr, 7, 974\nSeeger, 1979, Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity, Brain Res, 175, 49, 10.1016\u002F0006-8993(79)90513-4\nSelf, 1998, Neural substrates of drug craving and relapse in drug addiction, Ann Med, 30, 379, 10.3109\u002F07853899809029938\nSelf, 1995, Molecular mechanisms of drug reinforcement and addiction, Annu Rev Neurosci, 18, 463, 10.1146\u002Fannurev.ne.18.030195.002335\nSelf, 1998, Relapse to drug-seeking: neural and molecular mechanisms, Drug Alcohol Depend, 51, 49, 10.1016\u002FS0376-8716(98)00065-9\nSelf, 1996, Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists, Science, 271, 1586, 10.1126\u002Fscience.271.5255.1586\nSenoh, 1959, Chemical, enzymatic, and metabolic studies on the mechanism of oxidation of dopamine, J Am Chem Soc, 81, 6236, 10.1021\u002Fja01532a030\nSesack, 1992, Prefrontal cortical efferents in the rat synapse on unlabelled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area, J Comp Neurol, 320, 145, 10.1002\u002Fcne.903200202\nSesack, 1995, Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area, Brain Res, 672, 261, 10.1016\u002F0006-8993(94)01391-T\nShaham, 1993, Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on ‘relapse’ to opioid drugs, Psychopharmacology, 111, 477, 10.1007\u002FBF02253539\nShaham, 1995, Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal, Psychopharmacology, 119, 334, 10.1007\u002FBF02246300\nShaham, 1996, Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats, Psychopharmacology, 125, 385, 10.1007\u002FBF02246022\nShaham, 1996, Relapse to heroin-seeking under opioid maintenance: the effects of stress, heroin-priming, and withdrawal, J Neurosci, 16, 1957, 10.1523\u002FJNEUROSCI.16-05-01957.1996\nShaham, 1997, Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats, J Neurosci, 17, 2605, 10.1523\u002FJNEUROSCI.17-07-02605.1997\nShaham, 1998, CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug-seeking in cocaine- and heroin-trained rats, Psychopharmacology, 137, 184, 10.1007\u002Fs002130050608\nShaham, 2000, Stress-induced relapse to heroin and cocaine seeking in rats: a review, Brain Res Rev, 33, 13, 10.1016\u002FS0165-0173(00)00024-2\nShaham, 2000, Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons, Eur J Neurosci, 12, 292, 10.1046\u002Fj.1460-9568.2000.00899.x\nShaham, 2003, The reinstatement model of drug relapse: history, methodology and major findings, Psychopharmacology, 168, 3, 10.1007\u002Fs00213-002-1224-x\nShalev, 2000, Stress and relapse to drug seeking in rats: studies on the generality of the effect, Psychopharmacology, 150, 337, 10.1007\u002Fs002130000441\nShalev, 2002, Neurobiology of relapse to heroin and cocaine seeking: a review, Pharmacol Rev, 54, 1, 10.1124\u002Fpr.54.1.1\nShalev, 2003, The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat, Psychopharmacology, 168, 170, 10.1007\u002Fs00213-002-1200-5\nShiffman, 1982, Relapse following smoking cessation: a situational analysis, J Consult Clin Psychol, 50, 71, 10.1037\u002F0022-006X.50.1.71\nShiffman, 1996, First lapses to smoking: within-subjects analysis of real-time reports, J Consult Clin Psychol, 64, 366, 10.1037\u002F0022-006X.64.2.366\nShizgal, 1980, Behavioral methods for inferring anatomical linkage between rewarding brain stimulation sites, J Comp Physiol Psychol, 94, 227, 10.1037\u002Fh0077668\nShoaib, 1998, The GABAB agonist baclofen modifies cocaine self-administration in rats, Behav Pharmacol, 9, 195\nShoptaw, 2003, Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use, J Clin Psychiatry, 64, 1440, 10.4088\u002FJCP.v64n1207\nShuster, 1977, Sensitization to cocaine stimulation in mice, Psychopharmacology, 52, 185, 10.1007\u002FBF00439108\nSiegel, 1976, Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model, Science, 193, 323, 10.1126\u002Fscience.935870\n1992, vol. 116, 213\nSiegel, 1982, Heroin “overdose” death: contribution of drug-associated environmental cues, Science, 216, 436, 10.1126\u002Fscience.7200260\nSilverman, 1992, Low-dose caffeine discrimination and self-reported mood effects in normal volunteers, J Exp Anal Behav, 57, 91, 10.1901\u002Fjeab.1992.57-91\nSinha, 1999, Stress-induced craving and stress responses in cocaine dependent individuals, Psychopharmacology, 142, 343, 10.1007\u002Fs002130050898\nSlattery, 2005, The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat, J Clin Psychiatry, 64, 1440\nSmith, 1962, Subjective effects of heroin and morphine in normal subjects, J Pharmacol Exp Ther, 136, 47\nSmith, 2004, Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats, Psychopharmacology, 173, 105, 10.1007\u002Fs00213-003-1706-5\nSofuoglu, 2005, Novel approaches to the treatment of cocaine addiction, CNS Drugs, 19, 13, 10.2165\u002F00023210-200519010-00002\nSokoloff, 1990, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature, 347, 146, 10.1038\u002F347146a0\nSokoloff, 1992, The third dopamine receptor (D3) as a novel target for antipsychotics, Biochem Pharmacol, 43, 659, 10.1016\u002F0006-2952(92)90227-A\nSpyraki, 1983, Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system, Psychopharmacology, 79, 278, 10.1007\u002FBF00427827\nSpyraki, 1987, Intravenous cocaine-induced place preference: attenuation by haloperidol, Behav Brain Res, 26, 57, 10.1016\u002F0166-4328(87)90016-7\nStafford, 1998, Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review, Psychopharmacology, 139, 169, 10.1007\u002Fs002130050702\nStaley, 1996, Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities, J Neurosci, 16, 6100, 10.1523\u002FJNEUROSCI.16-19-06100.1996\nStein, 1962, Effects and interactions of imipramine, chlorpromazine, reserpine, and amphetamine on self-stimulation: possible neurophysiological basis of depression, Recent Adv Biol Psychiatry, 4, 297\nStein, 1977, Direct intracerebral self-administration of opiates in the rat, Soc Neurosci Abstr, 3, 302\nStein, 1960, Brain stimulation reward ‘thresholds’ self-determined in rat, Psychopharmacologia, 1, 251, 10.1007\u002FBF00402746\nStemp, 2000, Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): a potent and selective dopamine D3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J Med Chem, 43, 1878, 10.1021\u002Fjm000090i\nStewart, 1984, Reinstatement of heroin and cocaine self-administration in the rat by intracerebral application of morphine in the ventral tegmental area, Pharmacol Biochem Behav, 20, 917, 10.1016\u002F0091-3057(84)90017-0\nStewart, 1988, A comparison of the effect of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior, Brain Res, 457, 287, 10.1016\u002F0006-8993(88)90698-1\nStewart, 1992, Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction, Psychopharmacology, 108, 79, 10.1007\u002FBF02245289\nStretch, 1971, Factors affecting behavior maintained by response-contingent intravenous infusions of amphetamine in squirrel monkeys, Can J Physiol Pharmacol, 49, 581, 10.1139\u002Fy71-075\nStromberg, 2004, The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat, Pharmacol Biochem Behav, 78, 743, 10.1016\u002Fj.pbb.2004.05.006\nStromberg, 2001, The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat, Pharmacol Biochem Behav, 68, 291, 10.1016\u002FS0091-3057(00)00456-1\nSundstrom, 2002, Effects of isolation-rearing on intracranial self-stimulation reward of the lateral hypothalamus: baseline assessment and drug challenges, Life Sci, 70, 2799, 10.1016\u002FS0024-3205(02)01509-6\nSutton, 2000, Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats, Neuropsychopharmacology, 22, 626, 10.1016\u002FS0893-133X(99)00160-8\nTaepavarapruk, 2003, Neurochemical correlates of relapse to d-amphetamine self-administration by rats induced by stimulation of the ventral subiculum, Psychopharmacology, 168, 99, 10.1007\u002Fs00213-002-1337-2\nTernes, 1984, Nondependent monkeys self-administer hydromorphone, Behav Neurosci, 99, 583, 10.1037\u002F0735-7044.99.3.583\nThanos, 2005, The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats, Pharmacol Biochem Behav, 81, 190, 10.1016\u002Fj.pbb.2005.03.013\nThompson, 1964, Morphine self-administration, food-reinforced and avoidance behaviors in rhesus monkeys, Psychopharmacologia, 5, 87, 10.1007\u002FBF00413045\nTran-Nguyen, 1998, Time-dependent changes in cocaine-seeking behavior and dopamine overflow in the amygdala during cocaine withdrawal, Neuropsychopharmacology, 19, 48, 10.1016\u002FS0893-133X(97)00205-4\nTzschentke, 1998, Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues, Prog Neurobiol, 56, 613, 10.1016\u002FS0301-0082(98)00060-4\nUngerstedt, 1968, 6-Hydroxy-dopamine-induced degeneration of central dopamine neurons, Eur J Pharmacol, 5, 107, 10.1016\u002F0014-2999(68)90164-7\nUngerstedt, 1984, Measurement of neurotransmitter release by intracranial dialysis, vol. 6, 81\nUngerstedt, 1974, Functional correlates of dopamine neurotransmission, Bull Schweiz Akad Med Wiss, 30, 44\nUzwiak, 1997, Neurons in accumbens subterritories of the rat: phasic firing time-locked within seconds of intravenous cocaine self-infusion, Brain Res, 767, 363, 10.1016\u002FS0006-8993(97)00752-X\nValverde, 1996, Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal, Eur J Neurosci, 8, 2671, 10.1111\u002Fj.1460-9568.1996.tb01562.x\nVan Putten, 1978, Akinetic depression in schizophrenia, Arch Gen Psychiatry, 35, 1101, 10.1001\u002Farchpsyc.1978.01770330075006\nVan Putten, 1981, Subjective response to antipsychotic drugs, Arch Gen Psychiatry, 38, 187, 10.1001\u002Farchpsyc.1981.01780270073010\nvan Ree, 1980, Involvement of neurohypophyseal peptides in drug-mediated adaptive responses, Pharmacol Biochem Behav, 13, 1101\nVetulani, 2001, Drug addiction: Part III. Pharmacotherapy of addiction, Pol J Pharmacol, 53, 415\nVezina, 2004, Sensitization of midbrain dopamine neuron activity and the self-administration of psychomotor stimulant drugs, Neurosci Biobehav Rev, 27, 827, 10.1016\u002Fj.neubiorev.2003.11.001\nVolkow, 2004, Drug addiction: the neurobiology of behavior gone awry, Nat Rev Neurosci, 5, 963, 10.1038\u002Fnrn1539\nVolkow, 1999, Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors, J Pharmacol Exp Ther, 291, 409\nVolpicelli, 1990, Naltrexone and the treatment of alcohol dependence: initial observations, 195\nVolpicelli, 1992, Naltrexone in the treatment of alcohol dependence, Arch Gen Psychiatry, 49, 876, 10.1001\u002Farchpsyc.1992.01820110040006\nVorel, 2001, Drug addiction and the hippocampus, Science, 294, 1235a, 10.1126\u002Fscience.294.5545.1235a\nVorel, 2001, Relapse to cocaine-seeking after hippocampal theta burst stimulation, Science, 292, 1175, 10.1126\u002Fscience.1058043\nVorel, 2002, Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats, J Neurosci, 22, 9595, 10.1523\u002FJNEUROSCI.22-21-09595.2002\nVoruganti, 1997, Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse, J Nerv Ment Dis, 185, 463, 10.1097\u002F00005053-199707000-00008\nVoruganti, 2000, Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life, Schizophr Res, 43, 135, 10.1016\u002FS0920-9964(99)00154-1\nWalker, 2002, Conditioned opioid withdrawal decreases nociceptin\u002Forphanin FQ levels in the frontal cortex and olfactory tubercle, Neuropsychopharmacology, 27, 203, 10.1016\u002FS0893-133X(02)00292-0\nWang, 2000, Stress or drug priming induces reinstatement of extinguished conditioned place preference, NeuroReport, 11, 2781, 10.1097\u002F00001756-200008210-00034\nWarburton, 1996, Calcium dependent dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition, Behav Pharmacol, 7, 119, 10.1097\u002F00008877-199603000-00002\nWard, 1997, The effects of a monetary alternative on marijuana self-administration, Behav Pharmacol, 8, 275, 10.1097\u002F00008877-199708000-00001\nWard, 2000, Intraaccumbens baclofen selectively enhances feeding behavior in the rat, Physiol Behav, 68, 463, 10.1016\u002FS0031-9384(99)00197-3\nWeeks, 1964, Factors affecting voluntary morphine intake in self-maintained addicted rats, Psychopharmacologia, 6, 267, 10.1007\u002FBF00413156\nWegelius, 1993, Gamma-vinyl GABA decreases voluntary alcohol-consumption in alcohol-preferring AA rats, Pharmacol Toxicol, 73, 150, 10.1111\u002Fj.1600-0773.1993.tb01554.x\nWeiss, 1993, Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants, J Pharmacol Exp Ther, 267, 250\nWeiss, 2000, Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens, Proc Natl Acad Sci U S A, 97, 4321, 10.1073\u002Fpnas.97.8.4321\nWeissman, 1989, Opioid pseudoaddiction—an iatrogenic syndrome, Pain, 36, 363, 10.1016\u002F0304-3959(89)90097-3\nWhite, 1993, Amphetamine-conditioned cue preference and the neurobiology of drug-seeking, Semin Neurosci, 5, 329, 10.1016\u002FS1044-5765(05)80040-5\nWhitelaw, 1996, Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second order schedule of reinforcement, Psychopharmacology, 127, 213, 10.1007\u002FBF02805996\nWikler, 1948, Recent progress in research on the neurophysiological basis of morphine addiction, Am J Psychiatry, 105, 329, 10.1176\u002Fajp.105.5.329\nWikler, 1968, Interaction of physical dependence and classical and operant conditioning in the genesis of relapse, 280\nWikler, 1967, Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and relapse in morphine-addicted rats, Psychopharmacologia, 10, 255, 10.1007\u002FBF00401386\nWilson, 1995, Dopaminergic correlates of motivated behavior: importance of drive, J Neurosci, 15, 5169, 10.1523\u002FJNEUROSCI.15-07-05169.1995\nWise, 1980, The dopamine synapse and the notion of ‘pleasure centers’ in the brain, Trends Neurosci, 3, 91, 10.1016\u002F0166-2236(80)90035-1\nWise, 1980, Action of drugs of abuse on brain reward systems, Pharmacol Biochem Behav, 13, 213, 10.1016\u002FS0091-3057(80)80033-5\nWise, 1981, Brain dopamine and reward, vol. 1, 103\nWise, 1982, Neuroleptics and operant behavior: the anhedonia hypothesis, Behav Brain Sci, 5, 39, 10.1017\u002FS0140525X00010372\nWise, 1984, Neural mechanisms of the reinforcing action of cocaine, NIDA Res Monogr, 50, 15\nWise, 1989, The brain and reward, 377\nWise, 1989, Opiate reward: sites and substrates, Neurosci Biobehav Rev, 13, 129, 10.1016\u002FS0149-7634(89)80021-1\nWise, 1993, In vivo estimates of extracellular dopamine and dopamine metabolite levels during intravenous cocaine or heroin self-administration, Sem Neurosci, 5, 337, 10.1016\u002FS1044-5765(05)80041-7\nWise, 1996, Addictive drugs and brain stimulation reward, Annu Rev Neurosci, 19, 319, 10.1146\u002Fannurev.ne.19.030196.001535\nWise, 1996, Neurobiology of addiction, Curr Opin Neurobiol, 6, 129, 10.1016\u002FS0959-4388(96)80079-1\nWise, 1998, Drug-activation of brain reward pathways, Drug Alcohol Depend, 51, 13, 10.1016\u002FS0376-8716(98)00063-5\nWise, 2004, Dopamine, learning and motivation, Nat Rev Neurosci, 5, 1, 10.1038\u002Fnrn1406\nWise, 1981, Brain substrates for reinforcement and drug self-administration, Prog Neuropsychopharmacol, 5, 467, 10.1016\u002F0364-7722(81)90028-X\nWise, 1984, Brain reward circuitry: four circuit elements ‘wired’ in apparent series, Brain Res Bull, 12, 203, 10.1016\u002F0361-9230(84)90190-4\nWise, 2002, Functional anatomy of substance-related disorders, 509\nWise, 1989, Brain dopamine and reward, Annu Rev Psychol, 40, 191, 10.1146\u002Fannurev.ps.40.020189.001203\nWise, 1990, Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats, Psychopharmacology, 100, 355, 10.1007\u002FBF02244606\nWise, 1995, Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats, Psychopharmacology, 120, 10, 10.1007\u002FBF02246140\nWise, 1995, Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration, Synapse, 21, 140, 10.1002\u002Fsyn.890210207\nWoolverton, 1986, Effects of a D1 and D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys, Pharmacol Biochem Behav, 24, 531, 10.1016\u002F0091-3057(86)90553-8\nXi, 1999, Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release, J Pharmacol Exp Ther, 290, 1369\nXi, 2000, Increased mesolimbic GABA concentration blocks heroin self-administration in the rat, J Pharmacol Exp Ther, 294, 613\nXi, 2003, The dopamine D3 receptor antagonist NGB 2904 inhibits cocaine reward and cocaine-triggered reinstatement of cocaine-seeking behavior\nXi, 2004, Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats, Psychopharmacology, 176, 57, 10.1007\u002Fs00213-004-1858-y\nXi, 2005, Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats, Eur J Neurosci, 21, 3427, 10.1111\u002Fj.1460-9568.2005.04159.x\nYan, 1999, Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis, Eur J Pharmacol, 385, 7, 10.1016\u002FS0014-2999(99)00699-8\nYokel, 1975, Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward, Science, 187, 547, 10.1126\u002Fscience.1114313\nYokel, 1976, Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats, Psychopharmacology, 48, 311, 10.1007\u002FBF00496868\nYoung, 1998, Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli, Neuroscience, 83, 1175, 10.1016\u002FS0306-4522(97)00483-1\nYuan, 1998, NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists, Bioorg Med Chem Lett, 8, 2715, 10.1016\u002FS0960-894X(98)00469-7\nZangen, 2002, Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens, J Neurosci, 22, 7225, 10.1523\u002FJNEUROSCI.22-16-07225.2002",{"EN":115},"Critical assessment of how to study addiction and its treatment: Human and non-human animal models",{"VOID":117},"10.1016\u002Fj.pharmthera.2005.06.018","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725805001518",[123,139],{"id":124,"sortIndex":19,"researcher":18,"roles":125,"affiliations":127,"properties":136},"5bb8af1f-03f1-459c-a6e1-9140b13659e8",[126],"AUTHOR",[128],{"id":18,"sortIndex":19,"affiliation":129,"properties":18},{"id":130,"createTime":131,"updateTime":131,"relativeEntities":132,"slug":18,"properties":133,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"5983e24a-f090-42ad-8802-7878907b557e","2024-01-16T01:51:46.952+00:00",[],{"title":134},{"VI":135},"Department of Psychiatry, University of Pennsylvania School of Medicine, and Philadelphia, VA Medical Center, Mental Illness Research and Education Center, 3900 Chestnut Street, Philadelphia, PA, 19104, USA",{"title":137},{"VI":138},"Charles P. O'Brien",{"id":140,"sortIndex":141,"researcher":18,"roles":142,"affiliations":143,"properties":152},"43ee5654-eebb-4301-b712-bf32c29baaed",1,[126],[144],{"id":18,"sortIndex":19,"affiliation":145,"properties":18},{"id":146,"createTime":147,"updateTime":147,"relativeEntities":148,"slug":18,"properties":149,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"2a22018b-554e-4bf5-9456-e7e459b7503d","2024-01-16T01:51:46.961+00:00",[],{"title":150},{"VI":151},"Neuropsychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA",{"title":153},{"VI":154},"Eliot L. Gardner","ARTICLE",{"url":121,"publisher":157,"properties":179},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":158,"slug":10,"properties":159,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":162,"manageAffiliations":163,"indexDatabases":164,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":160,"title":161},{"VOID":13},{"EN":15},[],[],[165,172],{"id":83,"indexDatabase":166,"url":98,"indexYears":18,"academicFieldIds":171,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":167,"label":168,"description":169,"key":94,"publicationTags":170,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":173,"url":76,"indexYears":77,"academicFieldIds":178,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":174,"label":175,"description":176,"key":73,"publicationTags":177,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":180,"pages":182},{"VOID":181},"108",{"VOID":183},"18-58","2005-10-01",2005,false,{"id":188,"createTime":189,"updateTime":190,"relativeEntities":191,"slug":192,"properties":193,"entityType":118,"verifyStatus":119,"verifyTime":190,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":200,"fullTextUrl":18,"authors":201,"publicationType":155,"publisherRelationship":217,"citationCount":18,"citationInfo":18,"publishDate":245,"publishYear":246,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"c892a627-2d4f-4e35-aa6f-4cc90eb44f4f","2023-12-01T08:08:48.392+00:00","2025-02-08T23:58:49.119+00:00",[],"Botulinum-toxin-as-a-therapeutic-agent",{"references":194,"title":196,"doi":198},{"VOID":195},"Bertrand, 1987, Observations and analysis of results in 131 cases of spasmodic torticollis after selective denervation, Appl. Neurophysiol., 50, 319\nBigalke, 1980, Blockade of tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus, Naunyn Schmeidebergs Arch. Pharmacol., 31, 255, 10.1007\u002FBF00499155\nBiglan, 1989, Management of strabismus with botulinum toxin A, Ophthalmology, 96, 935, 10.1016\u002FS0161-6420(89)32776-X\nBlack, 1986, Interaction of 1251-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantification of distinct membrane acceptors for type A and B on motor nerves, J. Cell Biol., 103, 521, 10.1083\u002Fjcb.103.2.521\nBlack, 1986, Interaction of 1251-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptormediated endocytosis, J. Cell Biol., 103, 535, 10.1083\u002Fjcb.103.2.535\nBlasi, 1993, Botulinum neurotoxin-C1 blocks neurotransmitter release by means of cleaving HPC-1\u002Fsyntaxin, EMBO J., 12, 4821, 10.1002\u002Fj.1460-2075.1993.tb06171.x\nBlitzer, 1989, Botulinum toxin injection for the treatment of oromandibular dystonia, Ann. Otol. Rhinol. Laryngol., 98, 93, 10.1177\u002F000348948909800202\nBlitzer, 1992, Abductor laryngeal dystonia: a series treated with botulinum toxin, Laryngoscope, 102, 163, 10.1288\u002F00005537-199202000-00011\nBorodic, 1990, Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread, Head Neck, 12, 392, 10.1002\u002Fhed.2880120504\nBraun, 1973, Phenol nerve block in the treatment of acquired spastic hemiplegia in the upper limb, J. Bone Joint Surg., 55A, 580, 10.2106\u002F00004623-197355030-00015\nBrin, 1988, Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm, Adv. Neurol, 50, 599\nBrin, 1989, Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox), Mov. Disord., 4, 287, 10.1002\u002Fmds.870040401\nCarruthers, 1994, The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles, Cosmet. Dermatol., 7, 11\nCarruthers, 1985, Ophthalmologic use of botulinum A exotoxin, Can. J. Ophthalmol., 20, 135\nCarruthers, 1992, Treatment of glabellar frown lines with C. botulinum-A exotoxin, J. Dermatol. Surg. Oncol., 18, 17, 10.1111\u002Fj.1524-4725.1992.tb03295.x\nCarruthers, 1991, Botulinum toxin in the treatment of eye disorders, B. C. Med. J., 33, 271\nCarruthers, 1987, Botulinum toxin for benign essential blepharospasm, hemifacial spasm and agerelated lower eyelid entropion, Can. J. Neurol. Sci., 14, 42, 10.1017\u002FS0317167100026159\nCoffield, 1994, The site and mechanism of action of botulinum neurotoxin, 3\nCohen, 1989, Treatment of focal dystonias of the hand with botulinum toxin injections, J. Neurol. Neurosurg. Psychiatry, 52, 355, 10.1136\u002Fjnnp.52.3.355\nComella, 1992, Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance, Neurology, 42, 878, 10.1212\u002FWNL.42.4.878\nDasGupta, 1994, Structures of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin, 15\nDeuschl, 1991, Earclick in palatal tremor: its origin and treatment with botulinum toxin, Neurology, 41, 1677, 10.1212\u002FWNL.41.10.1677\nDezfulian, 1984, Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism, Clin. Microbiol., 20, 379, 10.1128\u002FJCM.20.3.379-383.1984\nDubinsky, 1991, Electromyographic guidance of botulinum toxin treatment in cervical dystonia, Clin. Neuropharmacol., 14, 262, 10.1097\u002F00002826-199106000-00011\nDuchen, 1970, Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of mouse: differences between fast and slow muscles, J. Neurol. Neurosurg. Psychiatry, 33, 40, 10.1136\u002Fjnnp.33.1.40\nDunn, 1986, Botulinum toxin tor the treatment of dysthyroid ocular myopathy, Ophthalmology, 93, 470, 10.1016\u002FS0161-6420(86)33713-8\nDykstra, 1990, Treatment of detrusorsphincter dyssynergia with botulinum A toxin: a double blind study, Arch. Phys. Med. Rehabil., 71, 24\nDykstra, 1988, Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients, J. Urol., 139, 919, 10.1016\u002FS0022-5347(17)42717-0\nFahn, 1995, Medical treatment of dystonia, 317\nFord, 1990, Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia, Otolaryngol. Head Neck Surg., 103, 752, 10.1177\u002F019459989010300515\nGacek, 1987, Botulinum toxin for relief of spasmodic dysphonia, Arch. Otolaryngol. Head Neck Surg., 113, 1240, 10.1001\u002Farchotol.1987.01860110106025\nGargland, 1993, Crystalline preparation of botulinum type A (Botox®): degradation impotency with storage, Otolaryngol. Head Neck Surg., 108, 135, 10.1177\u002F019459989310800205\nGautier, 1961, Enlargement of the inferior olivary nucleus in association with lesions of the central tegmental tract or dentate nucleus, Brain, 84, 341, 10.1093\u002Fbrain\u002F84.3.341\nGelb, 1989, Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis, Neurology, 39, 80, 10.1212\u002FWNL.39.1.80\nGonnering, 1988, Negative antibody response to long-term treatment of facial spasm with botulinum toxin, Am. J. Ophthalmol., 105, 313, 10.1016\u002F0002-9394(88)90016-5\nHallan, 1988, Treatment of anismus in intractable constipation with bofulinum A toxin, Lancet, ii, 714, 10.1016\u002FS0140-6736(88)90188-2\nHatheway, 1984, Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin types A, B, and E, J. Infect. Dis., 150, 407, 10.1093\u002Finfdis\u002F150.3.407\nHelveston, 1988, Treatment of acquired nystagmus with botulinum A toxin, Am. J. Ophthalmol., 106, 584, 10.1016\u002F0002-9394(88)90590-9\nHermanowicz, 1991, Treatment of oromandibular dystonia with botulinum toxin, Laryngoscope, 101, 1216, 10.1288\u002F00005537-199111000-00010\nHoch, 1985, Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes, 82, 1692\nHolds, 1990, Terminal nerve and motor end plate changes in human orbicularis muscle following botulinum A exotoxin injection, Invest. Ophthalmol. Vis. Sci., 31, 178\nHughes, 1962, Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin, J. Physiol. (Lond.), 160, 221, 10.1113\u002Fjphysiol.1962.sp006843\nHuttner, 1993, Snappy exocytoxins, Nature, 365, 104, 10.1038\u002F365104a0\nJankovic, 1993, Botulinum toxin in the treatment of tics associated with Tourette's syndrome, Neurology, 43, A310\nJankovic, 1990, Botulinum toxin injections for cervical dystonia, Neurology, 40, 277, 10.1212\u002FWNL.40.2.277\nJankovic, 1991, Botulinum treatment of tremors, Neurology, 41, 1185, 10.1212\u002FWNL.41.8.1185\nJankovic, 1990, Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm, J. Neurol. Neurosurg. Psychiatry, 53, 633, 10.1136\u002Fjnnp.53.8.633\nKoda, 1992, An evaluation of laryngeal muscle activation in patients with voice tremor, Otolaryngol. Head Neck Surg., 107, 684, 10.1177\u002F019459989210700510\nKolotkin, 1979, Electromyographic tension levels in stutterers and normal speakers, Percept. Mot. Skills, 49, 109, 10.2466\u002Fpms.1979.49.1.109\nKoman, 1994, Botulinum toxin: potential role in the management of cerebral pals during childhood, 511\nLal, 1979, Pathophysiology and pharmacotherapy of spasmodic torticollis: a review, Can. J. Neurol. Sci., 6, 427, 10.1017\u002FS0317167100023830\nLew, 1992, Adductor laryngeal “breathing dystonia” in a case of X-linked dystonia-parkinson syndrome, Mov. Disord., 7, 301\nLoeser, 1983, Hemifacial spasm: treatment by microsurgical facial decompression, Neurosurgery, 13, 141, 10.1227\u002F00006123-198308000-00006\nLomneth, 1993, Calcium-dependent release of norepinephrine for permeabilized PC12 cells is inhibited by ~48 and ~112 kDa fragments of botulinum neurotoxin type E, Neuropharmacology, 32, 285, 10.1016\u002F0028-3908(93)90113-H\nLudlow, 1990, Treatment of speech and voice disorders with botulinum toxin, JAMA, 264, 2671, 10.1001\u002Fjama.264.20.2671\nLudlow, 1995, Treating the spasmodic dysphonias with botulinum toxin: a comparison of results with adductor and abductor spasmodic dysphonia and vocal tremor, 431\nLudlow, 1990, Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery, Orololaryngol. Head Neck Surg., 102, 122, 10.1177\u002F019459989010200205\nLudlow, 1991, Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injections, Orolaryngol. Head Neck Surg., 104, 849, 10.1177\u002F019459989110400614\nMagoon, 1985, Botulinum toxin injection for vertical strabismus, Am. Orthopt. J., 35, 48, 10.1080\u002F0065955X.1985.11981662\nMauriello, 1987, Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias, Ophthalmology, 94, 976, 10.1016\u002FS0161-6420(87)33337-8\nMeige, 1910, Les convulsions de la face: une forme clinique de convulsions faciales, bilaterale et mediane, Rev. Neurol. (Paris), 21, 438\nMellman, 1986, Acidification of the endocytotic and exocytotic pathways, Annu. Rev. Biochem., 55, 663, 10.1146\u002Fannurev.bi.55.070186.003311\nMoyer, 1994, Botulinum toxin type B: experimental and clinical experience, 71\nNarayan, 1991, Intrathecal baclofen for intractable axial dystonia, Neurology, 41, 1141, 10.1212\u002FWNL.41.7.1141\nOzelius, 1989, Human gene for torsion dystonia on chromosome 9q32-35, Neuron, 2, 1427, 10.1016\u002F0896-6273(89)90188-8\nPasricha, 1993, Treatment of sphincter of Oddi dysfunction with botulinum toxin injection—case report, Gastrointest. Endosc., 39, 319\nPasricha, 1993, Botulinum toxin for achalasia, Lancet, 341, 244, 10.1016\u002F0140-6736(93)90109-T\nPenn, 1992, Intrathecal baclofen for spasticity of spinal origin: seven years of experience, J. Neurosurg., 77, 236, 10.3171\u002Fjns.1992.77.2.0236\nPoewe, 1992, Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients, J. Neurol., 239, 21, 10.1007\u002FBF00839206\nPreston, 1985, Anismus in chronic constipation, Dig. Dis. Sci., 30, 413, 10.1007\u002FBF01318172\nRanawaya, 1991, Usefulness of a writing device in writer's cramp, Neurology, 41, 1136, 10.1212\u002FWNL.41.7.1136\nRice, 1987, Pharmacotherapy of spasticity: some theoretical and practical considerations, Can. J. Neurol. Sci., 14, 510, 10.1017\u002FS0317167100038014\nRivest, 1991, Writer's cramp: treatment with botulinum toxin injections, Mov. Disord., 6, 55, 10.1002\u002Fmds.870060110\nRontal, 1991, A method for the treatment of abductor spasmodic dysphonia with botulinum injections: a preliminary report, Laryngoscope, 101, 911\nRosenbaum, 1989, Vertical rectus muscle transposition and botulinum toxin (Oculinum) to medial rectus for abducens palsy, Arch. Ophthalmol., 107, 820, 10.1001\u002Farchopht.1989.01070010842025\nSamson, 1984, The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin, J. Pharmacol. Exp. Then, 229, 182\nSanders, 1986, Botulinum toxin tor blepharospasm: single-fibre EMG studies, Neurology, 36, 545, 10.1212\u002FWNL.36.4.545\nSchapiro, 1980, An electromyographic analysis of the fluent and dysfluent utterances of several types of stutterers, Fluency Disord., 5, 203, 10.1016\u002F0094-730X(80)90029-7\nSchantz, 1990, Dose standardization of botulinum toxin, Lancet, 335, 421, 10.1016\u002F0140-6736(90)90263-5\nSchantz, 1978, Standardized assay for Clostridium botulinum toxins, J. Assoc. Anal. Chem., 61, 96\nSchantz, 1981, Use of crystalline type A botulinum toxin in medical research, 143\nSchiavo, 1992, Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin, Nature, 359, 832, 10.1038\u002F359832a0\nSchiavo, 1993, Identification of the nerve terminal targets of botulinum neurotoxin serotype-A, serotype-D, and serotype-E, J. Biol. Chem., 268, 23784, 10.1016\u002FS0021-9258(20)80452-9\nSchiavo, 1993, Botulinum neurotoxin serotype-F is a zinc endopeptidase specific for VAMP\u002Fsynaptobrevin, J. Biol. Chem., 268, 11516, 10.1016\u002FS0021-9258(19)50230-7\nSchiavo, 1994, Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus, Ann. NY Acad. Sci., 710, 65, 10.1111\u002Fj.1749-6632.1994.tb26614.x\nScott, 1981, Botulinum toxin injection of eye muscles to correct strabismus, Trans. Am. Ophthalmol. Soc., 79, 734\nScott, 1988, Systemic toxicity of botulinum toxin by intramuscular injection in the monkey, Mov. Disord., 3, 333, 10.1002\u002Fmds.870030409\nScott, 1973, Pharmacologic weakening of extraocular muscles, Invest. Ophthalmol. Vis. Sci., 12, 924\nScott, 1985, Botulinum toxin injection as a treatment for blepharospasm, Arch. Ophthalmol., 103, 347, 10.1001\u002Farchopht.1985.01050030043017\nScott, 1990, Botulinum treatment of strabismus in children, Trans. Am. Ophthalmol. Soc., 87, 174\nShimizu, 1994, Production and properties of type F toxin, 87\nSimpson, 1986, Molecular pharmacology of botulinum toxin and tetanus toxin, Ann. Rev. Pharmacol. Toxicol., 26, 427, 10.1146\u002Fannurev.pa.26.040186.002235\nSnow, 1990, Treatment of spasticity with botulinum toxin: a double-blind study, Ann. Neurol., 28, 512, 10.1002\u002Fana.410280407\nStell, 1988, Botulinum toxin in spasmodic torticollis, J. Neurol. Neurosurg. Psychiatry, 51, 920, 10.1136\u002Fjnnp.51.7.920\nTsui, 1995, Applications of botulinum toxin: cervical and limb dystonia, 415\nTsui, 1994, Clinical trials for spasticity, 523\nTsui, 1985, A pilot study on the use of botulinum toxin in spasmodic torticollis, Can. J. Neurol. Sci., 12, 314, 10.1017\u002FS031716710003540X\nTsui, 1986, Double-blind study of botulinum toxin in spasmodic torticollis, Lancet, ii, 245, 10.1016\u002FS0140-6736(86)92070-2\nTsui, 1987, Local treatment of spasmodic torticollis with botulinum toxin, Can. J. Neurol. Sci., 14, 533, 10.1017\u002FS0317167100038063\nTsui, 1988, Production of circulating antibodies to botulinum-A toxin in patients receiving repeated injections for dystonia, Ann. Neurol., 23, 181\nTsui, 1993, Botulinum toxin in the treatment of writer's cramp: a double-blind study, Neurology, 43, 183, 10.1212\u002FWNL.43.1_Part_1.183\nTsui, 1995, Botulinum toxin type B in the treatment of cervical dystonia: a pilot study, Neurology, 45, 2109, 10.1212\u002FWNL.45.11.2109\nWadsworth, 1990, Botulinum type F neurotoxin: large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes, Biochem. J., 268, 123, 10.1042\u002Fbj2680123\nYamada, 1986, Effects of aminoglycoside antibiotics on the neuromuscular junction: Part I, Int. J. Clin. Pharmacol. Ther. Toxicol., 24, 130\nYoung, 1981, Drug therapy: spasticity (first of two parts), N. Engl. J. Med., 304, 28\nYoung, 1981, Drug therapy: spasticity (second of two parts), N. Engl. J. Med., 304, 96\nZuber, 1993, Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance, Neurology, 43, 1715, 10.1212\u002FWNL.43.9.1715",{"EN":197},"Botulinum toxin as a therapeutic agent",{"VOID":199},"10.1016\u002Fs0163-7258(96)00091-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725896000915",[202],{"id":203,"sortIndex":19,"researcher":18,"roles":204,"affiliations":205,"properties":214},"b57c0f05-2216-41ce-9c40-8ddd491b169c",[126],[206],{"id":18,"sortIndex":19,"affiliation":207,"properties":18},{"id":208,"createTime":209,"updateTime":209,"relativeEntities":210,"slug":18,"properties":211,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"43d12c9e-7bfb-4d6f-81c0-d6b82429a963","2023-12-01T08:08:48.400+00:00",[],{"title":212},{"VI":213},"Neurodegenerative Disorders Centre, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada",{"title":215},{"VI":216},"Joseph K.C. Tsui",{"url":200,"publisher":218,"properties":240},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":219,"slug":10,"properties":220,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":221,"title":222},{"VOID":13},{"EN":15},[],[],[226,233],{"id":83,"indexDatabase":227,"url":98,"indexYears":18,"academicFieldIds":232,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":228,"label":229,"description":230,"key":94,"publicationTags":231,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":234,"url":76,"indexYears":77,"academicFieldIds":239,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":235,"label":236,"description":237,"key":73,"publicationTags":238,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":241,"pages":243},{"VOID":242},"72",{"VOID":244},"13-24","1996-01-01",1996,{"id":248,"createTime":249,"updateTime":250,"relativeEntities":251,"slug":252,"properties":253,"entityType":118,"verifyStatus":119,"verifyTime":250,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":260,"fullTextUrl":18,"authors":261,"publicationType":155,"publisherRelationship":412,"citationCount":18,"citationInfo":18,"publishDate":440,"publishYear":441,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"99ff7247-e50c-4025-9b7b-c1bae10ed190","2024-01-27T09:10:06.733+00:00","2025-01-14T23:58:39.812+00:00",[],"Integrin-linked-kinase-a-promising-cancer-therapeutic-target-biochemical-and-biological-properties",{"references":254,"title":256,"doi":258},{"VOID":255},"Alessi, 1997, Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha, Curr. Biol., 7, 261, 10.1016\u002FS0960-9822(06)00122-9\nAttwell, 2000, The integrin-linked kinase (ILK) suppresses anoikis, Oncogene, 19, 3811, 10.1038\u002Fsj.onc.1203711\nBalendran, 1999, PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2, Curr. Biol., 9, 393, 10.1016\u002FS0960-9822(99)80186-9\nBrennan, 1997, Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F, Immunity, 7, 679, 10.1016\u002FS1074-7613(00)80388-X\nBrown, 1996, Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding, J. Cell Biol., 135, 1109, 10.1083\u002Fjcb.135.4.1109\nCoffer, 1998, Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation, Biochem. J., 335, 1, 10.1042\u002Fbj3350001\nCote, 1999, Intact LIM 3 and LIM 4 domains of paxillin are required for the association to a novel polyproline region (Pro 2) of protein-tyrosine phosphatase-PEST, J. Biol. Chem., 274, 20550, 10.1074\u002Fjbc.274.29.20550\nDelcommenne, 1998, Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B\u002FAKT by the integrin-linked kinase, Proc. Natl. Acad. Sci. USA, 95, 11211, 10.1073\u002Fpnas.95.19.11211\nDeng, 2001, Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase, J. Biol. Chem., 276, 16365, 10.1074\u002Fjbc.M011634200\nDu, 1998, CREB is a regulatory target for the protein kinase Akt\u002FPKB, J. Biol. Chem., 273, 32377, 10.1074\u002Fjbc.273.49.32377\nGiancotti, 1999, Integrin signaling, Science, 285, 1028, 10.1126\u002Fscience.285.5430.1028\nGraff, 2001, Integrin-linked kinase expression increases with prostate tumor grade, Clin. Cancer Res., 7, 1987\nHannigan, 1996, Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase, Nature, 379, 91, 10.1038\u002F379091a0\nHannigan, 1997, Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15. 5-p15. 4, Genomics, 42, 177, 10.1006\u002Fgeno.1997.4719\nHobert, 1999, A conserved LIM protein that affects muscular adherens junction integrity and mechanosensory function in Caenorhabditis elegans, J. Cell Biol., 144, 45, 10.1083\u002Fjcb.144.1.45\nHowe, 1998, Integrin signaling and cell growth control, Curr. Opin. Cell. Biol., 10, 220, 10.1016\u002FS0955-0674(98)80144-0\nHuang, 2000, The roles of integrin-linked kinase in the regulation of myogenic differentiation, J. Cell Biol., 150, 861, 10.1083\u002Fjcb.150.4.861\nHynes, 1992, Integrins: versatility, modulation, and signaling in cell adhesion, Cell, 69, 11, 10.1016\u002F0092-8674(92)90115-S\nLeung-Hagesteijn, 2001, Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1, EMBO J., 20, 2160, 10.1093\u002Femboj\u002F20.9.2160\nLi, 1999, Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats, J. Cell Sci., 112, 4589, 10.1242\u002Fjcs.112.24.4589\nLi, 1999, A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation, J. Cell Biol., 147, 1391, 10.1083\u002Fjcb.147.7.1391\nMarotta, 2001, Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis, Oncogene, 20, 6250, 10.1038\u002Fsj.onc.1204791\nMcMenamin, 1999, Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage, Cancer Res., 59, 4291\nMorimoto, 2000, The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity, Oncogene, 19, 200, 10.1038\u002Fsj.onc.1203288\nNikolopoulos, 2001, Integrin-linked kinase (ilk) binding to paxillin ld1 motif regulates ILK localization to focal adhesions, J. Biol. Chem., 276, 23499, 10.1074\u002Fjbc.M102163200\nNovak, 1998, Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways, Proc. Natl. Acad. Sci. USA, 95, 4374, 10.1073\u002Fpnas.95.8.4374\nParadis, 1998, Caenorhabditis elegans Akt\u002FPKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor, Genes Dev., 12, 2488, 10.1101\u002Fgad.12.16.2488\nPeifer, 2000, Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus, Science, 287, 1606, 10.1126\u002Fscience.287.5458.1606\nPersad, 2000, Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B\u002FAkt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells, Proc. Natl. Acad. Sci. USA, 97, 3207, 10.1073\u002Fpnas.060579697\nPersad, 2001, Regulation of protein kinase B\u002FAkt-serine-473 phosphorylation by integrin linked kinase (ILK): critical roles for kinase activity and amino acids arginine-211 and serine-343, J. Biol. Chem., 276, 27462, 10.1074\u002Fjbc.M102940200\nRadeva, 1997, Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression, J. Biol. Chem., 272, 13937, 10.1074\u002Fjbc.272.21.13937\nRearden, 1994, A new LIM protein containing an autoepitope homologous to “senescent cell antigen”, Biochem. Biophys. Res. Commun., 201, 1124, 10.1006\u002Fbbrc.1994.1822\nRomashkova, 1999, NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling, Nature, 401, 86, 10.1038\u002F43474\nSastry, 1999, Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal, J. Cell Biol., 144, 1295, 10.1083\u002Fjcb.144.6.1295\nSomlyo, 1994, Signal transduction and regulation in smooth muscle, Nature, 372, 231, 10.1038\u002F372231a0\nStambolic, 1998, Negative regulation of PKB\u002FAkt-dependent cell survival by the tumor suppressor PTEN, Cell, 95, 29, 10.1016\u002FS0092-8674(00)81780-8\nTan, 2001, Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef\u002FTcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−\u002F− human colon carcinoma cells, Oncogene, 20, 133, 10.1038\u002Fsj.onc.1204052\nTorres, 2000, Colocalization and redistribution of dishevelled and actin during Wnt-induced mesenchymal morphogenesis, J. Cell Biol., 149, 1433, 10.1083\u002Fjcb.149.7.1433\nTroussard, 1999, Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner, Mol. Cell. Biol., 19, 7420, 10.1128\u002FMCB.19.11.7420\nTroussard, 2000, The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9), Oncogene, 19, 5444, 10.1038\u002Fsj.onc.1203928\nTu, 1999, The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells, Mol. Cell. Biol., 19, 2425, 10.1128\u002FMCB.19.3.2425\nTu, 2001, A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading, J. Cell Biol., 153, 585, 10.1083\u002Fjcb.153.3.585\nVlietstra, 1998, Frequent inactivation of PTEN in prostate cancer cell lines and xenografts, Cancer Res., 58, 2720\nWennerberg, 1998, Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin beta1A. Requirement for threonines 788–789 in receptor activation, J. Cell Sci., 111, 1117, 10.1242\u002Fjcs.111.8.1117\nWestermarck, 1999, Regulation of matrix metalloproteinase expression in tumor invasion, FASEB J., 13, 781, 10.1096\u002Ffasebj.13.8.781\nWhang, 1998, Inactivation of the tumor suppressor PTEN\u002FMMAC1 in advanced human prostate cancer through loss of expression, Proc. Natl. Acad. Sci. USA, 95, 5246, 10.1073\u002Fpnas.95.9.5246\nWu, 1995, Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix, Cell, 83, 715, 10.1016\u002F0092-8674(95)90184-1\nWu, 1998, Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity, J. Biol. Chem., 273, 528, 10.1074\u002Fjbc.273.1.528\nYamaji, 2001, A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction, J. Cell Biol., 153, 1251, 10.1083\u002Fjcb.153.6.1251",{"EN":257},"Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties",{"VOID":259},"10.1016\u002Fs0163-7258(02)00192-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725802001924",[262,280,298,310,322,335,348,360,373,386,399],{"id":263,"sortIndex":264,"researcher":18,"roles":265,"affiliations":266,"properties":277},"8f8e0ad2-ffe2-48c9-9b45-a193438671ba",9,[126],[267],{"id":18,"sortIndex":19,"affiliation":268,"properties":18},{"id":269,"createTime":270,"updateTime":271,"relativeEntities":272,"slug":273,"properties":274,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"034fee66-b138-417a-b5e9-decc2f96e40f","2024-01-27T09:10:06.862+00:00","2025-06-11T16:39:39.369+00:00",[],"Jack-Bell-Research-Centre-University-of-British-Columbia-Vancouver-B-C-Canada",{"title":275},{"VI":276},"Jack Bell Research Centre, University of British Columbia, Vancouver, B.C., Canada",{"title":278},{"VI":279},"S. Dedhar",{"id":281,"sortIndex":282,"researcher":18,"roles":283,"affiliations":284,"properties":295},"b52f6b25-9109-4e53-bb4b-2818f59943c2",2,[126],[285],{"id":18,"sortIndex":19,"affiliation":286,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":290,"slug":291,"properties":292,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"0b037b4d-1957-47d9-8ee8-540d0f5ce53a","2024-01-27T09:10:06.838+00:00","2025-06-11T23:54:17.997+00:00",[],"Kinetek-Pharmaceuticals-Inc-Suite-850-1200-West-73rd-Avenue-Vancouver-B-C-Canada-V6P-6G5",{"title":293},{"VI":294},"Kinetek Pharmaceuticals Inc., Suite 850, 1200 West 73rd Avenue, Vancouver, B.C., Canada V6P 6G5",{"title":296},{"VI":297},"Z. Zhang",{"id":299,"sortIndex":19,"researcher":18,"roles":300,"affiliations":301,"properties":307},"07445846-f47b-414c-b571-a8d1fc3f5a75",[126],[302],{"id":18,"sortIndex":19,"affiliation":303,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":304,"slug":291,"properties":305,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":306},{"VI":294},{"title":308},{"VI":309},"N. Yoganathan",{"id":311,"sortIndex":141,"researcher":18,"roles":312,"affiliations":313,"properties":319},"7bf3985f-28d3-4ca4-95f4-6452eb3f9c02",[126],[314],{"id":18,"sortIndex":19,"affiliation":315,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":316,"slug":291,"properties":317,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":318},{"VI":294},{"title":320},{"VI":321},"A. Yee",{"id":323,"sortIndex":324,"researcher":18,"roles":325,"affiliations":326,"properties":332},"4c5e96c9-3d4a-4e48-bf8f-ad2a66e58eed",6,[126],[327],{"id":18,"sortIndex":19,"affiliation":328,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":329,"slug":291,"properties":330,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":331},{"VI":294},{"title":333},{"VI":334},"D.L. Kojic",{"id":336,"sortIndex":337,"researcher":18,"roles":338,"affiliations":339,"properties":345},"97266b9f-d94b-43da-a599-0e6ccd018010",3,[126],[340],{"id":18,"sortIndex":19,"affiliation":341,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":342,"slug":291,"properties":343,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":344},{"VI":294},{"title":346},{"VI":347},"D. Leung",{"id":349,"sortIndex":48,"researcher":18,"roles":350,"affiliations":351,"properties":357},"843442a5-552d-442e-914a-496e4202e373",[126],[352],{"id":18,"sortIndex":19,"affiliation":353,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":354,"slug":291,"properties":355,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":356},{"VI":294},{"title":358},{"VI":359},"J. Sanghera",{"id":361,"sortIndex":362,"researcher":18,"roles":363,"affiliations":364,"properties":370},"56c5df5a-c0e1-41f1-bea5-79b21bc3e562",5,[126],[365],{"id":18,"sortIndex":19,"affiliation":366,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":367,"slug":291,"properties":368,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":369},{"VI":294},{"title":371},{"VI":372},"L. Fazli",{"id":374,"sortIndex":375,"researcher":18,"roles":376,"affiliations":377,"properties":383},"428e7489-7cea-4086-aa0c-8becd99c8cfe",8,[126],[378],{"id":18,"sortIndex":19,"affiliation":379,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":380,"slug":291,"properties":381,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":382},{"VI":294},{"title":384},{"VI":385},"M. Jabali",{"id":387,"sortIndex":388,"researcher":18,"roles":389,"affiliations":390,"properties":396},"511e4d99-00b4-4ebc-8884-473b4bc27ae3",7,[126],[391],{"id":18,"sortIndex":19,"affiliation":392,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":393,"slug":291,"properties":394,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":395},{"VI":294},{"title":397},{"VI":398},"P.C. Costello",{"id":400,"sortIndex":401,"researcher":18,"roles":402,"affiliations":403,"properties":409},"19a238dd-550f-4f4a-9c2b-e3c015c47872",4,[126],[404],{"id":18,"sortIndex":19,"affiliation":405,"properties":18},{"id":287,"createTime":288,"updateTime":289,"relativeEntities":406,"slug":291,"properties":407,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":408},{"VI":294},{"title":410},{"VI":411},"J. Yan",{"url":260,"publisher":413,"properties":435},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":414,"slug":10,"properties":415,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":418,"manageAffiliations":419,"indexDatabases":420,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":416,"title":417},{"VOID":13},{"EN":15},[],[],[421,428],{"id":83,"indexDatabase":422,"url":98,"indexYears":18,"academicFieldIds":427,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":423,"label":424,"description":425,"key":94,"publicationTags":426,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":429,"url":76,"indexYears":77,"academicFieldIds":434,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":430,"label":431,"description":432,"key":73,"publicationTags":433,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":436,"pages":438},{"VOID":437},"93",{"VOID":439},"233-242","2002-02-01",2002,{"id":443,"createTime":444,"updateTime":445,"relativeEntities":446,"slug":447,"properties":448,"entityType":118,"verifyStatus":119,"verifyTime":445,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":455,"fullTextUrl":18,"authors":456,"publicationType":155,"publisherRelationship":472,"citationCount":18,"citationInfo":18,"publishDate":500,"publishYear":501,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"32638467-846c-48a7-9af7-aa00b2d06d7b","2024-01-25T14:55:31.009+00:00","2025-01-13T23:58:36.839+00:00",[],"The-role-of-neuronal-calcium-channels-in-dependence-on-ethanol-and-other-sedatives-hypnotics",{"references":449,"title":451,"doi":453},{"VOID":450},"Akaike, 1989, Dihydropyridine sensitive low-threshold calcium channels in isolated rat hypothalamic neurones, J. Physiol. Lond., 412, 181, 10.1113\u002Fjphysiol.1989.sp017610\nArmbrecht, 1983, Ethanol-induced disordering of membranes from different age groups of C57 BL\u002F6 NN1A mice, J. Pharmac. exp. Ther., 226, 387\nBaeyens, 1987, Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats, Eur. J. Pharmac., 137, 9, 10.1016\u002F0014-2999(87)90176-2\nBarrios, 1988, Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro, Eur. J. Pharmac., 152, 175, 10.1016\u002F0014-2999(88)90852-7\nBean, 1984, Nitrendipine block of cardiac calcium channels: high affinity binding to the inactivated state, 81, 6388\nBeleslin, 1986, Verapamil induced behavioural, autonomic and motor effects in cats, Pharmac. Biochem. Behav., 24, 329, 10.1016\u002F0091-3057(86)90360-6\nBender, 1985, Pharmacological evidence that the nonneuronal diazepam binding site in primary cultures of glial cells is associated with a calcium channel, Eur. J. Pharmac., 110, 287, 10.1016\u002F0014-2999(85)90226-2\nBenedek, 1984, Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists, Pharmac. Res. Commun., 16, 1009, 10.1016\u002FS0031-6989(84)80065-X\nBenson, 1989, Ethanol suppresses hippocampal cell firing through a calcium and cyclic AMP-sensitive mechanism, Eur. J. Pharmac., 164, 591, 10.1016\u002F0014-2999(89)90270-7\nBergamaschi, 1988, Acute ethanol and acetaldehyde administration produce similar effects of L-type calcium channels in rat brain, Alcohol, 5, 337, 10.1016\u002F0741-8329(88)90076-6\nBichard, 1984, Differential effects of the benzodiazepine antagonist Ro 15-1788 after “general anaesthetic” doses of benzodiazepines in mice, Br. J. Anaesth., 56, 1153, 10.1093\u002Fbja\u002F56.10.1153\nBlaustein, 1975, Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro, Molec. Pharmac., 11, 369\nBongianni, 1986, Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats, Br. J. Pharmac., 88, 561, 10.1111\u002Fj.1476-5381.1986.tb10236.x\nBrennan, 1990, Second messengers involved in genetic regulation of the number of calcium channels in bovine adrenal chromaffin cells in culture, Neuropharmacology, 29, 689, 10.1016\u002F0028-3908(90)90031-L\nBrennan, 1989, Membrane receptors involved in upregulation of calcium channels in bovine adrenal chromaffin cells, chronically exposed to ethanol, Neuropharmacology, 28, 1303, 10.1016\u002F0028-3908(89)90003-8\nBrown, 1982, The alcohol withdrawal syndrome, A. emerg. Med., 11, 276, 10.1016\u002FS0196-0644(82)80101-7\nCantor, 1984, Interaction of calcium channel blockers with nonneuronal benzodiazepine binding sites, 81, 1549\nCarlen, 1982, Ethanol in low doses augments calcium-mediated mechanisms measured intracellularly in hippocampal neurones, Science, 215, 306, 10.1126\u002Fscience.7053581\nCarlen, 1983, Low-dose benzodiazepine neuronal inhibition: enhanced Ca2+-mediated K+-conductance, Brain Res., 271, 358, 10.1016\u002F0006-8993(83)90302-5\nCarlen, 1985, Enhanced neurones K+ conductance: a possible common mechanism for sedative-hypnotic drug action, Can. J. Physiol. Pharmac., 63, 831, 10.1139\u002Fy85-137\nCherubini, 1985, Benzodiazepines both enhance gamma-aminobutyrate responses and decrease calcium action potentials in guinea pig myenteric neurones, Neuroscience, 14, 309, 10.1016\u002F0306-4522(85)90180-0\nChin, 1977, Effect of low concentrations of ethanol on the fluidity of spin labeled erythrocyte and brain membranes, Molec. Pharmac., 13, 435\nChin, 1977, Drug tolerance in biomembranes: a spin label study of the effects of ethanol, Science, 196, 684, 10.1126\u002Fscience.193186\nContreras, 1988, Calcium channel antagonists increase morphine induced analgesia and antagonise morphine tolerance, Eur. J. Pharmac., 148, 463, 10.1016\u002F0014-2999(88)90129-X\nCowen, 1981, Ethyl-betacarboline carboxylase lowers seizure threshold and antagonises flurazepam-induced sedation in rats, Nature, 290, 54, 10.1038\u002F290054a0\nCrowder, 1986, Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes, Biochem. Pharmac., 351, 2501, 10.1016\u002F0006-2952(86)90046-8\nDaniell, 1988, Neuronal intracellular calcium are altered by anesthetics: relationship to membrane fluidisation, J. Pharmac. exp. Ther., 245, 1\nDaniell, 1988, Effect of chronic ethanol treatment and selective breeding for hypnotic sensitivity to ethanol on intracellular ionised calcium concentrations in synaptosomes, Alcoholism, 12, 179, 10.1111\u002Fj.1530-0277.1988.tb00156.x\nDaniell, 1989, Ethanol and inositol 1,4,5, triphosphate release calcium from separate stores of brain microsomes, J. Pharmac. exp. Ther., 250, 875\nDaniell, 1987, Effect of ethanol on intracellular ionised calcium concentrations in synaptosomes and hepatocytes, Molec. Pharmac., 32, 831\nDavidson, 1988, Ethanol increases synaptosomal free calcium, Neurosci. Lett., 89, 169, 10.1016\u002F0304-3940(88)90375-8\nDeitrich, 1989, Mechanism of action of ethanol; initial central nervous system actions, Pharmac. Rev., 41, 489\nDocherty, 1986, Interaction of 1,4-dihydropyridines with somatic Ca2+ currents in hippocampal CA1 neurones of the guinea pig in vitro, Neurosci. Lett., 70, 106, 10.1016\u002F0304-3940(86)90447-7\nDolin, 1986, Augmentation by calcium channel antagonists of general anaesthetic potency in mice, Br. J. Pharmac., 88, 909, 10.1111\u002Fj.1476-5381.1986.tb16265.x\nDolin, 1989, Are changes in neuronal calcium channels involved in ethanol tolerance, J. Pharmac. exp. Ther., 250, 985\nDolin, 1987, Increased dihydropyridine sensitive calcium channels in rat brain may underlie ethanolo physical dependence, Neuropharmacology, 26, 275, 10.1016\u002F0028-3908(87)90220-6\nDolin, 1988, Effects of the calcium channel agonist, BAY K 8644, on a general anaesthetic potency in mice, Br. J. Pharmac., 94, 413, 10.1111\u002Fj.1476-5381.1988.tb11543.x\nDolin, 1988, Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine, Eur. J. Pharmac., 152, 19, 10.1016\u002F0014-2999(88)90831-X\nDolin, 1988, Evidence for the involvement of dihydropyridine-sensitive calcium channels in ethanol dependence, Br. J. Pharmac., 95, 877p\nDolin, 1990, Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs, Br. J. Pharmac., 101, 691, 10.1111\u002Fj.1476-5381.1990.tb14142.x\nDolin, 1991, Differential interactions between benzodizepines and the dihydropyridines, nitrendipine and Bay K 8644, Neuropharmacology, 10.1016\u002F0028-3908(91)90148-5\nDraski, 1985, Nimodipine's interactions with other drugs: II, diazepam, Life Sci., 37, 2123, 10.1016\u002F0024-3205(85)90584-3\nDurand, 1984, Decreased neuronal inhibition in vitro after long-term administration of ethanol, Science, 224, 1359, 10.1126\u002Fscience.6328654\nEdmonds, 1983, Dietary manipulation of alcohol withdrawal in the rat, Res. Commun. Subst. Abuse, 4, 89\nEdwards, 1990, Withdrawal symptoms and alcohol dependence: fruitful mysteries, Br. J. Addict., 85, 447, 10.1111\u002Fj.1360-0443.1990.tb01665.x\nElrod, 1980, Acute and chronic effects of barbiturates on depolarisation induced calcium influx into synaptosomes from rat brain regions, J. Pharmac. exp. Ther., 212, 131\nEskuri, 1985, Development of ethanol tolerance in sensory neurones in culture, Alcohol. clin. exp. Res., 9, 197\nFalk, 1972, Behavioral maintenance of high concentrations of blood ethanol and physical dependence in the rat, Science, 177, 811, 10.1126\u002Fscience.177.4051.811\nFerendelli, 1982, Comparative actions of phenytoin and other anticonvulsant drugs on potassium- and veratridine-stimulated calcium uptake in synaptosomes, J. Pharmac. exp. Ther., 220, 29\nFriedman, 1980, Effects of acute and chronic ethanol administration on whole mouse brain synaptosomal calcium influx, Biochem. Pharmac., 29, 1903, 10.1016\u002F0006-2952(80)90101-X\nGandhi, 1988, In vitro morphine decreases [3H]-nimodipine receptor binding in rat brain regions, Neurochem. Res., 13, 1175, 10.1007\u002FBF00971636\nGandhi, 1988, The effect of kappa agonist U50-488H on [3H]-nimodipine receptor binding in rat brain region, Eur. J. Pharmac., 150, 51, 10.1016\u002F0014-2999(88)90749-2\nGibbins, 1971, The effect of chronic administration of ethanol on startle threshold in rats, Psychopharmacology, 19, 95, 10.1007\u002FBF00402633\nGoldstein, 1972, Relationship of alcohol dose to intensity of alcohol withdrawal signs in mice, J. Pharmac. exp. Ther., 180, 203\nGoldstein, 1986, The alcohol withdrawal syndrome. A view from the laboratory, Recent Dev. Alcohol., 4, 231, 10.1007\u002F978-1-4899-1695-2_10\nGoldstein, 1971, Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction, Science, 172, 288, 10.1126\u002Fscience.172.3980.288\nGreenberg, 1986, Depolarization dependent binding of the calcium channel antagonist (+)-[3H] PN 200-110, to intact cultured PC12 cells, J. Pharmac. exp. Ther., 238, 1021\nGreenberg, 1987, Ethanol induced component of 45Ca2+ uptake in PC12 cells is sensitive to Ca2+ channel modulating drugs, Brain Res., 410, 143, 10.1016\u002FS0006-8993(87)80036-7\nGross, 1987, Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion cells in cell culture, 84, 5469\nGross, 1988, Barbiturates and nifedipine have different and selective effects on calcium currents of mouse DRG neurones in culture: a possible basis for differing clinical actions, Neurology, 38, 443, 10.1212\u002FWNL.38.3.443\nGrover, 1990, Two components of long-term potentiation induced by different patterns of afferent activation, Nature, 346, 477, 10.1038\u002F347477a0\nGuerrero-Menoz, 1979, Effect of morphine on calcium-uptake by lysed synaptosomes, J. Pharmac. exp. Ther., 211, 370\nGundersen, 1988, Barbiturates depress currents through human brain calcium channels studied in Xenopus oocytes, J. Pharmac. exp. Ther., 247, 824\nGuppy, 1987, Increased [3H]-dihydropyridine binding sites in brain, heart and smooth muscle of ethanol dependent rats, Br. J. Pharmac., 92, 662P\nHarper, 1987, Altered characteristics of catecholamine release from rat cortical slices and bovine adrenal chromaffin cells in culture after chronic exposure to ethanol and the effect of the dihydropyridine drugs on these systems, Alcohol Alcohol, 1, 724\nHarper, 1989, Genetic upregulation of calcium channels in a cellular model of ethanol dependence, Neuropharmacology, 28, 1299, 10.1016\u002F0028-3908(89)90002-6\nHarris, 1981, Ethanol and pentobarbital inhibition of intrasynaptosomal sequestration of calcium, Biochem. Pharmac., 30, 3209, 10.1016\u002F0006-2952(81)90520-7\nHarris, 1984, Differential effects of membrane pertubants on voltage activated sodium and calcium channels and calcium dependent potassium channels, J. Biophys., 45, 132, 10.1016\u002FS0006-3495(84)84137-5\nHarris, 1982, Ethanol and synaptosomal calcium binding, Biochem. Pharmac., 31, 1790, 10.1016\u002F0006-2952(82)90688-8\nHarris, 1980, Inhibition of synaptosomal calcium uptake by ethanol, J. Pharmac. exp. Ther., 213, 562\nHarris, 1982, Effects of a sedative and a convulsant barbiturate on synaptosomal calcium transport, Brain Res., 242, 157, 10.1016\u002F0006-8993(82)90506-6\nHarris, 1977, Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence, Life Sci., 20, 501, 10.1016\u002F0024-3205(77)90393-9\nHarris, 1984, Relationship of membrane physical properties to alcohol dependence in mice selected for genetic differences in alcohol withdrawal, Life Sci., 35, 2601, 10.1016\u002F0024-3205(84)90027-4\nHarris, 1985, Effects of dihydropyridine derivatives and anticonvulsant drugs on [3H]-nitrendipine binding and calcium and sodium fluxes in brain, Biochem. Pharmac., 34, 2187, 10.1016\u002F0006-2952(85)90416-2\nHarris, 1988, Effects of ethanol and calcium on lipid other of membranes from mice selected for genetic differences in ethanol intoxication, Alcohol, 5, 251, 10.1016\u002F0741-8329(88)90060-2\nHeyer, 1982, Barbiturate reduction of calcium-dependent action potentials: correlation with anaesthetic action, Brain Res., 236, 157, 10.1016\u002F0006-8993(82)90042-7\nHirning, 1988, Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurones, Science, 239, 57, 10.1126\u002Fscience.2447647\nHitchcott, 1990, Acute CGS8216 reverses, and concurrent verapamil prevents, diazepam withdrawal-induced anxiety in rats, Br. J. Pharmac., 100, 354P\nHoffmeister, 1986, Calcium and agonists and antagonists of the dihydropyridine type: antinociceptive effects; interference with opiate μ-receptor agonists and pharmacological effect in rodents, Psychopharmacology, 90, 299, 10.1007\u002FBF00179181\nHunkeler, 1981, Selective antagonists of benzodiazepine receptors, Nature, 290, 514, 10.1038\u002F290514a0\nIsaacson, 1985, Nimodipine interactions with other drugs, 1. Ethanol, Life Sci., 36, 2195, 10.1016\u002F0024-3205(85)90329-7\nKoppi, 1987, Calcium channel blocking agent in the treatment of acute alcohol withdrawal. Caroverine versus meprobamate in a randomized double blind study, Neuropharmacology, 17, 49\nLace, 1986, The ethanol sensitivity of calcium taken up by a depolarisation-dependent process in mouse strains DBA and C57BL, Pharmac. Biochem. Behav., 24, 1137, 10.1016\u002F0091-3057(86)90468-5\nLe, 1979, Effect of L-tryptophan on the acquisition of tolerance to ethanol-induced motor impairment and hypothermia, Psychopharmacology, 61, 125, 10.1007\u002FBF00426725\nLeslie, 1980, Effects of chlordiazepoxide on depolarisation induced calcium influx into synaptosomes, Biochem. Pharmac., 29, 2439, 10.1016\u002F0006-2952(80)90347-0\nLeslie, 1980, Acute and chronic effects of barbiturates on depolarisation induced calcium influx into rat synaptosomes, Brain Res., 185, 409, 10.1016\u002F0006-8993(80)91078-1\nLeslie, 1983, Inhibition of fast and slow phase depolarisation dependent synaptosomal calcium uptake by ethanol, J. Pharmac. exp. Ther., 225, 571\nLieber, 1982, The feeding of alcohol in liquid diets; two decades of applications and 1982 uptake, Alcohol. clin. exp. Res., 6, 523, 10.1111\u002Fj.1530-0277.1982.tb05017.x\nLima-Landman, 1989, Ethanol potentiates and blocks NMDA activated single-channel currents in rat hippocampal pyramidal cells, FEBS Lett., 247, 61, 10.1016\u002F0014-5793(89)81241-4\nLittle, 1991, Possible mechanisms that may underlie the behavioural effects of ethanol, Prog. Neurobiol., 36, 171, 10.1016\u002F0301-0082(91)90029-Z\nLittle, 1987, Lack of tolerance to ethanol after concurrent administration of nitrendipine, Br. J. Pharmac., 92, 606P\nLittle, 1986, Calcium channel antagonists decrease the ethanol withdrawal syndrome, Life Sci., 39, 2059, 10.1016\u002F0024-3205(86)90356-5\nLittleton, 1990, Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecifivity and actions of BAY K 8644, Psychopharmacology, 100, 387, 10.1007\u002FBF02244612\nLlinas, 1988, The intrinsic electrophysiological properties of mammalian neurones: insights into central nervous system function, Science, 242, 1654, 10.1126\u002Fscience.3059497\nLlinas, 1986, Specific blockage of the low threshold calcium channel by high molecular weight alcohols, Soc. Neurosci. Abstr., 12, 174\nLovinger, 1989, Ethanol inhibits NMDA activated ion currents in hippocampal neurones, Science, 243, 1721, 10.1126\u002Fscience.2467382\nLucchi, 1985, Ethanol administration in vivo alters calcium ions control in rat straitum, Brain Res., 332, 376, 10.1016\u002F0006-8993(85)90608-0\nLuthin, 1984, Effects of ethanol on calmodulin levels in mouse striatum and cerebral cortex, Alcohol. clin. exp. Res., 8, 68\nLynch, 1983, Possible association of alcohol tolerance with increased synaptic Ca2+ sensitivity, Nature, 303, 175, 10.1038\u002F303175a0\nMacdonald, 1979, Anticonvulsant and anaesthetic barbiturates: different postsynaptic actions in cultured mammalian neurones, Neurology, 29, 432, 10.1212\u002FWNL.29.4.432\nMajchrowicz, 1975, Induction of physical dependence upon ethanol and the associated behavioural changes in the rat, Psychopharmacology, 43, 245, 10.1007\u002FBF00429258\nMansour, 1988, Anatomy of CNS opioid receptors, Trends Neurosci., 11, 308, 10.1016\u002F0166-2236(88)90093-8\nMarks, 1989, Comparative effects of chronic exposure to ethanol and calcium channel antagonists on calcium antagonists receptors in cultured neural (PC12) cells, J. Neurochem., 53, 168, 10.1111\u002Fj.1471-4159.1989.tb07309.x\nMcCaslin, 1987, 2-amino-7-phosphonohepatanic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats, Neuropharmacology, 26, 731, 10.1016\u002F0028-3908(87)90235-8\nMcCaslin, 1988, Anticonvulsant activity of several excitatory amino acid antagonists against barbital induced spontaneous convulsions, Eur. J. Pharmac., 147, 381, 10.1016\u002F0014-2999(88)90172-0\nMcCaslin, 1989, Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats, Eur. J. Pharmac., 173, 127, 10.1016\u002F0014-2999(89)90509-8\nMello, 1973, A review of methods to induce alcohol addiction in animals, Pharmac. Biochem. Behav., 1, 89, 10.1016\u002F0091-3057(73)90061-0\nMenelson, 1984, Nifedipine blocks sleep induction by flurazepam in the rat, Sleep, 7, 64, 10.1093\u002Fsleep\u002F7.1.64\nMendelson, 1984, Diazepam stimulated increases in the synaptosomal uptake pf 45Ca2+: reversal by dihydropyridine calcium channel antagonists, Eur. J. Pharmac., 104, 181, 10.1016\u002F0014-2999(84)90388-1\nMessing, 1986, Ethanol regulates calcium channels in clonal neural cells, 83, 6213\nMichaelis, 1979, Calcium binding to brain synaptosomes, effects of chronic ethanol intake, Biochem. Pharmac., 28, 2081, 10.1016\u002F0006-2952(79)90227-2\nMichaelis, 1985, Differential effects of ethanol on two synaptic membrane calcium transport systems, Alcohol, 100, 129, 10.1016\u002F0741-8329(85)90029-1\nMichaelis, 1987, Effects of chronic ethanol administration of synaptic membrane Na+-Ca2+ exchange activity, Brain Res., 414, 239, 10.1016\u002F0006-8993(87)90004-7\nMiljkovic, 1986, Voltage-dependent block of excitatory amino acid currents by pentobarbital, Brain Res., 376, 396, 10.1016\u002F0006-8993(86)90207-6\nMorgan, 1977, Pentobarbital: presynaptic effect in squid giant synapse, Experientia, 33, 487, 10.1007\u002FBF01922226\nNicoll, 1980, The effects of pentobarbital and related compounds on frog motoneurons, Brain Res., 191, 225, 10.1016\u002F0006-8993(80)90325-X\nNiesen, 1988, Reversed ethanol effects on potassium conductances in aged hippocampal dentate granule neurones, Brain Res., 445, 137, 10.1016\u002F0006-8993(88)91082-7\nNishi, 1983, Barbiturates increased the rate of voltage-dependent inactivation of the calcium current in snail neurones, Br. J. Pharmac., 80, 761, 10.1111\u002Fj.1476-5381.1983.tb10068.x\nNowycky, 1985, Three types of neuronal calcium channel with different calcium agonist sensitivity, Nature, 316, 440, 10.1038\u002F316440a0\nNutt, 1982, Unusual interactions of benzodiazepine receptor antagonists, Nature, 295, 436, 10.1038\u002F295436a0\nOakes, 1982, Electrophysiological effects of acute ethanol exposure. II. Alterations in the calcium component of action potentials from sensory neurons in dissociated culture, Devl Brain Res., 5, 251, 10.1016\u002F0165-3806(82)90123-7\nOgata, 1972, A comparison of techniques to induce alcohol dependence and tolerance in the mouse, J. Pharmac. exp. Ther., 180, 216\nOgura, 1984, Differential effects of a dihydropyridine derivative to Ca2+ entry pathways in neuronal preparations, Brain Res., 201, 323, 10.1016\u002F0006-8993(84)91101-6\nOhnishi, 1988, Decrease in analgesic effect of nifedipine following chronic administration of morphine, Eur. J. Pharmac., 158, 173, 10.1016\u002F0014-2999(88)90270-1\nOhnishi, 1989, Changes in [3H]-nitrendipine binding and gamma-aminobutyric acid release in rat hippocampus following repeated morphine administration, J. Neurochem., 53, 1507, 10.1111\u002Fj.1471-4159.1989.tb08545.x\nOlsen, 1981, GABA-benzodiazepine-barbiturate receptor interactions, J. Neurochem., 37, 1, 10.1111\u002Fj.1471-4159.1981.tb05284.x\nPant, 1985, Cerebral alteration in calmodulin levels associated with the induction of physical dependence upon ethanol in rats, Brain Res., 342, 379, 10.1016\u002F0006-8993(85)91141-2\nPanza, 1985, Evidence for down regulation of 3H-nitrendipine recognition sites in mouse brain about long term treatment with nifedipine or verapamil, Neuropharmacology, 24, 1113, 10.1016\u002F0028-3908(85)90200-X\nPillai, 1986, Interaction of k-receptor agonists with Ca2+ channel antagonists in the modulation of hypothermia, Eur. J. Pharmac., 132, 237, 10.1016\u002F0014-2999(86)90610-2\nPucilowski, 1989, Different effect of diltiazen and nifedipine on some central actions of ethanol in the rat, Alcohol, 6, 165, 10.1016\u002F0741-8329(89)90042-6\nRabbani, 1990, Increased action of the partial inverse agonist, FG 7142, during barbiturate withdrawal; protective effect of the calcium channel antagonist, nitrendipine, Br. J. Pharmac., 100, 422P\nRabbani, 1990, Changes in dihydropyridine binding in the cerebral cortex following chronic barbital treatment, Br. J. Pharmac., 101, 568P\nRabbani, 1991, An NMDA antagonist protects against the barbiturate withdrawal syndrome, but does not appear to cause cross-tolerance, Br. J. Pharmac.\nRamkumar, 1988, Morphine treatment increases [3H]-nimodipine binding sites in rat brain, Ann. N.Y. Acad. Sci., 552, 207, 10.1111\u002Fj.1749-6632.1988.tb33357.x\nRamkumar, 1988, Prolonged morphine treatment increase rat brain dihydropyridine binding sites: possible involvement in development of dependence, Eur. J. Pharmac., 146, 73, 10.1016\u002F0014-2999(88)90488-8\nRegehr, 1989, Optical imaging of calcium accumulation in hippocampal pyramidal cells during synaptic activation, Nature, 341, 533, 10.1038\u002F341533a0\nReynolds, 1990, Ethanol tolerance in hippocampal neurones: adaptive changes in cellular responses to ethanol measured in vivo, J. Pharmac. exp. Ther., 252, 265\nRitzmann, 1976, Body temperature in mice: A quantitative measure of alcohol tolerance and physical dependence, J. Pharmac. exp. Ther., 199, 158\nRius, 1987, Acute ethanol effect on calcium antagonist binding in rat brain, Brain Res., 402, 359, 10.1016\u002F0006-8993(87)90045-X\nRoss, 1980, Molecular aspects of calcium-membrane interactions: a model for cellular adaptation to ethanol, 227\nRoss, 1986, Chronic ethanol administration inhibits calmodulin dependent Ca2+ uptake in synaptosomal membranes, Pharmac. Biochem. Behav., 24, 1659, 10.1016\u002F0091-3057(86)90502-2\nRoss, 1979, Nerve cell calcium as a messenger for opiate and endorphin actions, Adv. Biochem. Psychopharmac., 20, 301\nRoss, 1974, Morphine and ethanol: selective depletion of regional brain calcium, Science, 186, 63, 10.1126\u002Fscience.186.4158.63\nRoss, 1977, Modification of glycoprotein residues as Ca2+ receptor sites after chronic ethanol exposure, Drug Alcohol Dep., 2, 303, 10.1016\u002F0376-8716(77)90033-3\nSaito, 1985, Selective enhancement in striatal [3H]-nitrendipine binding following chronic treatment with morphine, Neurochem. Int., 6, 1033, 10.1016\u002F0197-0186(85)90152-4\nSanna, 1986, Evidence for a selective localisation of voltage sensitive Ca2+ channels in nerve cell bodies of corpus striatum, J. Neurochem., 47, 1552, 10.1111\u002Fj.1471-4159.1986.tb00794.x\nSawada, 1985, Blocking action of pentobarbital on receptors for excitatory amino acids in the guinea pig hippocampus, Expl Brain Res., 59, 226, 10.1007\u002FBF00230901\nScott, 1990, Modulation of neuronal T-type calcium channel currents by photoactivation of intracellular guanosine 5′-o(3-thio) triphosphate, Neuroscience, 38, 285, 10.1016\u002F0306-4522(90)90028-3\nShah, 1988, Spontaneous calcium release induced by ethanol in the isolated rat brain microsomes, Brain Res., 474, 94, 10.1016\u002F0006-8993(88)90672-5\nShanley, 1985, Ethanol tolerance and enhanced calcium\u002Fcalmodulin dependent phosphorylation of synaptic membrane proteins, Neurosci. Lett., 58, 55, 10.1016\u002F0304-3940(85)90328-3\nSiggins, 1987, Effects of ethanol on CA1 and CA3 pyramidal cells in the hippocampal slice preparation: an intracellular study, Brain Res., 414, 22, 10.1016\u002F0006-8993(87)91323-0\nSkerritt, 1984, Diazepam and its analogous p-chloro derivative, Ro 5-4864. Comparative effects on mouse neurones in cell culture, Brain Res., 310, 99, 10.1016\u002F0006-8993(84)90013-1\nSpedding, 1985, Calcium antagonist subgroups, Trends Pharmac. Sci., 6, 109, 10.1016\u002F0165-6147(85)90052-5\nSquires, 1977, Benzodiazepine receptors in rat brain, Nature, 266, 732, 10.1038\u002F266732a0\nSwandulla, 1991, Do calcium channel classifications account for neuronal calcium channel diversity, Trends Neurosci., 14, 46, 10.1016\u002F0166-2236(91)90018-P\nSzikszay, 1986, Interactions between verapamil and morphine on physiological parameters in rats, J. Pharmac. exp. Ther., 238, 192\nTaft, 1984, Micromolar affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminals, 81, 3118\nTakahashi, 1989, Hippocampal CA1 pyramidal cells of rats have four voltage-dependent calcium conductances, Neurosci. Lett., 104, 229, 10.1016\u002F0304-3940(89)90359-5\nTeichberg, 1984, Barbiturates, alcohols and the CNS excitatory transmission: specific effects on the kainate and quisqualate receptors, Brain Res., 291, 285, 10.1016\u002F0006-8993(84)91260-5\nThayer, 1986, Widespread distribution of dihydropyridine sensitive calcium channels in the central nervous system, Molec. Pharmac., 30, 505\nTsien, 1988, Multiple types of neuronal calcium channels and their selective modulation, Trends Neurosci., 11, 431, 10.1016\u002F0166-2236(88)90194-4\nTsunoo, 1986, Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG108-15 cells, 83, 9832\nVirmani, 1985, Alteration in calcium binding activity in synaptosomal membranes from rat brains in association with physical dependence upon ethanol, Brain Res., 359, 371, 10.1016\u002F0006-8993(85)91454-4\nWatlins, 1981, Excitatory amino acid transmitters, A. Rev. Pharmac. Toxic., 21, 165, 10.1146\u002Fannurev.pa.21.040181.001121\nWenger, 1981, Ethanol tolerance in the rat is learned, Science, 213, 575, 10.1126\u002Fscience.7244656\nWerz, 1985, Barbiturates decrease voltage dependent calcium conductance of mouse neurons in dissociated cell cultured, Molec. Pharmac., 28, 269\nWestenbroek, 1990, Clustering of L-type calcium channels at the base of major dendrites in hippocampal pyramidal neurones, Nature, 347, 281, 10.1038\u002F347281a0\nWhittington, 1989, Chronic ethanol increases excitability and hippocampal cell bodies; effects decreased by chronic nitrendipine treatment, Br. J. Pharmac., 97, 435P\nWhittington, 1990, Patterns of changes in field potentials in the isolated hippocampal slice on withdrawal from chronic ethanol treatment of mice in vivo, Brain Res., 523, 237, 10.1016\u002F0006-8993(90)91492-Y\nWhittington, 1991, A calcium channel antagonists stereoaselectively decreases ethanol withdrawal hyperexcitability, but not due to bicuculline, in hippocampal slices, Br. J. Pharmac., 103, 1313, 10.1111\u002Fj.1476-5381.1991.tb09786.x\nWhittington, 1991, Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal, Br. J. Pharmac., 103, 1677, 10.1111\u002Fj.1476-5381.1991.tb09846.x\nWhityington, 1991, Chronic dihydropyridine treatment can reverse the behavioural consequences and prevent adaptations to chronic ethanol, Br. J. Pharmac., 103, 1669, 10.1111\u002Fj.1476-5381.1991.tb09845.x\nWu, 1987, J. Neurochem. Suppl., 48, 5109D\nWu, 1987, Nifedipine delays the acquisition of ethanol tolerance, Eur. J. Pharmac., 139, 233, 10.1016\u002F0014-2999(87)90256-1\nXiang, 1990, The k-opiate agonist U50488H decreases the entry of 45Ca into rat cortical synaptosomes by inhibiting N- but not L-type calcium channels, Neuropharmacology, 29, 439, 10.1016\u002F0028-3908(90)90165-N\nYamamoto, 1978, Effects of acute and chronic morphine treatments on calcium localization and binding in brain, J. Pharmac. exp. Ther., 205, 255",{"EN":452},"The role of neuronal calcium channels in dependence on ethanol and other sedatives\u002Fhypnotics",{"VOID":454},"10.1016\u002F0163-7258(91)90050-v","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F016372589190050V",[457],{"id":458,"sortIndex":19,"researcher":18,"roles":459,"affiliations":460,"properties":469},"355bc724-7a5b-4c45-b98b-09269d2008b7",[126],[461],{"id":18,"sortIndex":19,"affiliation":462,"properties":18},{"id":463,"createTime":464,"updateTime":464,"relativeEntities":465,"slug":18,"properties":466,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"564674c2-150c-4c5c-8a13-d7c25819298c","2024-01-03T05:32:51.803+00:00",[],{"title":467},{"VI":468},"Pharmacology Department, The Medical School, University Walk, Bristol BS8 1TD, U.K.",{"title":470},{"VI":471},"H.J. Little",{"url":455,"publisher":473,"properties":495},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":474,"slug":10,"properties":475,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":478,"manageAffiliations":479,"indexDatabases":480,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":476,"title":477},{"VOID":13},{"EN":15},[],[],[481,488],{"id":83,"indexDatabase":482,"url":98,"indexYears":18,"academicFieldIds":487,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":483,"label":484,"description":485,"key":94,"publicationTags":486,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":489,"url":76,"indexYears":77,"academicFieldIds":494,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":490,"label":491,"description":492,"key":73,"publicationTags":493,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":496,"pages":498},{"VOID":497},"50",{"VOID":499},"347-365","1991-01-01",1991,{"id":503,"createTime":504,"updateTime":504,"relativeEntities":505,"slug":18,"properties":506,"entityType":118,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":513,"fullTextUrl":18,"authors":514,"publicationType":155,"publisherRelationship":544,"citationCount":18,"citationInfo":18,"publishDate":572,"publishYear":573,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"d7387296-156b-40da-be0d-81e72ef50fe8","2024-01-05T23:58:13.210+00:00",[],{"references":507,"title":509,"doi":511},{"VOID":508},"Abba, 2016, MicroRNA regulation of epithelial to mesenchymal transition, Journal of Clinical Medicine, 5, 8, 10.3390\u002Fjcm5010008\nAndrae, 2008, Role of platelet-derived growth factors in physiology and medicine, Genes & Development, 22, 1276, 10.1101\u002Fgad.1653708\nAurora, 2014, Macrophages are required for neonatal heart regeneration, The Journal of Clinical Investigation, 124, 1382, 10.1172\u002FJCI72181\nBanai, 1994, Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs, Circulation, 89, 2183, 10.1161\u002F01.CIR.89.5.2183\nBanerjee, 2012, Thymosin beta 4 is dispensable for murine cardiac development and function, Circulation Research, 110, 456, 10.1161\u002FCIRCRESAHA.111.258616\nBao, 2016, Long-term self-renewing human epicardial cells generated from pluripotent stem cells under defined xeno-free conditions, Nature Biomedical Engineering, 1, 0003, 10.1038\u002Fs41551-016-0003\nBartram, 2001, Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-β2-knockout mice, Circulation, 103, 2745, 10.1161\u002F01.CIR.103.22.2745\nBlom, 2016, Myocardial infarction in neonatal mice, a model of cardiac regeneration, Journal of Visualized Experiments, 111\nBlom, 2016, Primary cilia disassembly promotes mammalian cardiac regeneration, The FASEB Journal, 30, 1207.7\nBoopathy, 2015, Intramyocardial delivery of notch ligand-containing hydrogels improves cardiac function and angiogenesis following infarction, Tissue Engineering. Part A, 21, 2315, 10.1089\u002Ften.tea.2014.0622\nBorovina, 2010, Vangl2 directs the posterior tilting and asymmetric localization of motile primary cilia, Nature Cell Biology, 12, 407, 10.1038\u002Fncb2042\nBronnum, 2013, miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving programmed cell death 4 and Sprouty-1, PLoS One, 8, 10.1371\u002Fjournal.pone.0056280\nCai, 2008, A myocardial lineage derives from Tbx18 epicardial cells, Nature, 454, 104, 10.1038\u002Fnature06969\nCao, 2010, Intraflagellar transport proteins are essential for cilia formation and for planar cell polarity, Journal of the American Society of Nephrology: JASN, 21, 1326, 10.1681\u002FASN.2009091001\nCaspary, 2007, The graded response to sonic hedgehog depends on cilia architecture, Developmental Cell, 12, 767, 10.1016\u002Fj.devcel.2007.03.004\nCervantes, 2010, Primary cilia regulate Gli\u002Fhedgehog activation in pancreas, Proceedings of the National Academy of Sciences of the United States of America, 107, 10109, 10.1073\u002Fpnas.0909900107\nChen, 2002, Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor, Developmental Biology, 250, 198, 10.1006\u002Fdbio.2002.0796\nChen, 2013, Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery, Gene Therapy, 20, 225, 10.1038\u002Fgt.2012.89\nChiu, 2012, Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction, Regenerative Medicine, 7, 523, 10.2217\u002Frme.12.35\nChristensen, 2017, Primary cilia and coordination of receptor tyrosine kinase (RTK) and transforming growth factor β (TGF-β) signaling, Cold Spring Harbor Perspectives in Biology, 9, 10.1101\u002Fcshperspect.a028167\nChristia, 2013, Targeting inflammatory pathways in myocardial infarction, European Journal of Clinical Investigation, 43, 986, 10.1111\u002Feci.12118\nClement, 2013, TGF-β signaling is associated with endocytosis at the pocket region of the primary cilium, Cell Reports, 3, 1806, 10.1016\u002Fj.celrep.2013.05.020\nClement, 2009, The primary cilium coordinates early cardiogenesis and hedgehog signaling in cardiomyocyte differentiation, Journal of Cell Science, 122, 3070, 10.1242\u002Fjcs.049676\nCong, 2013, Downregulated microRNA-200a promotes EMT and tumor growth through the Wnt\u002Fβ-catenin pathway by targeting the E-cadherin repressors ZEB1\u002FZEB2 in gastric adenocarcinoma, Oncology Reports, 29, 1579, 10.3892\u002For.2013.2267\nCorbit, 2008, Kif3a constrains β-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms, Nature Cell Biology, 10, 70, 10.1038\u002Fncb1670\nDavenport, 2005, An incredible decade for the primary cilium: A look at a once-forgotten organelle, American Journal of Physiology. Renal Physiology, 289, F1159, 10.1152\u002Fajprenal.00118.2005\nDavid, 2012, Dishonorable discharge: The oncogenic roles of cleaved E-cadherin fragments, Cancer Research, 72, 2917, 10.1158\u002F0008-5472.CAN-11-3498\nde Vreede, 1991, Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis, Journal of the American College of Cardiology, 18, 698, 10.1016\u002F0735-1097(91)90792-8\nDelewi, 2014, Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: A collaborative meta-analysis, European Heart Journal, 35, 989, 10.1093\u002Feurheartj\u002Feht372\nDjebali, 2012, Landscape of transcription in human cells, Nature, 489, 101, 10.1038\u002Fnature11233\nDuan, 2012, Wnt1\u002Fβ-catenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair, The EMBO Journal, 31, 429, 10.1038\u002Femboj.2011.418\nDuim, 2015, Cardiac endothelial cells express Wilms' tumor-1: Wt1 expression in the developing, adult and infarcted heart, Journal of Molecular and Cellular Cardiology, 81, 127, 10.1016\u002Fj.yjmcc.2015.02.007\nEgorova, 2011, Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition, Circulation Research, 108, 1093, 10.1161\u002FCIRCRESAHA.110.231860\nEncode Project Consortium, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038\u002Fnature11247\nEzratty, 2011, A role for the primary cilium in notch signaling and epidermal differentiation during skin development, Cell, 145, 1129, 10.1016\u002Fj.cell.2011.05.030\nFang, 2016, Epicardium-derived fibroblasts in heart development and disease, Journal of Molecular and Cellular Cardiology, 91, 23, 10.1016\u002Fj.yjmcc.2015.12.019\nFoglio, 2015, Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis, International Journal of Cardiology, 197, 333, 10.1016\u002Fj.ijcard.2015.06.008\nForsythe, 1996, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Molecular and Cellular Biology, 16, 4604, 10.1128\u002FMCB.16.9.4604\nFrangogiannis, 2014, The immune system and the remodeling infarcted heart: Cell biological insights and therapeutic opportunities, Journal of Cardiovascular Pharmacology, 63, 185, 10.1097\u002FFJC.0000000000000003\nFujita, 2005, Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction, The Journal of Surgical Research, 126, 27, 10.1016\u002Fj.jss.2004.12.025\nGaetani, 2015, Epicardial application of cardiac progenitor cells in a 3D-printed gelatin\u002Fhyaluronic acid patch preserves cardiac function after myocardial infarction, Biomaterials, 61, 339, 10.1016\u002Fj.biomaterials.2015.05.005\nGerber, 2016, Mortality associated with heart failure after myocardial infarction: A contemporary community perspective, Circulation. Heart Failure, 9, 10.1161\u002FCIRCHEARTFAILURE.115.002460\nGermani, 2015, Generation of cardiac progenitor cells through epicardial to mesenchymal transition, Journal of Molecular Medicine (Berlin, Germany), 93, 735, 10.1007\u002Fs00109-015-1290-2\nGherghiceanu, 2012, Cardiac telocytes - Their junctions and functional implications, Cell and Tissue Research, 348, 265, 10.1007\u002Fs00441-012-1333-8\nGidh-Jain, 1998, Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction, Journal of Molecular and Cellular Cardiology, 30, 627, 10.1006\u002Fjmcc.1997.0628\nGong, 2018, Knockdown of long non-coding RNA MEG3 protects H9c2 cells from hypoxia-induced injury by targeting microRNA-183, Journal of Cellular Biochemistry, 119, 1429, 10.1002\u002Fjcb.26304\nGonzalez-Rosa, 2012, Pan-epicardial lineage tracing reveals that epicardium derived cells give rise to myofibroblasts and perivascular cells during zebrafish heart regeneration, Developmental Biology, 370, 173, 10.1016\u002Fj.ydbio.2012.07.007\nGrieskamp, 2011, Notch signaling regulates smooth muscle differentiation of epicardium-derived cells, Circulation Research, 108, 813, 10.1161\u002FCIRCRESAHA.110.228809\nGuadix, 2011, Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2, Development, 138, 1093, 10.1242\u002Fdev.044594\nGuo, 2017, Regulatory non-coding RNAs in acute myocardial infarction, Journal of Cellular and Molecular Medicine, 21, 1013, 10.1111\u002Fjcmm.13032\nGutschner, 2013, MALAT1 — A paradigm for long noncoding RNA function in cancer, Journal of Molecular Medicine (Berlin, Germany), 91, 791, 10.1007\u002Fs00109-013-1028-y\nHartsock, 2008, Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton, Biochimica et Biophysica Acta, 1778, 660, 10.1016\u002Fj.bbamem.2007.07.012\nHassounah, 2012, Molecular pathways: The role of primary cilia in cancer progression and therapeutics with a focus on hedgehog signaling, Clinical Cancer Research, 18, 2429, 10.1158\u002F1078-0432.CCR-11-0755\nHaubner, 2012, Complete cardiac regeneration in a mouse model of myocardial infarction, Aging (Albany NY), 4, 966, 10.18632\u002Faging.100526\nHayashi, 2015, The spectrum of epidemiology underlying sudden cardiac death, Circulation Research, 116, 1887, 10.1161\u002FCIRCRESAHA.116.304521\nHaycraft, 2005, Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function, PLoS Genetics, 1, 10.1371\u002Fjournal.pgen.0010053\nHeery, 2017, Long non-coding RNAs: Key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells, Cancer, 9, 38, 10.3390\u002Fcancers9040038\nHesse, 2017, CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction, FASEB Journal, 31, 3040, 10.1096\u002Ffj.201601307R\nHuangfu, 2003, Hedgehog signalling in the mouse requires intraflagellar transport proteins, Nature, 426, 83, 10.1038\u002Fnature02061\nIbrahim, 2017, Hypoxia causes downregulation of dicer in hepatocellular carcinoma, which is required for upregulation of hypoxia-inducible factor 1α and epithelial-mesenchymal transition, Clinical Cancer Research, 1\nIyer, 2015, Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells, Development, 142, 1528, 10.1242\u002Fdev.119271\nJacoby, 2009, INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse, Nature Genetics, 41, 1027, 10.1038\u002Fng.427\nJechlinger, 2006, Autocrine PDGFR signaling promotes mammary cancer metastasis, The Journal of Clinical Investigation, 116, 1561, 10.1172\u002FJCI24652\nJeong, 2013, The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction, Stem Cell Research & Therapy, 4, 82, 10.1186\u002Fscrt233\nJi, 2003, MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer, Oncogene, 22, 8031, 10.1038\u002Fsj.onc.1206928\nJing, 2016, Hypoxia induced the differentiation of Tbx18-positive epicardial cells to CoSMCs, Scientific Reports, 6\nJones, 2008, Ciliary proteins link basal body polarization to planar cell polarity regulation, Nature Genetics, 40, 69, 10.1038\u002Fng.2007.54\nJopling, 2010, Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation, Nature, 464, 606, 10.1038\u002Fnature08899\nKikuchi, 2011, Tcf21+ epicardial cells adopt non-myocardial fates during zebrafish heart development and regeneration, Development, 138, 2895, 10.1242\u002Fdev.067041\nKim, 2010, PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts, Proceedings of the National Academy of Sciences of the United States of America, 107, 17206, 10.1073\u002Fpnas.0915016107\nKoefoed, 2014, Cilia and coordination of signaling networks during heart development, Organogenesis, 10, 108, 10.4161\u002Forg.27483\nKong, 2009, miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells, Stem Cells, 27, 1712, 10.1002\u002Fstem.101\nKorpal, 2008, The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis, RNA Biology, 5, 115, 10.4161\u002Frna.5.3.6558\nKorpal, 2008, The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2, The Journal of Biological Chemistry, 283, 14910, 10.1074\u002Fjbc.C800074200\nKoudstaal, 2014, Sustained delivery of insulin-like growth factor-1\u002Fhepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart, Journal of Cardiovascular Translational Research, 7, 232, 10.1007\u002Fs12265-013-9518-4\nKozminski, 1993, A motility in the eukaryotic flagellum unrelated to flagellar beating, Proceedings of the National Academy of Sciences of the United States of America, 90, 5519, 10.1073\u002Fpnas.90.12.5519\nKreidberg, 1993, WT-1 is required for early kidney development, Cell, 74, 679, 10.1016\u002F0092-8674(93)90515-R\nKumarswamy, 2012, MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer, International Journal of Cancer, 130, 2044, 10.1002\u002Fijc.26218\nLamouille, 2013, Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs, Current Opinion in Cell Biology, 25, 200, 10.1016\u002Fj.ceb.2013.01.008\nLamouille, 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nature Reviews. Molecular Cell Biology, 15, 178, 10.1038\u002Fnrm3758\nLancaster, 2011, Subcellular spatial regulation of canonical Wnt signalling at the primary cilium, Nature Cell Biology, 13, 700, 10.1038\u002Fncb2259\nLechtreck, 2015, IFT-cargo interactions and protein transport in cilia, Trends in Biochemical Sciences, 40, 765, 10.1016\u002Fj.tibs.2015.09.003\nLeitch, 2014, Basal body proteins regulate notch signaling through endosomal trafficking, Journal of Cell Science, 127, 2407, 10.1242\u002Fjcs.130344\nLepilina, 2006, A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration, Cell, 127, 607, 10.1016\u002Fj.cell.2006.08.052\nLetterio, 1994, Maternal rescue of transforming growth factor-beta 1 null mice, Science, 264, 1936, 10.1126\u002Fscience.8009224\nLi, 2015, Global genetic analysis in mice unveils central role for cilia in congenital heart disease, Nature, 521, 520, 10.1038\u002Fnature14269\nLimana, 2010, Myocardial infarction induces embryonic reprogramming of epicardial c-kit+ cells: Role of the pericardial fluid, Journal of Molecular and Cellular Cardiology, 48, 609, 10.1016\u002Fj.yjmcc.2009.11.008\nLin, 2003, Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease, Proceedings of the National Academy of Sciences of the United States of America, 100, 5286, 10.1073\u002Fpnas.0836980100\nLiu, 2014, Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials, International Journal of Cardiology, 177, 764, 10.1016\u002Fj.ijcard.2014.11.005\nLiu, 2014, Epicardium-to-fat transition in injured heart, Cell Research, 24, 1367, 10.1038\u002Fcr.2014.125\nMa, 2005, PKD2 functions as an epidermal growth factor-activated plasma membrane channel, Molecular and Cellular Biology, 25, 8285, 10.1128\u002FMCB.25.18.8285-8298.2005\nMa, 2005, Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning, Development, 132, 5601, 10.1242\u002Fdev.02156\nMa, 2010, miR-9, a MYC\u002FMYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nature Cell Biology, 12, 247, 10.1038\u002Fncb2024\nManner, 1999, Does the subepicardial mesenchyme contribute myocardioblasts to the myocardium of the chick embryo heart? A quail-chick chimera study tracing the fate of the epicardial primordium, The Anatomical Record, 255, 212, 10.1002\u002F(SICI)1097-0185(19990601)255:2\u003C212::AID-AR11>3.0.CO;2-X\nMannherz, 2009, The beta-thymosins: Intracellular and extracellular activities of a versatile actin binding protein family, Cell Motility and the Cytoskeleton, 66, 839, 10.1002\u002Fcm.20371\nMartinez-Estrada, 2010, Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of snail and E-cadherin, Nature Genetics, 42, 89, 10.1038\u002Fng.494\nMay-Simera, 2010, Bbs8, together with the planar cell polarity protein Vangl2, is required to establish left-right asymmetry in zebrafish, Developmental Biology, 345, 215, 10.1016\u002Fj.ydbio.2010.07.013\nMellgren, 2008, Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations, Circulation Research, 103, 1393, 10.1161\u002FCIRCRESAHA.108.176768\nMendez, 2010, Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition, The FASEB Journal, 24, 1838, 10.1096\u002Ffj.09-151639\nMerki, 2005, Epicardial retinoid X receptor α is required for myocardial growth and coronary artery formation, Proceedings of the National Academy of Sciences of the United States of America, 102, 18455, 10.1073\u002Fpnas.0504343102\nMewhort, 2014, Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling, The Journal of Thoracic and Cardiovascular Surgery, 147, 1650, 10.1016\u002Fj.jtcvs.2013.08.005\nMichalik, 2014, Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth, Circulation Research, 114, 1389, 10.1161\u002FCIRCRESAHA.114.303265\nMissinato, 2015, Extracellular component hyaluronic acid and its receptor Hmmr are required for epicardial EMT during heart regeneration, Cardiovascular Research, 107, 487, 10.1093\u002Fcvr\u002Fcvv190\nMitsos, 2012, Therapeutic angiogenesis for myocardial ischemia revisited: Basic biological concepts and focus on latest clinical trials, Angiogenesis, 15, 1, 10.1007\u002Fs10456-011-9240-2\nMiyagawa, 2017, Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy, Journal of the American Heart Association, 6, 10.1161\u002FJAHA.116.003918\nMondal, 2015, MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA-DNA triplex structures, Nature Communications, 6, 7743, 10.1038\u002Fncomms8743\nMoore, 1999, YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis, Development, 126, 1845, 10.1242\u002Fdev.126.9.1845\nMoyer, 1994, Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice, Science, 264, 1329, 10.1126\u002Fscience.8191288\nMurcia, 2000, The oak ridge polycystic kidney (Orpk) disease gene is required for left-right axis determination, Development, 127, 2347, 10.1242\u002Fdev.127.11.2347\nMurry, 2004, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts, Nature, 428, 664, 10.1038\u002Fnature02446\nNeugebauer, 2009, FGF signalling during embryo development regulates cilia length in diverse epithelia, Nature, 458, 651, 10.1038\u002Fnature07753\nNielsen, 2015, PDGFRβ and oncogenic mutant PDGFRα D842V promote disassembly of primary cilia through a PLCγ- and AURKA-dependent mechanism, Journal of Cell Science, 128, 3543, 10.1242\u002Fjcs.173559\nOishi, 2006, Regulation of primary cilia formation and left-right patterning in zebrafish by a noncanonical Wnt signaling mediator, duboraya, Nature Genetics, 38, 1316, 10.1038\u002Fng1892\nOlson, 2009, The actin cytoskeleton in cancer cell motility, Clinical & Experimental Metastasis, 26, 273, 10.1007\u002Fs10585-008-9174-2\nPaunovic, 2017, Phenotypic screen for cardiac regeneration identifies molecules with differential activity in human epicardium-derived cells versus cardiac fibroblasts, ACS Chemical Biology, 12, 132, 10.1021\u002Facschembio.6b00683\nPazour, 2000, Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella, The Journal of Cell Biology, 151, 709, 10.1083\u002Fjcb.151.3.709\nPennisi, 2009, FGFR-1 is required by epicardium-derived cells for myocardial invasion and correct coronary vascular lineage differentiation, Developmental Biology, 328, 148, 10.1016\u002Fj.ydbio.2009.01.023\nPiccoli, 2017, Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction, Circulation Research, 121, 575, 10.1161\u002FCIRCRESAHA.117.310624\nPopescu, 2010, Telocytes in human epicardium, Journal of Cellular and Molecular Medicine, 14, 2085, 10.1111\u002Fj.1582-4934.2010.01129.x\nPorrello, 2011, Transient regenerative potential of the neonatal mouse heart, Science, 331, 1078, 10.1126\u002Fscience.1200708\nPorrello, 2013, Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family, Proceedings of the National Academy of Sciences of the United States of America, 110, 187, 10.1073\u002Fpnas.1208863110\nPoss, 2002, Heart regeneration in zebrafish, Science, 298, 2188, 10.1126\u002Fscience.1077857\nPtaszek, 2012, Towards regenerative therapy for cardiac disease, Lancet, 379, 933, 10.1016\u002FS0140-6736(12)60075-0\nPublic Health Agency of Canada, 2009, Tracking heart and stroke in Canada 2009\nRamjee, 2017, Epicardial YAP\u002FTAZ orchestrate an immunosuppressive response following myocardial infarction, The Journal of Clinical Investigation, 127, 899, 10.1172\u002FJCI88759\nRane, 2011, Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction, PLoS One, 6, 10.1371\u002Fjournal.pone.0021571\nRao, 2015, Human epicardial cell-conditioned medium contains HGF\u002FIgG complexes that phosphorylate RYK and protect against vascular injury, Cardiovascular Research, 107, 277, 10.1093\u002Fcvr\u002Fcvv168\nReiss, 1993, ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure, The American Journal of Physiology, 264, H760\nRidley, 2011, Life at the leading edge, Cell, 145, 1012, 10.1016\u002Fj.cell.2011.06.010\nRohatgi, 2007, Patched1 regulates hedgehog signaling at the primary cilium, Science, 317, 372, 10.1126\u002Fscience.1139740\nRoush, 2008, The let-7 family of microRNAs, Trends in Cell Biology, 18, 505, 10.1016\u002Fj.tcb.2008.07.007\nRozycki, 2014, The fate of the primary cilium during myofibroblast transition, Molecular Biology of the Cell, 25, 643, 10.1091\u002Fmbc.e13-07-0429\nRui, 2014, Extending the time window of mammalian heart regeneration by thymosin β4, Journal of Cellular and Molecular Medicine, 18, 2417, 10.1111\u002Fjcmm.12421\nRuiz-Villalba, 2015, Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar, Journal of the American College of Cardiology, 65, 2057, 10.1016\u002Fj.jacc.2015.03.520\nRussell, 2011, A dynamic notch injury response activates epicardium and contributes to fibrosis repair, Circulation Research, 108, 51, 10.1161\u002FCIRCRESAHA.110.233262\nSadoshima, 1992, Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy, The Journal of Biological Chemistry, 267, 10551, 10.1016\u002FS0021-9258(19)50052-7\nSanchez-Duffhues, 2015, SLUG is expressed in endothelial cells lacking primary cilia to promote cellular calcification, Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 616, 10.1161\u002FATVBAHA.115.305268\nSasaki, 2013, The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium, PLoS One, 8, 10.1371\u002Fjournal.pone.0075010\nSchneider, 2010, Directional cell migration and chemotaxis in wound healing response to PDGF-AA are coordinated by the primary cilium in fibroblasts, Cellular Physiology and Biochemistry, 25, 279, 10.1159\u002F000276562\nSchneider, 2005, PDGFRαα signaling is regulated through the primary cilium in fibroblasts, Current Biology, 15, 1861, 10.1016\u002Fj.cub.2005.09.012\nSeeger, 2016, Inhibition of let-7 augments the recruitment of epicardial cells and improves cardiac function after myocardial infarction, Journal of Molecular and Cellular Cardiology, 94, 145, 10.1016\u002Fj.yjmcc.2016.04.002\nSeeley, 2009, Constructing and deconstructing roles for the primary cilium in tissue architecture and cancer, Methods in Cell Biology, 94, 299, 10.1016\u002FS0091-679X(08)94015-2\nSerpooshan, 2013, The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction, Biomaterials, 34, 9048, 10.1016\u002Fj.biomaterials.2013.08.017\nShyu, 2002, Intramyocardial injection of naked DNA encoding HIF-1α\u002FVP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat, Cardiovascular Research, 54, 576, 10.1016\u002FS0008-6363(02)00259-6\nSingh, 2011, MicroRNA-processing enzyme dicer is required in epicardium for coronary vasculature development, The Journal of Biological Chemistry, 286, 41036, 10.1074\u002Fjbc.M111.268573\nSmart, 2011, De novo cardiomyocytes from within the activated adult heart after injury, Nature, 474, 640, 10.1038\u002Fnature10188\nSmart, 2007, Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization, Nature, 445, 177, 10.1038\u002Fnature05383\nSmith, 2011, Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling, Circulation Research, 108, e15, 10.1161\u002FCIRCRESAHA.110.235531\nStark, 2016, Systemic dosing of thymosin beta 4 before and after ischemia does not attenuate global myocardial Iischemia-reperfusion injury in pigs, Frontiers in Pharmacology, 7, 115, 10.3389\u002Ffphar.2016.00115\nStatistics Canada, 2011\nSu, 2013, MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells, PLoS One, 8, 10.1371\u002Fjournal.pone.0071309\nSu, 2012, MicroRNA-200a suppresses the Wnt\u002Fβ-catenin signaling pathway by interacting with β-catenin, International Journal of Oncology, 40, 1162\nSun, 2014, Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer, Tumour Biology, 35, 1065, 10.1007\u002Fs13277-013-1142-z\nTalman, 2016, Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration, Cell and Tissue Research, 365, 563, 10.1007\u002Fs00441-016-2431-9\nTano, 2014, Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study, Molecular Therapy, 22, 1864, 10.1038\u002Fmt.2014.110\nTao, 2013, Epicardial HIF signaling regulates vascular precursor cell invasion into the myocardium, Developmental Biology, 376, 136, 10.1016\u002Fj.ydbio.2013.01.026\nTarride, 2009, A review of the cost of cardiovascular disease, The Canadian Journal of Cardiology, 25, e195, 10.1016\u002FS0828-282X(09)70098-4\nTaulman, 2001, Polaris, a protein involved in left-right axis patterning, localizes to basal bodies and cilia, Molecular Biology of the Cell, 12, 589, 10.1091\u002Fmbc.12.3.589\nTripathi, 2010, The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, Molecular Cell, 39, 925, 10.1016\u002Fj.molcel.2010.08.011\nUmberger, 2015, Ciliary transport regulates PDGF-AA\u002Fαα signaling via elevated mammalian target of rapamycin signaling and diminished PP2A activity, Molecular Biology of the Cell, 26, 350, 10.1091\u002Fmbc.e14-05-0952\nValenta, 2012, The many faces and functions of β-catenin, The EMBO Journal, 31, 2714, 10.1038\u002Femboj.2012.150\nvan den Akker, 2005, Platelet-derived growth factors in the developing avian heart and maturating coronary vasculature, Developmental Dynamics, 233, 1579, 10.1002\u002Fdvdy.20476\nvan den Borne, 2010, Myocardial remodeling after infarction: The role of myofibroblasts, Nature Reviews. Cardiology, 7, 30, 10.1038\u002Fnrcardio.2009.199\nVan der Heiden, 2006, Monocilia on chicken embryonic endocardium in low shear stress areas, Developmental Dynamics, 235, 19, 10.1002\u002Fdvdy.20557\nvan Tuyn, 2007, Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro, Stem Cells, 25, 271, 10.1634\u002Fstemcells.2006-0366\nvan Wijk, 2012, Cardiac regeneration from activated epicardium, PLoS One, 7, 10.1371\u002Fjournal.pone.0044692\nVicente-Steijn, 2015, Regional differences in WT-1 and Tcf21 expression during ventricular development: Implications for myocardial compaction, PLoS One, 10, 10.1371\u002Fjournal.pone.0136025\nVieira, 2017, BRG1-SWI\u002FSNF-dependent regulation of the Wt1 transcriptional landscape mediates epicardial activity during heart development and disease, Nature Communications, 8, 10.1038\u002Fncomms16034\nvon Gise, 2012, Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease, Circulation Research, 110, 1628, 10.1161\u002FCIRCRESAHA.111.259960\nWang, 2015, Epicardial regeneration is guided by cardiac outflow tract and hedgehog signalling, Nature, 522, 226, 10.1038\u002Fnature14325\nWang, 2015, Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: Insights from the Canadian global registry of acute coronary events, The Canadian Journal of Cardiology, 31, 1455, 10.1016\u002Fj.cjca.2015.04.007\nWang, 2017, Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium, Journal of Cellular and Molecular Medicine, 21, 1751, 10.1111\u002Fjcmm.13097\nWare, 1997, Angiogenesis in ischemic heart disease, Nature Medicine, 3, 158, 10.1038\u002Fnm0297-158\nWei, 2015, Epicardial FSTL1 reconstitution regenerates the adult mammalian heart, Nature, 525, 479, 10.1038\u002Fnature15372\nWinter, 2007, Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart, Circulation, 116, 917, 10.1161\u002FCIRCULATIONAHA.106.668178\nWinter, 2009, A new direction for cardiac regeneration therapy: Application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells, Circulation. Heart Failure, 2, 643, 10.1161\u002FCIRCHEARTFAILURE.108.843722\nWitty, 2014, Generation of the epicardial lineage from human pluripotent stem cells, Nature Biotechnology, 32, 1026, 10.1038\u002Fnbt.3002\nWorld Health Organization, 2015, 937\nWu, 2013, Tbx18 regulates development of the epicardium and coronary vessels, Developmental Biology, 383, 307, 10.1016\u002Fj.ydbio.2013.08.019\nXiang, 2016, Silencing of long non-coding RNA MALAT1 promotes apoptosis of glioma cells, Journal of Korean Medical Science, 31, 688, 10.3346\u002Fjkms.2016.31.5.688\nXiang, 2014, Cardiac-specific overexpression of human stem cell factor promotes epicardial activation and arteriogenesis after myocardial infarction, Circulation. Heart Failure, 7, 831, 10.1161\u002FCIRCHEARTFAILURE.114.001423\nXiang, 2009, Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice, Circulation, 120, 1065, 10.1161\u002FCIRCULATIONAHA.108.839068\nXiang, 2017, MALAT1 modulates TGF-beta1-induced endothelial-to-mesenchymal transition through downregulation of miR-145, Cellular Physiology and Biochemistry, 42, 357, 10.1159\u002F000477479\nXin, 2013, Hippo pathway effector Yap promotes cardiac regeneration, Proceedings of the National Academy of Sciences of the United States of America, 110, 13839, 10.1073\u002Fpnas.1313192110\nYanagisawa-Miwa, 1992, Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor, Science, 257, 1401, 10.1126\u002Fscience.1382313\nYang, 2015, Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer, American Journal of Cancer Research, 5, 748\nYang, 2016, Long non-coding RNA MALAT1 mediates transforming growth factor β1-induced epithelial-mesenchymal transition of retinal pigment epithelial cells, PLoS One, 11\nYeh, 2013, IGF-1 activates a cilium-localized noncanonical Gbetagamma signaling pathway that regulates cell-cycle progression, Developmental Cell, 26, 358, 10.1016\u002Fj.devcel.2013.07.014\nZakharova, 2012, Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transition, PLoS One, 7, 10.1371\u002Fjournal.pone.0037800\nZamora, 2007, Epicardium-derived progenitor cells require beta-catenin for coronary artery formation, Proceedings of the National Academy of Sciences of the United States of America, 104, 18109, 10.1073\u002Fpnas.0702415104\nZangi, 2013, Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction, Nature Biotechnology, 31, 898, 10.1038\u002Fnbt.2682\nZangi, 2017, Insulin-like growth factor 1 receptor-dependent pathway drives epicardial adipose tissue formation after myocardial injury, Circulation, 135, 59, 10.1161\u002FCIRCULATIONAHA.116.022064\nZhang, 1996, Mice deficient for BMP2 are nonviable and have defects in amnion\u002Fchorion and cardiac development, Development, 122, 2977, 10.1242\u002Fdev.122.10.2977\nZhang, 2017, LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer, Biomedicine & Pharmacotherapy, 91, 312, 10.1016\u002Fj.biopha.2017.04.085\nZhang, 2009, Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: A meta-analysis of randomised controlled trials, International Journal of Cardiology, 136, 178, 10.1016\u002Fj.ijcard.2008.04.071\nZhao, 2017, Efficient differentiation of TBX18+\u002FWT1+ epicardial-like cells from human pluripotent stem cells using small molecular compounds, Stem Cells and Development, 26, 528, 10.1089\u002Fscd.2016.0208\nZhao, 2013, Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat, Journal of Cellular and Molecular Medicine, 17, 123, 10.1111\u002Fj.1582-4934.2012.01655.x\nZhou, 2011, Adult mouse epicardium modulates myocardial injury by secreting paracrine factors, The Journal of Clinical Investigation, 121, 1894, 10.1172\u002FJCI45529\nZhou, 2012, Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes, Journal of Molecular and Cellular Cardiology, 52, 43, 10.1016\u002Fj.yjmcc.2011.08.020\nZhou, 2015, Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma, Scientific Reports, 5",{"EN":510},"Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium",{"VOID":512},"10.1016\u002Fj.pharmthera.2018.01.002","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725818300093",[515,532],{"id":516,"sortIndex":19,"researcher":18,"roles":517,"affiliations":518,"properties":529},"a71b8aaf-ef3c-4ef0-bfb8-b87c6b296b64",[126],[519],{"id":18,"sortIndex":19,"affiliation":520,"properties":18},{"id":521,"createTime":522,"updateTime":523,"relativeEntities":524,"slug":525,"properties":526,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"3edffabf-192f-447c-8b99-7eceee56acc4","2024-01-30T12:03:39.206+00:00","2025-01-26T19:05:19.443+00:00",[],"Department-of-Physiology-and-Pharmacology-Schulich-School-of-Medicine-and-Dentistry-University-of-Western-Ontario-London-Ontario-Canada",{"title":527},{"VI":528},"Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada",{"title":530},{"VI":531},"Jessica N. Blom",{"id":533,"sortIndex":141,"researcher":18,"roles":534,"affiliations":535,"properties":541},"922684d3-9f57-44d6-a1fe-f8cb14c43dd3",[126],[536],{"id":18,"sortIndex":19,"affiliation":537,"properties":18},{"id":521,"createTime":522,"updateTime":523,"relativeEntities":538,"slug":525,"properties":539,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":540},{"VI":528},{"title":542},{"VI":543},"Qingping Feng",{"url":513,"publisher":545,"properties":567},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":546,"slug":10,"properties":547,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":550,"manageAffiliations":551,"indexDatabases":552,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":548,"title":549},{"VOID":13},{"EN":15},[],[],[553,560],{"id":83,"indexDatabase":554,"url":98,"indexYears":18,"academicFieldIds":559,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":555,"label":556,"description":557,"key":94,"publicationTags":558,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":561,"url":76,"indexYears":77,"academicFieldIds":566,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":562,"label":563,"description":564,"key":73,"publicationTags":565,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":568,"pages":570},{"VOID":569},"186",{"VOID":571},"114-129","2018-06-01",2018,{"id":575,"createTime":576,"updateTime":576,"relativeEntities":577,"slug":18,"properties":578,"entityType":118,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":585,"fullTextUrl":18,"authors":586,"publicationType":155,"publisherRelationship":602,"citationCount":18,"citationInfo":18,"publishDate":630,"publishYear":631,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"e6af0aa7-94d0-4a5b-b679-8f15ee850d9f","2024-01-11T23:58:02.529+00:00",[],{"references":579,"title":581,"doi":583},{"VOID":580},"Antic, 1976, The influence of clinical factors on site of airway obstruction in asthma, Am. Rev. resp. Dis., 114, 851\nBloomfield, 1979, Comparison of salbutamol given intravenously and by intermittent positive pressure breathing in life-threatening asthma, Br. med. J., i, 848, 10.1136\u002Fbmj.1.6167.848\nBritish Thoracic and Tuberculosis Association, 1975, A controlled trial of inhaled corticosteroids in patients receiving prednisolone tablets for asthma, Br. J. Dis. Chest, 70, 95\nCochrane, 1975, A survey of asthma mortality in patients between ages 35–64 in the Greater London Hospitals in 1971, Thorax, 30, 300, 10.1136\u002Fthx.30.3.300\nCostello, 1974, Response of patients receiving high dose beclomethasone diproprionate, Thorax, 29, 571, 10.1136\u002Fthx.29.5.571\nDavies, 1982, Anti-allergic compounds, Pharmac. Ther., 10.1016\u002F0163-7258(82)90018-3\nEiser, 1982, Histamine antagonists and asthma, Pharmac. Ther., 10.1016\u002F0163-7258(82)90015-8\nGodfrey, 1977, Exercise induced asthma, 56\nHartley, 1979, Exercise-induced asthma, Thorax, 34, 571, 10.1136\u002Fthx.34.5.571\nHendeles, 1980, Poisoning patients with intravenous theophylline, Am. J. Hosp. Pharm., 37, 49\nHendeles, 1982, Improved efficacy and safety of theophylline in the control of airways hyperreactivity, Pharmac. Ther., 10.1016\u002F0163-7258(82)90027-4\nHetzel, 1981, The pulmonary clock, Thorax, 36, 481, 10.1136\u002Fthx.36.7.481\nHetzel, 1977, Do sympathomimetic amines prevent exercise induced asthma by bronchodilatation alone?, Br. J. Dis. Chest, 71, 109, 10.1016\u002F0007-0971(77)90091-2\nHetzel, 1977, Physiological patterns in early morning asthma, Thorax, 32, 418, 10.1136\u002Fthx.32.4.418\nJones, 1971, The intensive therapy of asthma, 64, 1151\nMilner, 1982, Steroids and asthma, Pharmac. Ther., 10.1016\u002F0163-7258(82)90014-6\n1980\nPaterson, 1976, Use of pressurised aerosols by asthmatic patients, Br. med. J., 1, 76, 10.1136\u002Fbmj.1.6001.76-a\nPatterson, 1978, The in vivo transfer of antigen-induced airway reactions by bronchial lumen cells, J. clin Invest., 62, 519, 10.1172\u002FJCI109155\nPermutt, 1980, Irritability and Allergy: the neurone and the mast cell, Am. Rev. resp. Dis., 122, 187\nPierce, 1981, Comparison of intravenous and inhaled terbutaline in the treatment of asthma, Chest, 79, 506, 10.1378\u002Fchest.79.5.506\nRebuck, 1971, Assessment and management of severe asthma, Am. J. Med., 51, 788, 10.1016\u002F0002-9343(71)90307-X\nRichardson, 1973, Localisation of antigen in experimental bronchoconstriction in guinea pigs, J. Allergy clin. Immunol., 52, 172, 10.1016\u002F0091-6749(73)90034-1\nRossing, 1980, Emergency therapy of asthma: a comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline, Am. Rev. resp. Dis., 122, 365\nRubinfeld, 1976, Perception of asthma, Lancet, i, 882, 10.1016\u002FS0140-6736(76)92097-3\nSpeizer, 1968, Investigation into use of drug preceding death from asthma, Br. med. J., i, 339, 10.1136\u002Fbmj.1.5588.339\nThiringer, 1976, Comparison of infused and inhaled Terbutaline in patients with severe asthma, Scand. J. resp. Dis., 57, 17\nToogood, 1977, A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma, J. Allergy, 59, 298\nToogood, 1978, Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisolone, J. Allergy, 61, 355\nTurner-Warwick, 1977, On observing patterns of airflow obstruction asthma, Br. J. Dis. Chest., 71, 73, 10.1016\u002F0007-0971(77)90086-9\nWebb, 1981, Influence on breath holding at total lung capacity on maximal expiratory flow measurements, Clin. Sci., 60, 11, 10.1042\u002Fcs0600011\nWebb, 1981, Time course of response to prednisolone in chronic airflow obstruction, Thorax, 36, 18, 10.1136\u002Fthx.36.1.18",{"EN":582},"Choice of drug treatment in asthma",{"VOID":584},"10.1016\u002F0163-7258(82)90013-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0163725882900134",[587],{"id":588,"sortIndex":19,"researcher":18,"roles":589,"affiliations":590,"properties":599},"4fbea039-12a7-4c87-a5c4-b4bfbc36db8c",[126],[591],{"id":18,"sortIndex":19,"affiliation":592,"properties":18},{"id":593,"createTime":594,"updateTime":594,"relativeEntities":595,"slug":18,"properties":596,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"1752dd22-ca2a-44d5-a819-dfe01f5861e2","2024-01-11T23:58:02.563+00:00",[],{"title":597},{"VI":598},"Guy's Hospital, St. Thomas Street, London SE1 9RT, U.K.",{"title":600},{"VI":601},"T.J.H. Clark",{"url":585,"publisher":603,"properties":625},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":604,"slug":10,"properties":605,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":608,"manageAffiliations":609,"indexDatabases":610,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":606,"title":607},{"VOID":13},{"EN":15},[],[],[611,618],{"id":83,"indexDatabase":612,"url":98,"indexYears":18,"academicFieldIds":617,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":613,"label":614,"description":615,"key":94,"publicationTags":616,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":619,"url":76,"indexYears":77,"academicFieldIds":624,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":620,"label":621,"description":622,"key":73,"publicationTags":623,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":626,"pages":628},{"VOID":627},"17",{"VOID":629},"221-228","1982-01-01",1982,{"id":633,"createTime":634,"updateTime":635,"relativeEntities":636,"slug":637,"properties":638,"entityType":118,"verifyStatus":119,"verifyTime":635,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":645,"fullTextUrl":18,"authors":646,"publicationType":155,"publisherRelationship":731,"citationCount":18,"citationInfo":18,"publishDate":759,"publishYear":760,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"2ebedce4-6418-4e32-b548-9a0811bcead8","2023-12-26T14:20:23.818+00:00","2025-02-26T23:57:41.292+00:00",[],"Advances-in-understanding-cancer-associated-neurogenesis-and-its-implications-on-the-neuroimmune-axis-in-cancer",{"references":639,"title":641,"doi":643},{"VOID":640},"Amit, 2016, Mechanisms of cancer dissemination along nerves, Nature Reviews. Cancer, 16, 399, 10.1038\u002Fnrc.2016.38\nAmit, 2020, Loss of p53 drives neuron reprogramming in head and neck cancer, Nature, 578, 449, 10.1038\u002Fs41586-020-1996-3\nArmaiz-Pena, 2013, Src activation by beta-adrenoreceptors is a key switch for tumour metastasis, Nature Communications, 4, 1403, 10.1038\u002Fncomms2413\nArmaiz-Pena, 2015, Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth, Oncotarget, 6, 4266, 10.18632\u002Foncotarget.2887\nBecker, 2016, Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis, Cancer Cell, 30, 836, 10.1016\u002Fj.ccell.2016.10.009\nBelo, 2011, Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion, American Journal of Physiology. Gastrointestinal and Liver Physiology, 300, G749, 10.1152\u002Fajpgi.00306.2010\nBernabe, 2011, Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells, Brain, Behavior, and Immunity, 25, 574, 10.1016\u002Fj.bbi.2010.12.012\nBoonstra, 2015, Neurotransmitters as food supplements: The effects of GABA on brain and behavior, Frontiers in Psychology, 6, 1520, 10.3389\u002Ffpsyg.2015.01520\nBravo-Calderon, 2020, Beta adrenergic receptor activation inhibits oral cancer migration and invasiveness, Archives of Oral Biology, 118, 10.1016\u002Fj.archoralbio.2020.104865\nBrosnan, 2013, Glutamate: a truly functional amino acid, Amino Acids, 45, 413, 10.1007\u002Fs00726-012-1280-4\nBrzozowska, 2017, Gamma-amino butyric acid (GABA) level as an overall survival risk factor in breast cancer, Annals of Agricultural and Environmental Medicine, 24, 435, 10.26444\u002Faaem\u002F75891\nBudczies, 2015, Glutamate enrichment as new diagnostic opportunity in breast cancer, International Journal of Cancer, 136, 1619, 10.1002\u002Fijc.29152\nCalvani, 2019, beta3 -adrenoceptor as a potential immuno-suppressor agent in melanoma, British Journal of Pharmacology, 176, 2509, 10.1111\u002Fbph.14660\nCalvani, 2018, beta3-Adrenoreceptors control mitochondrial dormancy in melanoma and embryonic stem cells, Oxidative Medicine and Cellular Longevity, 2018, 6816508, 10.1155\u002F2018\u002F6816508\nCampbell, 2012, Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice, PLoS Biology, 10, 10.1371\u002Fjournal.pbio.1001363\nCervantes-Villagrana, 2020, Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies, Signal Transduction and Targeted Therapy, 5, 99, 10.1038\u002Fs41392-020-0205-z\nCeyhan, 2009, Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases, Gastroenterology, 136, 10.1053\u002Fj.gastro.2008.09.029\nChakroborty, 2008, Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization, The Journal of Clinical Investigation, 118, 1380, 10.1172\u002FJCI33125\nChen, 2018, Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response, Nature, 560, 382, 10.1038\u002Fs41586-018-0392-8\nChen, 2018, Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype, Cancer Letters, 435, 80, 10.1016\u002Fj.canlet.2018.08.001\nCheng, 2008, Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation, American Journal of Physiology. Gastrointestinal and Liver Physiology, 295, G591, 10.1152\u002Fajpgi.00055.2008\nChin, 2016, Selective beta2-AR blockage suppresses colorectal cancer growth through regulation of EGFR-Akt\u002FERK1\u002F2 signaling, G1-phase arrest, and apoptosis, Journal of Cellular Physiology, 231, 459, 10.1002\u002Fjcp.25092\nCiurea, 2017, B2 adrenergic receptors and morphological changes of the enteric nervous system in colorectal adenocarcinoma, World Journal of Gastroenterology, 23, 1250, 10.3748\u002Fwjg.v23.i7.1250\nClancy, 2014, Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity, Brain Stimulation, 7, 871, 10.1016\u002Fj.brs.2014.07.031\nCoarfa, 2018, Influence of the neural microenvironment on prostate cancer, Prostate, 78, 128, 10.1002\u002Fpros.23454\nCole, 2010, Computational identification of gene-social environment interaction at the human IL6 locus, Proceedings of the National Academy of Sciences of the United States of America, 107, 5681, 10.1073\u002Fpnas.0911515107\nCole, 2015, Sympathetic nervous system regulation of the tumour microenvironment, Nature Reviews. Cancer, 15, 563, 10.1038\u002Fnrc3978\nCortese, 2020, The neuro-immune axis in cancer: Relevance of the peripheral nervous system to the disease, Immunology Letters, 227, 60, 10.1016\u002Fj.imlet.2020.07.010\nDal Monte, 2014, beta3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling, Naunyn-Schmiedeberg’s Archives of Pharmacology, 387, 533, 10.1007\u002Fs00210-014-0969-1\nDu, 2016, Glutamate in peripheral organs: Biology and pharmacology, European Journal of Pharmacology, 784, 42, 10.1016\u002Fj.ejphar.2016.05.009\nErin, 2013, Vagus nerve regulates breast cancer metastasis to the adrenal gland, Anticancer Research, 33, 3675\nGanguly, 2010, Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Kruppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation, The American Journal of Pathology, 177, 2701, 10.2353\u002Fajpath.2010.100617\nGanor, 2014, The neurotransmitter glutamate and human T cells: Glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells, Journal of Neural Transmission (Vienna), 121, 983, 10.1007\u002Fs00702-014-1167-5\nGoldfarb, 2011, Improving postoperative immune status and resistance to cancer metastasis: A combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses, Annals of Surgery, 253, 798, 10.1097\u002FSLA.0b013e318211d7b5\nHarris, 2015, Exosomes released from breast cancer carcinomas stimulate cell movement, PLoS One, 10, 10.1371\u002Fjournal.pone.0117495\nHayakawa, 2017, Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling, Cancer Cell, 31, 21, 10.1016\u002Fj.ccell.2016.11.005\nHe, 2017, Activation of beta-adrenergic receptor promotes cellular proliferation in human glioblastoma, Oncology Letters, 14, 3846, 10.3892\u002Fol.2017.6653\nHerner, 2011, Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling, International Journal of Cancer, 129, 2349, 10.1002\u002Fijc.25898\nHicks, 2013, beta-blocker usage and colorectal cancer mortality: A nested case-control study in the UK clinical practice research datalink cohort, Annals of Oncology, 24, 3100, 10.1093\u002Fannonc\u002Fmdt381\nHuang, 2016, Association of ovarian tumor beta2-adrenergic receptor status with ovarian cancer risk factors and survival, Cancer Epidemiology, Biomarkers & Prevention, 25, 1587, 10.1158\u002F1055-9965.EPI-16-0534\nHuang, 2022, Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression, Nature Cell Biology, 24, 230, 10.1038\u002Fs41556-021-00820-9\nHunt, 2021, Mini-review: Trophic interactions between cancer cells and primary afferent neurons, Neuroscience Letters, 746, 10.1016\u002Fj.neulet.2021.135658\nHutchings, 2020, Nerve input to tumours: Pathophysiological consequences of a dynamic relationship, Biochimica Et Biophysica Acta. Reviews on Cancer, 1874, 10.1016\u002Fj.bbcan.2020.188411\nInbar, 2011, Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity, PLoS One, 6, 10.1371\u002Fjournal.pone.0019246\nJia, 2017, Exosome: Emerging biomarker in breast cancer, Oncotarget, 8, 41717, 10.18632\u002Foncotarget.16684\nJobling, 2015, Nerve-cancer cell cross-talk: A novel promoter of tumor progression, Cancer Research, 75, 1777, 10.1158\u002F0008-5472.CAN-14-3180\nKamiya, 2019, Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression, Nature Neuroscience, 22, 1289, 10.1038\u002Fs41593-019-0430-3\nKamiya, 2021, Sympathetic and parasympathetic innervation in cancer: Therapeutic implications, Clinical Autonomic Research, 31, 165, 10.1007\u002Fs10286-020-00724-y\nKang, 2016, Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer, Clinical Cancer Research, 22, 1713, 10.1158\u002F1078-0432.CCR-15-1275\nKim, 2006, N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer, Cancer Research, 66, 3409, 10.1158\u002F0008-5472.CAN-05-1608\nKim-Fuchs, 2014, Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment, Brain, Behavior, and Immunity, 40, 40, 10.1016\u002Fj.bbi.2014.02.019\nKoochekpour, 2013, Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer, Asian Journal of Andrology, 15, 212, 10.1038\u002Faja.2012.145\nKoochekpour, 2012, Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells, Clinical Cancer Research, 18, 5888, 10.1158\u002F1078-0432.CCR-12-1308\nLan, 2017, The potential roles of dopamine in malignant glioma, Acta Neurologica Belgica, 117, 613, 10.1007\u002Fs13760-016-0730-2\nLee, 2010, Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells, Journal of the National Cancer Institute, 102, 1322, 10.1093\u002Fjnci\u002Fdjq300\nLeone, 2020, Metabolism of immune cells in cancer, Nature Reviews. Cancer, 20, 516, 10.1038\u002Fs41568-020-0273-y\nLiao, 2010, The beta-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor kappaB signaling, Oncology Reports, 24, 1669\nLiebig, 2009, Perineural invasion in cancer: A review of the literature, Cancer, 115, 3379, 10.1002\u002Fcncr.24396\nLopes-Santos, 2021, Beta-adrenergic pathway activation enhances aggressiveness and inhibits stemness in head and neck cancer, Translational Oncology, 14, 10.1016\u002Fj.tranon.2021.101117\nLu, 2017, Isoprenaline\u002Fbeta2-AR activates Plexin-A1\u002FVEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis, BMC Cancer, 17, 875, 10.1186\u002Fs12885-017-3894-0\nLucido, 2019, Innervation of cervical carcinoma is mediated by cancer-derived exosomes, Gynecologic Oncology, 154, 228, 10.1016\u002Fj.ygyno.2019.04.651\nMadeo, 2018, Cancer exosomes induce tumor innervation, Nature Communications, 9, 4284, 10.1038\u002Fs41467-018-06640-0\nMagnon, 2013, Autonomic nerve development contributes to prostate cancer progression, Science, 341, 1236361, 10.1126\u002Fscience.1236361\nMartino, 2013, Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells, Oncogene, 32, 4366, 10.1038\u002Fonc.2012.471\nMohammadpour, 2019, beta2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells, The Journal of Clinical Investigation, 129, 5537, 10.1172\u002FJCI129502\nNazarenko, 2010, Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation, Cancer Research, 70, 1668, 10.1158\u002F0008-5472.CAN-09-2470\nNguyen, 2014, Inflammation and prostate cancer: The role of interleukin 6 (IL-6), BJU International, 113, 986, 10.1111\u002Fbju.12452\nNilsson, 2007, Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism, The Journal of Biological Chemistry, 282, 29919, 10.1074\u002Fjbc.M611539200\nO’Donnell, 2009, Axon growth and guidance: Receptor regulation and signal transduction, Annual Review of Neuroscience, 32, 383, 10.1146\u002Fannurev.neuro.051508.135614\nPalm, 2007, Neoneurogenesis and the neuro-neoplastic synapse, Progress in Experimental Tumor Research, 39, 91, 10.1159\u002F000100049\nPartecke, 2017, Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFalpha in a murine pancreatic cancer model, Oncotarget, 8, 22501, 10.18632\u002Foncotarget.15019\nQin, 2015, Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma, Toxicology and Applied Pharmacology, 286, 112, 10.1016\u002Fj.taap.2015.03.021\nRaposo, 2013, Extracellular vesicles: Exosomes, microvesicles, and friends, The Journal of Cell Biology, 200, 373, 10.1083\u002Fjcb.201211138\nRaufman, 2011, Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin\u002F+ mice, Carcinogenesis, 32, 1396, 10.1093\u002Fcarcin\u002Fbgr118\nReitzer, 1979, Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells, The Journal of Biological Chemistry, 254, 2669, 10.1016\u002FS0021-9258(17)30124-2\nRenz, 2018, beta2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer, Cancer Cell, 33, 75, 10.1016\u002Fj.ccell.2017.11.007\nRenz, 2018, Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness, Cancer Discovery, 8, 1458, 10.1158\u002F2159-8290.CD-18-0046\nSarkar, 2008, Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models, Clinical Cancer Research, 14, 2502, 10.1158\u002F1078-0432.CCR-07-1778\nSarkar, 2004, Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells, American Journal of Physiology. Heart and Circulatory Physiology, 287, H1554, 10.1152\u002Fajpheart.00272.2004\nScheff, 2021, Neuroimmunology of cancer and associated symptomology, Immunology and Cell Biology, 99, 949, 10.1111\u002Fimcb.12496\nSenogles, 2007, D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69, Anti-Cancer Drugs, 18, 801, 10.1097\u002FCAD.0b013e3280b10d36\nSetordzi, 2021, The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy, European Journal of Pharmacology, 895, 10.1016\u002Fj.ejphar.2021.173867\nSloan, 2010, The sympathetic nervous system induces a metastatic switch in primary breast cancer, Cancer Research, 70, 7042, 10.1158\u002F0008-5472.CAN-10-0522\nSolorzano, 2018, GABA promotes gastrin-releasing peptide secretion in NE\u002FNE-like cells: Contribution to prostate cancer progression, Scientific Reports, 8, 10272, 10.1038\u002Fs41598-018-28538-z\nStepulak, 2014, Glutamate and its receptors in cancer, Journal of Neural Transmission (Vienna), 121, 933, 10.1007\u002Fs00702-014-1182-6\nSung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: a Cancer Journal for Clinicians, 71, 209\nTakehara, 2007, Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit, Cancer Research, 67, 9704, 10.1158\u002F0008-5472.CAN-07-2099\nTamura, 2011, Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma, BMC Cancer, 11, 220, 10.1186\u002F1471-2407-11-220\nTanaka, 2017, Regulatory T cells in cancer immunotherapy, Cell Research, 27, 109, 10.1038\u002Fcr.2016.151\nTatsuta, 1988, Effects of bilateral and unilateral vagotomy on gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats, International Journal of Cancer, 42, 414, 10.1002\u002Fijc.2910420318\nTatsuta, 1985, Promotion by vagotomy of gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats, Cancer Research, 45, 194\nThaker, 2006, Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma, Nature Medicine, 12, 939, 10.1038\u002Fnm1447\nValadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nature Cell Biology, 9, 654, 10.1038\u002Fncb1596\nValenti, 2006, Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes, Cancer Research, 66, 9290, 10.1158\u002F0008-5472.CAN-06-1819\nVander Heiden, 2009, Understanding the Warburg effect: The metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126\u002Fscience.1160809\nVenkatesh, 2015, Neuronal activity promotes glioma growth through neuroligin-3 secretion, Cell, 161, 803, 10.1016\u002Fj.cell.2015.04.012\nVenkatesh, 2017, Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma, Nature, 549, 533, 10.1038\u002Fnature24014\nWang, 2014, The neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancer, Carcinogenesis, 35, 103, 10.1093\u002Fcarcin\u002Fbgt312\nWang, 2018, Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer, Oncogenesis, 7, 88, 10.1038\u002Fs41389-018-0099-6\nWang, 2018, Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\u002FPI3Kgamma to promote pancreatic Cancer metastasis, Cancer Research, 78, 4586, 10.1158\u002F0008-5472.CAN-17-3841\nWieckowski, 2009, Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes, Journal of Immunology, 183, 3720, 10.4049\u002Fjimmunol.0900970\nWolter, 2014, Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma, Oncotarget, 5, 161, 10.18632\u002Foncotarget.1083\nYamanaka, 2002, Epinephrine inhibits invasion of oral squamous carcinoma cells by modulating intracellular cAMP, Cancer Letters, 176, 143, 10.1016\u002FS0304-3835(01)00764-9\nYang, 2014, Stress-related hormone norepinephrine induces interleukin-6 expression in GES-1 cells, Brazilian Journal of Medical and Biological Research, 47, 101, 10.1590\u002F1414-431X20133346\nYe, 2018, Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion, Journal for Immunotherapy of Cancer, 6, 145, 10.1186\u002Fs40425-018-0451-6\nYi, 2019, Glutamate in cancers: From metabolism to signaling, Journal of Biomedical Research, 34, 260, 10.7555\u002FJBR.34.20190037\nYu, 2017, Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation, Scientific Reports, 7, 40802, 10.1038\u002Fsrep40802\nYu, 2017, Metabotropic glutamate receptors in cancer, Neuropharmacology, 115, 193, 10.1016\u002Fj.neuropharm.2016.02.011\nYu, 2021, Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation, Molecular Cell, 81, 1216, 10.1016\u002Fj.molcel.2021.01.010\nZahalka, 2017, Adrenergic nerves activate an angio-metabolic switch in prostate cancer, Science, 358, 321, 10.1126\u002Fscience.aah5072\nZeng, 2019, Synaptic proximity enables NMDAR signalling to promote brain metastasis, Nature, 573, 526, 10.1038\u002Fs41586-019-1576-6\nZhang, 2014, GABAergic signaling facilitates breast cancer metastasis by promoting ERK1\u002F2-dependent phosphorylation, Cancer Letters, 348, 100, 10.1016\u002Fj.canlet.2014.03.006\nZhang, 2021, VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment. JCI, Insight, 6\nZhao, 2014, Denervation suppresses gastric tumorigenesis, Science Translational Medicine, 6, 250ra115, 10.1126\u002Fscitranslmed.3009569\nZhou, 2018, Expression and significance of autonomic nerves and alpha9 nicotinic acetylcholine receptor in colorectal cancer, Molecular Medicine Reports, 17, 8423",{"EN":642},"Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer",{"VOID":644},"10.1016\u002Fj.pharmthera.2022.108199","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725822000936",[647,665,677,692,714],{"id":648,"sortIndex":19,"researcher":18,"roles":649,"affiliations":650,"properties":662},"b3280069-26f7-4550-b537-60a31b963beb",[126],[651],{"id":652,"sortIndex":19,"affiliation":653,"properties":660},"6a0e2a8f-3d51-4f03-879c-3fb5ba63605f",{"id":654,"createTime":655,"updateTime":655,"relativeEntities":656,"slug":18,"properties":657,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"0ed1d57a-25a9-416f-b340-5cb3030c25d3","2024-01-13T08:27:57.903+00:00",[],{"title":658},{"VI":659},"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",{"title":661},{"VI":659},{"title":663},{"VI":664},"Ismail Yaman",{"id":666,"sortIndex":282,"researcher":18,"roles":667,"affiliations":668,"properties":674},"be930007-059b-4fad-9489-e4bb6659189d",[126],[669],{"id":18,"sortIndex":19,"affiliation":670,"properties":18},{"id":654,"createTime":655,"updateTime":655,"relativeEntities":671,"slug":18,"properties":672,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":673},{"VI":659},{"title":675},{"VI":676},"Tongxin Xie",{"id":678,"sortIndex":337,"researcher":18,"roles":679,"affiliations":680,"properties":689},"01ddca8f-50ab-4ac9-be10-3099cbecf4a7",[126],[681],{"id":18,"sortIndex":19,"affiliation":682,"properties":18},{"id":683,"createTime":684,"updateTime":684,"relativeEntities":685,"slug":18,"properties":686,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"2de7339e-e09b-41a0-b1e8-5e189dc0f7bc","2023-12-26T14:20:23.862+00:00",[],{"title":687},{"VI":688},"Bluestone Center for Clinical Research, New York University College of Dentistry, New York, NY, USA",{"title":690},{"VI":691},"Yi Ye",{"id":693,"sortIndex":401,"researcher":18,"roles":694,"affiliations":695,"properties":711},"febc8862-1c78-4cc9-ae1e-9321e56cd8be",[126],[696,701],{"id":18,"sortIndex":19,"affiliation":697,"properties":18},{"id":654,"createTime":655,"updateTime":655,"relativeEntities":698,"slug":18,"properties":699,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":700},{"VI":659},{"id":702,"sortIndex":141,"affiliation":703,"properties":710},"113b69fa-7958-46e4-ba79-ac89d5c7d403",{"id":704,"createTime":705,"updateTime":705,"relativeEntities":706,"slug":18,"properties":707,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a39294bc-15e1-426e-bce7-626118dad8c2","2023-12-26T14:20:23.876+00:00",[],{"title":708},{"VI":709},"Department of Head and Neck Surgery, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA",{},{"title":712},{"VI":713},"Moran Amit",{"id":715,"sortIndex":141,"researcher":18,"roles":716,"affiliations":717,"properties":728},"5c33fd1e-37ee-4401-bb2b-02b38d57dfbc",[126],[718],{"id":18,"sortIndex":19,"affiliation":719,"properties":18},{"id":720,"createTime":721,"updateTime":722,"relativeEntities":723,"slug":724,"properties":725,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"bb80a1f7-04e8-4eff-a1b2-7f590b36d0f7","2024-02-08T18:37:36.121+00:00","2024-10-05T09:54:59.914+00:00",[],"Department-of-Immunology-The-University-of-Texas-MD-Anderson-Cancer-Center-Houston-TX-USA",{"title":726},{"VI":727},"Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",{"title":729},{"VI":730},"Didem Ağaç Çobanoğlu",{"url":645,"publisher":732,"properties":754},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":733,"slug":10,"properties":734,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":737,"manageAffiliations":738,"indexDatabases":739,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":735,"title":736},{"VOID":13},{"EN":15},[],[],[740,747],{"id":83,"indexDatabase":741,"url":98,"indexYears":18,"academicFieldIds":746,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":742,"label":743,"description":744,"key":94,"publicationTags":745,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":748,"url":76,"indexYears":77,"academicFieldIds":753,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":749,"label":750,"description":751,"key":73,"publicationTags":752,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":755,"pages":757},{"VOID":756},"239",{"VOID":758},"108199","2022-11-01",2022,{"id":762,"createTime":763,"updateTime":764,"relativeEntities":765,"slug":766,"properties":767,"entityType":118,"verifyStatus":119,"verifyTime":774,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":775,"fullTextUrl":18,"authors":776,"publicationType":155,"publisherRelationship":816,"citationCount":18,"citationInfo":18,"publishDate":844,"publishYear":845,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"c7b583e6-b345-4ed5-8837-0b0ff93749ff","2024-01-16T07:52:01.912+00:00","2024-12-13T23:57:19.943+00:00",[],"Interactions-of-anesthetics-with-their-targets-Non-specific-specific-or-both-",{"references":768,"title":770,"doi":772},{"VOID":769},"Adriani, 1962\nAkabas, 2002, GABA- and drug-induced conformational changes detected in the GABAA receptor channel-lining segments, 130\nAkinshola, 2001, Straight-chain alcohols exhibit a cutoff in potency for the inhibition of recombinant glutamate receptor subunits, Br J Pharmacol, 133, 651, 10.1038\u002Fsj.bjp.0704112\nAlbrecht, 1999, The effect of age on the pharmacokinetics and pharmacodynamics of midazolam, Clin Pharmacol Ther, 65, 630, 10.1016\u002FS0009-9236(99)90084-X\nAlifimoff, 1989, Anaesthetic potencies of primary alkanols: implications for the molecular dimensions of the anaesthetic site, Br J Pharmacol, 96, 9, 10.1111\u002Fj.1476-5381.1989.tb11777.x\nAllison, 1970, The effect of inhalational anaesthetics on the microtubular system in actinosphaerium nucleofilum, J Cell Sci, 7, 483, 10.1242\u002Fjcs.7.2.483\nAndoh, 1997, Volatile anaesthetic effects on calcium conductance of planar lipid bilayers formed with synthetic lipids or extracted lipids from sarcoplasmic reticulum, Br J Anaesth, 78, 66, 10.1093\u002Fbja\u002F78.1.66\nAndoh, 1997, Differential effects of thiopental on neuronal nicotinic acetylcholine receptors and P2X purinergic receptors in PC12 cells, Anesthesiology, 87, 1199, 10.1097\u002F00000542-199711000-00025\nAngel, 1982, The effect of anaesthetic agents on cerebral cortical responses in the rat, Br J Pharmacol, 76, 541, 10.1111\u002Fj.1476-5381.1982.tb09252.x\nAntkowiak, 2002, In vitro networks: cortical mechanisms of anaesthetic action, Br J Anaesth, 89, 102, 10.1093\u002Fbja\u002Faef154\nAntkowiak, 1999, Different actions of general anesthetics on the firing patterns of neocortical neurons mediated by the GABAA receptor, Anesthesiology, 91, 500, 10.1097\u002F00000542-199908000-00025\nAntognini, 2002, In vivo characterization of clinical anaesthesia and its components, Br J Anaesth, 89, 156, 10.1093\u002Fbja\u002Faef156\nAntognini, 2002\nArden, 1986, Increased sensitivity to etomidate in the elderly: Initial distribution versus altered brain response, Anesthesiology, 65, 19, 10.1097\u002F00000542-198607000-00004\nArmendi, 1993, Barbiturate action is dependent on the conformational state of the acetylcholine receptor, Anesthesiology, 79, 1033, 10.1097\u002F00000542-199311000-00022\nArtusio, 1955, Ether analgesia during major surgery, J Am Med Assoc, 157, 33, 10.1001\u002Fjama.1955.02950180035009\nAsahi, 2002, Effects of volatile anesthetics, n-alcohols and ketamine on synaptic and non-synaptic pathways in rat hippocampal slices in vitro, 348\nAshcroft, 1977, The molecular organisation of bimolecular lipid membranes. The effect of benzyl alcohol on the structure, Biochim Biophys Acta, 469, 13, 10.1016\u002F0005-2736(77)90321-2\nBaber, 1995, Distribution of general anesthetics in phospholipid bilayers determined using 2H NMR and 1H-1H NOE spectroscopy, Biochemistry, 34, 6533, 10.1021\u002Fbi00019a035\nBaden, 2000, Metabolism and toxicity of inhaled anesthetics, 147\nBali, 2004, Defining the propofol binding site location on the GABAA receptor, Mol Pharmacol, 65, 68, 10.1124\u002Fmol.65.1.68\nBanks, 1999, Dual actions of volatile anesthetics on GABAA IPSCs: dissociation of blocking and prolonging effects, Anesthesiology, 90, 120, 10.1097\u002F00000542-199901000-00018\nBanoub, 2003, Pharmacologic and physiologic influences affecting sensory evoked potentials: implications for perioperative monitoring, Anesthesiology, 99, 716, 10.1097\u002F00000542-200309000-00029\nBarann, 1993, Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells, Naunyn-Schmiedeberg's Arch Pharmacol, 347, 125, 10.1007\u002FBF00169256\nBarann, 1997, 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital, Neuropharmacology, 36, 655, 10.1016\u002FS0028-3908(97)00059-2\nBarann, 2000, Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements, Neuropharmacology, 39, 1064, 10.1016\u002FS0028-3908(99)00205-1\nBarchfeld, 1985, The effect of general anesthetics on the proton and potassium permeabilities of liposomes, Biochim Biophys Acta, 819, 161, 10.1016\u002F0005-2736(85)90170-1\nBaudoux, 2002, General anesthetics do not prevent action potential invasion of axon branches or synaptic boutons, 284\nBeckstead, 2000, Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse, Mol Pharmacol, 57, 1199\nBeckstead, 2001, Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function, J Biol Chem, 276, 24959, 10.1074\u002Fjbc.M011627200\nBelelli, 1996, Interaction of positive allosteric modulators with human and drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes, Br J Pharmacol, 118, 563, 10.1111\u002Fj.1476-5381.1996.tb15439.x\nBelelli, 1997, The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type a receptor is influenced by a single amino acid, Proc Natl Acad Sci U S A, 94, 11031, 10.1073\u002Fpnas.94.20.11031\nBelelli, 1999, The interaction of general anaesthetics and neurosteroids with GABAA and glycine receptors, Neurochem Int, 34, 447, 10.1016\u002FS0197-0186(99)00037-6\nBelelli, 1999, General anaesthetic action at transmitter-gated inhibitory amino acid receptors, Trends Pharmacol Sci, 20, 496, 10.1016\u002FS0165-6147(99)01405-4\nBelelli, 2003, The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia, Neuropharmacology, 45, 57, 10.1016\u002FS0028-3908(03)00144-8\nBenkwitz, 2002, Anesthetic action on neuronal network activity in hippocampus: electrophysiology and Ca-imaging, 355\nBenoit, 1995, Effects of intravenous anaesthetics on nerve axons, Eur J Anaesthesiol, 12, 59\nBenoit, 1986, Mechanism of action of ketamine in the current and voltage clamped myelinated nerve fibre of the frog, Br J Pharmacol, 87, 291, 10.1111\u002Fj.1476-5381.1986.tb10817.x\nBenoit, 1987, Electrophysiological studies of the effects of the general anaesthetic etomidate on frog myelinated nerve fibre, Br J Pharmacol, 90, 7, 10.1111\u002Fj.1476-5381.1987.tb16819.x\nBjornstrom, 2003, The difference between sleep and anaesthesia is in the intracellular signal: propofol and GABA use different subtypes of the GABAA receptor beta subunit and vary in their interaction with actin, Acta Anaesthesiol Scand, 47, 157, 10.1034\u002Fj.1399-6576.2003.00007.x\nBleckwenn, M. (2003). Which Validity Does the Meyer-Overton-Correlation Possess Today? (German). Doctoral Dissertation, 142 pp. Faculty of Medicine, University of Bonn, Bonn, Germany. Download of pdf-copy Bleckwenn.pdf available at: http:\u002F\u002Fwww.ukb.uni-bonn.de\u002Fexa\nBosnjak, 2002, Anesthetic-induced cardiac preconditioning, 184\nBradley, 1981, Effects of halothane on channel activity of N-acetyl gramicidin, Biochem Biophys Res Commun, 101, 963, 10.1016\u002F0006-291X(81)91843-X\nBräu, 1998, Local anaesthetic effects on tetrodotoxin-resistant Na+ currents in rat dorsal root ganglion neurones, Eur J Anaesthesiol, 15, 80, 10.1046\u002Fj.1365-2346.1998.00218.x\nBräu, 1997, Blocking mechanisms of ketamine and its enantiomers in enzymatically demyelinated peripheral nerve as revealed by single-channel experiments, Anesthesiology, 86, 394, 10.1097\u002F00000542-199702000-00014\nBräu, 1998, Fundamental properties of local anesthetics: half-maximal blocking concentrations for tonic block of Na+ and K+ channels in peripheral nerve, Anesth Analg, 87, 885\nBremer, 1948, Action particuliere des barbituriques sur la transmission synaptique centrale, Arch Int Physiol, 56, 100\nBrooks, 1947, A study of the effects of anaesthesia and asphyxia on the monosynaptic pathway through the spinal cord, J Neurophysiol, 10, 349, 10.1152\u002Fjn.1947.10.5.349\nBurt, 1989, Volatile anesthetics block intercellular communication between neonatal rat myocardial cells, Circ Res, 65, 829, 10.1161\u002F01.RES.65.3.829\nButler, 1950, Theories of general anesthesia, J Pharmacol Exp Ther, 98, 121\nCampagna, 2003, Mechanisms of actions of inhaled anesthetics, N Engl J Med, 348, 2110, 10.1056\u002FNEJMra021261\nCannon, 1993, Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels, Biophys J, 65, 270, 10.1016\u002FS0006-3495(93)81045-2\nCantor, 1997, The lateral pressure profile in membranes: a physical mechanism of general anesthesia, Biochemistry, 36, 2339, 10.1021\u002Fbi9627323\nCaraiscos, 2004, Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane, J Neurosci, 24, 8454, 10.1523\u002FJNEUROSCI.2063-04.2004\nCatterall, 2002, Molecular mechanisms of gating and drug block of sodium channels, Novartis Found Symp, 241, 206, 10.1002\u002F0470846682.ch14\nCatterall, 2003, International union of pharmacology: XL. Compendium of voltage-gated ion channels: calcium channels, Pharmacol Rev, 55, 579, 10.1124\u002Fpr.55.4.8\nChan, 2002, Low-affinity analytical chromatography for measuring inhaled anesthetic binding to isolated proteins, Anal Biochem, 301, 308, 10.1006\u002Fabio.2001.5506\nChang, 2001, Effects of propofol on mitochondrial function and intracellular calcium shift in bovine aortic endothelial model, Acta Anaesthesiol Sin, 39, 115\nCharlesworth, 1994, Calcium channel currents in bovine adrenal chromaffin cells and their modulation by anaesthetic agents, J Physiol (Lond), 481, 543, 10.1113\u002Fjphysiol.1994.sp020462\nCheng, 2000, Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABAA or glycine receptors, Anesthesiology, 93, 1075, 10.1097\u002F00000542-200010000-00032\nChortkoff, 1995, Concentrations of desflurane and propofol that suppress response to command in humans, Anesth Analg, 81, 737, 10.1097\u002F00000539-199510000-00014\nClarkson, 1989, Stereoselective block of cardiac sodium channels by RAC109 in single guinea pig ventricular myocytes, Circ Res, 65, 1306, 10.1161\u002F01.RES.65.5.1306\nCohen, 1973, Effect of anesthetics on mitochondrial function, Anesthesiology, 39, 153, 10.1097\u002F00000542-197308000-00007\nCordato, 1999, Stereoselective interaction of thiopentone enantiomers with the GABAA receptor, Br J Pharmacol, 128, 77, 10.1038\u002Fsj.bjp.0702744\nCroxton, 1995, Inhibitory effects of thiopental, ketamine, and propofol on voltage-dependent Ca2+ channels in porcine tracheal smooth muscle cells, Anesthesiology, 83, 1274, 10.1097\u002F00000542-199512000-00018\nDavies, 1974, A quantitative interpretation of phase effects in anaesthesia, Int J Quantum Chem: Quantum Biology Symp, 1, 201\nDavies, 1976, The hydrogen bond proton donor properties of volatile halogenated hydrocarbons and ethers and their mode of action in anaesthesia, Int J Quantum Chem: Quantum Biology Symp, 3, 171\nDavies, 2000, Effects of isoflurane, sevoflurane, and halothane on myofilament Ca2+ sensitivity and sarcoplasmic reticulum Ca2+ release in rat ventricular myocytes, Anesthesiology, 93, 1034, 10.1097\u002F00000542-200010000-00027\nDavies, 2001, Evidence for the formation of functionally distinct alphabetagammaepsilon GABAA receptors, J Physiol, 537, 101, 10.1111\u002Fj.1469-7793.2001.0101k.x\nDe Weer, 2000, A century of thinking about cell membranes, Annu Rev Physiol, 62, 919, 10.1146\u002Fannurev.physiol.62.1.919\nDickinson, 2002, Anaesthetic actions on hippocampal autapses, 417\nDiFazio, 1972, Additive effects of anesthetics and theories of anesthesia, Anesthesiology, 36, 57, 10.1097\u002F00000542-197201000-00010\nDildy-Mayfield, 1996, Anesthetics produce subunit-selective actions on glutamate receptors, J Pharmacol Exp Ther, 276, 1058\nDilger, 2002, The effects of general anaesthetics on ligand-gated ion channels, Br J Anaesth, 89, 41, 10.1093\u002Fbja\u002Faef161\nDilger, 1992, Effects of isoflurane on acetylcholine receptor channels: 1. Single-channel currents, Mol Pharmacol, 41, 127\nDilger, 1993, The effects of isoflurane on acetylcholine receptor channels: 2. Currents elicited by rapid perfusion of acetylcholine, Mol Pharmacol, 44, 1056\nDilger, 1995, Effects of general anesthetics on acetylcholine receptor channels, Prog Anesth Mech, 3, 50\nDilger, 1997, Mechanisms of barbiturate inhibition of acetylcholine receptor channels, J Gen Physiol, 109, 401, 10.1085\u002Fjgp.109.3.401\nDingledine, 1999, The glutamate receptor ion channels, Pharmacol Rev, 51, 7\nDodson, 1985, The physiological effects of hydrostatic pressure are not equivalent to those of helium pressure on rana pipiens, J Physiol (Lond), 362, 233, 10.1113\u002Fjphysiol.1985.sp015673\nDownie, 2000, Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors, Anesthesiology, 93, 774, 10.1097\u002F00000542-200009000-00027\nDreixler, 2000, Patch-clamp analysis of anesthetic interactions with recombinant SK2 subtype neuronal calcium-activated potassium channels, Anesth Analg, 90, 727, 10.1097\u002F00000539-200003000-00040\nDuncum, 1994\nDwyer, 1994, The electroencephalogram does not predict depth of isoflurane anesthesia, Anesthesiology, 81, 403, 10.1097\u002F00000542-199408000-00019\nDybek, A. (1999). Comparison of Anesthetic Effects on an Acetylcholine Receptor Channel and on a Potassium Channel in the Human Neuroblastoma Cell Line SH-SY5Y Using Patch-Clamp and Fast Superfusion Technology (German). Doctoral Dissertation, 112 pp. Faculty of Medicine, University of Bonn, Bonn, Germany.\nEckenhoff, 2001, Promiscuous ligands and attractive cavities: how do the inhaled anesthetics work?, Molecular Interventions, 1, 258\nEckenhoff, 1999, On the relevance of “Clinically Relevant Concentrations” of inhaled anesthetics in in vitro experiments, Anesthesiology, 91, 856, 10.1097\u002F00000542-199909000-00039\nEckenhoff, 1999, Steric hindrance is not required for N-alkanol cutoff in soluble proteins, Mol Pharmacol, 56, 414, 10.1124\u002Fmol.56.2.414\nEckenhoff, 2001, Cooperative binding of inhaled anesthetics and ATP to firefly luciferase, Proteins, 42, 436, 10.1002\u002F1097-0134(20010301)42:4\u003C436::AID-PROT20>3.0.CO;2-I\nEger, 1974\nEger, 2000, MAC\nEger, 2001, Relevant concentrations of inhaled anesthetics for in vitro studies of anesthetic mechanisms, Anesthesiology, 94, 915, 10.1097\u002F00000542-200105000-00032\nEger, 1965, Minimum alveolar anesthetic concentration: a standard of anesthetic potency, Anesthesiology, 26, 756, 10.1097\u002F00000542-196511000-00010\nElliott, 1989, The actions of neutral anaesthetics on ion conductances of nerve membranes, Biochim Biophys Acta, 988, 257, 10.1016\u002F0304-4157(89)90021-X\nElliott, 1995, Integrative effects of general anaesthetics: why nerve axons should not be ignored, Eur J Anaesthesiol, 12, 41\nElliott, 1989, The effects of homologous series of anaesthetics on a resting potassium conductance of the squid giant axon, Biochim Biophys Acta, 978, 337, 10.1016\u002F0005-2736(89)90134-X\nEnders, 1990, The influence of general, volatile anesthetics on the dynamic properties of model membranes, Biochim Biophys Acta, 1029, 43, 10.1016\u002F0005-2736(90)90434-P\nEvans, 1987, Clinical signs and autonomic responses, 18\nEvers, 1997, Supersensitive sites in the central nervous system, anesthetics block brain nicotinic receptors, Anesthesiology, 86, 760, 10.1097\u002F00000542-199704000-00003\nEyring, 1973, A molecular mechanism of general anesthesia, Anesthesiology, 38, 415, 10.1097\u002F00000542-197305000-00001\nFeinstein, 1975, Fluidity of natural membranes and phosphatidylserine and ganglioside dispersions. Effect of local anesthetics, cholesterol and protein, Biochim Biophys Acta, 413, 354, 10.1016\u002F0005-2736(75)90121-2\nFerguson, 1939, The use of chemical potentials as indices of toxicity, Proc Roy Soc Lond (Biol), 127, 387, 10.1098\u002Frspb.1939.0030\nFink, 1975\nFink, 1980\nFirestone, 1986, Appendix: tables of physical and pharmacological properties of anesthetics, 455\nFirestone, 1986, Actions of general anesthetics on acetylcholine receptor-rich membranes from torpedo californica, Anesthesiology, 64, 694, 10.1097\u002F00000542-198606000-00004\nFirestone, 1994, Does general anesthetic-induced desensitization of the torpedo acetylcholine receptor correlate with lipid disordering?, Mol Pharmacol, 46, 508\nFlood, 1997, Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected, Anesthesiology, 86, 859, 10.1097\u002F00000542-199704000-00016\nForman, 1995, A discrete site for general anesthetics on a postsynaptic receptor, Mol Pharmacol, 48, 574\nFragen, 2000, Barbiturate, 216\nFranks, 1998, Which molecular targets are most relevant to general anaesthesia?, Toxicol Lett, 100–101, 1, 10.1016\u002FS0378-4274(98)00158-1\nFranks, 1996, Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments, Anesthesiology, 84, 716, 10.1097\u002F00000542-199603000-00027\nFranks, 1984, Do general anaesthetics act by competitive binding to specific receptors?, Nature, 310, 599, 10.1038\u002F310599a0\nFranks, 1985, Mapping of general anaesthetic target sites provides a molecular basis for cutoff effects, Nature, 316, 349, 10.1038\u002F316349a0\nFranks, 1998, How does xenon produce anaesthesia?, Nature, 396, 324, 10.1038\u002F24525\nFranqueza, 1997, Molecular determinants of stereoselective bupivacaine block of HKv1.5 channels, Circ Res, 81, 1053, 10.1161\u002F01.RES.81.6.1053\nFrenkel, 1991, Human brain sodium channels as one of the molecular target sites for the new intravenous anaesthetic propofol (2,6-Diisopropylphenol), Eur J Pharmacol, 208, 75, 10.1016\u002F0922-4106(91)90054-L\nFrenkel, 1992, Molecular actions of racemic ketamine on human CNS sodium channels, Br J Anaesth, 69, 292, 10.1093\u002Fbja\u002F69.3.292\nFrenkel, 1994, Interactions of intravenous anesthetics with human CNS ion channels. Electrophysiologic studies with a new type of voltage clamp technique, Anaesthesist, 43, 229, 10.1007\u002Fs001010050052\nFrenkel, 1994, Interaktionen intravenöser Anästhetika mit menschlichen ZNS-Ionenkanälen, Anaesthesist, 43, 229, 10.1007\u002Fs001010050052\nFrenkel, 1989, Pentobarbital suppresses human brain sodium channels, Brain Res Mol Brain Res, 6, 211, 10.1016\u002F0169-328X(89)90056-9\nFrenkel, 1990, Molecular actions of pentobarbital isomers on sodium channels from human brain cortex, Anesthesiology, 72, 640, 10.1097\u002F00000542-199004000-00012\nFrenkel, 1998, Blocking effects of the anaesthetic etomidate on human brain sodium channels, Neurosci Lett, 249, 131, 10.1016\u002FS0304-3940(98)00412-1\nFriederich, P. (1997). Untersuchungen zum Einfluß von Allgemeinanästhetika auf einen menschlichen neuronalen Kaliumstrom mit der Ganzzell Patch-Clamp Methode (German). Doctoral Dissertation, 104 pp. Faculty of Medicine, University of Bonn, Bonn, Germany.\nFriederich, 1997, Abhängigkeit der Wirkung von Etomidat auf einen neuronalen Kaliumstrom des Menschen von der extrazellulären Kaliumkonzentration, Anaesthesist, 12, 1090\nFriederich, 1997, Etomidate inhibits neuronal potassium channels in humans, Anaesthesist, 46, 434, 10.1007\u002Fs001010050422\nFriederich, 1998, The inhibition of human neuronal K+ currents by general anesthetic agents is altered by extracellular K, Brain Res Mol Brain Res, 60, 301, 10.1016\u002FS0169-328X(98)00209-5\nFriederich, 1999, Interaction of intravenous anesthetics with human neuronal potassium currents in relation to clinical concentrations, Anesthesiology, 91, 1853, 10.1097\u002F00000542-199912000-00040\nFriederich, 2000, Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells, Anesthesiology, 93, 818, 10.1097\u002F00000542-200009000-00032\nFriederich, 2001, Ketamine and propofol differentially inhibit human neuronal K(+) channels, Eur J Anaesthesiol, 18, 177, 10.1097\u002F00003643-200103000-00007\nFriederich, 2001, Epileptic seizure from etomidate? The human Kv 1.1 potassium channel in humans, Anasthesiol Intensivmed Notfallmed Schmerzther, 36, 100, 10.1055\u002Fs-2001-11054\nFriederich, 2001, Interaction of volatile anesthetics with human Kv channels in relation to clinical concentrations, Anesthesiology, 95, 954, 10.1097\u002F00000542-200110000-00026\nFriederich, 2002, Bupivacaine inhibits human neuronal Kv3 channels in SH-SY5Y human neuroblastoma cells, Br J Anaesth, 88, 864, 10.1093\u002Fbja\u002F88.6.864\nFrohlich, 2002, Thiopental impairs neutrophil oxidative response by inhibition of intracellular signalling, Eur J Anaesthesiol, 19, 474, 10.1097\u002F00003643-200207000-00003\nFromming, 1999, Isoform-specific interactions between halothane and the ryanodine receptor Ca(2+)-release channel: implications for malignant hyperthermia and the protein theory of anaesthetic action, Naturwissenschaften, 86, 584, 10.1007\u002Fs001140050678\nFuruya, 1999, The effects of ketamine and propofol on neuronal nicotinic acetylcholine receptors and P2x purinoceptors in PC12 cells, Anesth Analg, 88, 174, 10.1097\u002F00000539-199901000-00033\nGalla, 1980, Asymmetric antagonistic effects of an inhalation anesthetic and high pressure on the phase transition temperature of dipalmitoyl phosphatidic acid bilayers, Biochim Biophys Acta, 599, 336, 10.1016\u002F0005-2736(80)90080-2\nGauldie, 2001, Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints, Br J Pharmacol, 132, 617, 10.1038\u002Fsj.bjp.0703890\nGenna, 1980, Effects of tertiary amine local anesthetics on the assembly and disassembly of brain microtubules in vitro, Eur J Biochem, 110, 457, 10.1111\u002Fj.1432-1033.1980.tb04887.x\nGlass, 1997, Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers, Anesthesiology, 86, 836, 10.1097\u002F00000542-199704000-00014\nGlass, 2000, Intravenous drug delivery systems, 377\nGomez, 2001, Halothane-induced intracellular calcium release in cholinergic cells, Brain Res, 921, 106, 10.1016\u002FS0006-8993(01)03098-0\nGöthert, 1976, Inhibition of receptor-mediated noradrenaline release from the sympathetic nerves of the isolated rabbit heart by anaesthetics and alcohols in proportion to their hydrophobic property, Naunyn-Schmiedeberg's Arch Pharmacol, 292, 145, 10.1007\u002FBF00498585\nGrasshoff, 2002, Effects of volatile anesthetics on action potential firing of spinal neurons in organotypic slice cultures, 363\nGray, 1998, TOK1 is a volatile anesthetic stimulated K+ channel, Anesthesiology, 88, 1076, 10.1097\u002F00000542-199804000-00029\nGruen, 1981, A mean-field model of the alkane-saturated lipid bilayer above its phase transition: II. Results and comparison with experiment, Biophys J, 33, 167, 10.1016\u002FS0006-3495(81)84879-5\nGruss, 2002, Ethanol modifies action potentials in a subtype of small sensory neurones by activation of BK Ca-channels, 190\nGruss, 2004, Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane, Mol Pharmacol, 65, 443, 10.1124\u002Fmol.65.2.443\nGundersen, 1988, Barbiturates depress currents through human brain calcium channels studied in xenopus oocytes, J Pharmacol Exp Ther, 247, 824\nGutman, 2003, International union of pharmacology: XLI. Compendium of voltage-gated ion channels: potassium channels, Pharmacol Rev, 55, 583, 10.1124\u002Fpr.55.4.9\nHaeseler, 2002, The potency of a phenol derivative for direct activation of chloride currents via GABAA receptors is related to the position of methyl and isopropyl groups with respect to the phenolic hydroxyl group, 151\nHales, 1991, The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones, Br J Pharmacol, 104, 619, 10.1111\u002Fj.1476-5381.1991.tb12479.x\nHales, 1994, Basic pharmacology of intravenous induction agents, 295\nHansch, 1987, Hydrophobicity and central nervous system agents:on the principle of minimal hydrophobicity in drug design, Journal of Pharmaceutical Sciences, 76, 663, 10.1002\u002Fjps.2600760902\nHardman, 2001\nHaydon, 1972, Ion transport across thin lipid membranes: a critical discussion of mechanisms in selected systems, Q Rev Biophys, 5, 187, 10.1017\u002FS0033583500000883\nHaydon, 1988, Excitation of the squid giant axon by general anaesthetics, J Physiol, 402, 375, 10.1113\u002Fjphysiol.1988.sp017210\nHaydon, 1986, The actions of some general anaesthetics on the potassium current of the squid giant axon, J Physiol (Lond), 373, 311, 10.1113\u002Fjphysiol.1986.sp016049\nHaydon, 1977, The molecular mechanisms of anaesthesia, Nature, 268, 356, 10.1038\u002F268356a0\nHaydon, 1977, Anaesthesia by the N-alkanes. A comparative study of nerve impulse blockage and the properties of black lipid bilayer membranes, Biochim Biophys Acta, 470, 17, 10.1016\u002F0005-2736(77)90058-X\nHaydon, 1980, Some effects of aliphatic hydrocarbons on the electrical capacity and ionic currents of the squid giant axon membrane, J Physiol, 309, 229, 10.1113\u002Fjphysiol.1980.sp013506\nHaydon, 1986, The action of nonionic anesthetics substances on voltage-gated ion conductances in squid giant axons, 267\nHaydon, 1988, The potassium conductance of the resting squid axon and its blockage by clinical concentrations of general anaesthetics, J Physiol, 402, 363, 10.1113\u002Fjphysiol.1988.sp017209\nHe, 2000, Mechanism and selectivity of the effects of halothane on gap junction channel function, Circ Res, 86, E104, 10.1161\u002F01.RES.86.11.e104\nHeinke, 2002, In vivo imaging of anaesthetic action in humans: approaches with positron emission tomography (PET) and functional magnetic resonance imaging (FMRI), Br J Anaesth, 89, 112, 10.1093\u002Fbja\u002Faef155\nHerrington, 1992, Kinetic and pharmacological properties of low voltage-activated Ca2+ current in rat clonal (GH3) pituitary cells, J Neurophysiol, 68, 213, 10.1152\u002Fjn.1992.68.1.213\nHertle, 1997, Interaction of midazolam with the nicotinic acetylcholine receptor of mouse myotubes, Anesth Analg, 85, 174, 10.1097\u002F00000539-199707000-00031\nHille, 2001\nHirota, 1996, I.v. anaesthetic agents do not interact with the verapamil binding site on L-type voltage-sensitive Ca2+ channels, Br J Anaesth, 77, 385, 10.1093\u002Fbja\u002F77.3.385\nHirota, 2002, The agent- and pathway-specific actions of general anesthetics in hippocampus in vitro, 370\nHirota, 2003, The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptors, Anesth Analg, 96, 1656, 10.1213\u002F01.ANE.0000061580.89627.91\nHladky, 1970, Discreteness of conductance change in bimolecular lipid membranes in the presence of certain antibiotics, Nature, 5231, 451, 10.1038\u002F225451a0\nHomer, 1985, The effect of increasing age on thiopental disposition and anesthetic requirement, Anesthesiology, 62, 714, 10.1097\u002F00000542-198506000-00004\nHonemann, 2001, The inhibitory effect of bupivacaine on prostaglandin E(2) (EP(1)) receptor functioning: mechanism of action, Anesth Analg, 93, 628, 10.1097\u002F00000539-200109000-00019\nHopkins, 2002, Postgraduate issue: molecular and basic mechanisms of anaesthesia, British Journal of Anaesthesia, 89, 1, 10.1093\u002Fbja\u002Faef192\nHormuzdi, 2004, Electrical synapses: a dynamic signaling system that shapes the activity of neuronal networks, Biochim Biophys Acta, 1662, 113, 10.1016\u002Fj.bbamem.2003.10.023\nHug, 1990, Does opioid “Anesthesia” exist?, Anesthesiology, 73, 1, 10.1097\u002F00000542-199007000-00001\nHuidobro-Toro, 1987, Neurochemical actions of anesthetic drugs on the gamma-aminobutyric acid receptor-chloride channel complex, J Pharmacol Exp Ther, 242, 963\nJacobs, 1995, Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam, Anesth Analg, 80, 143, 10.1097\u002F00000539-199501000-00024\nJanoff, 1981, Correlation of general anesthetic potency with solubility in membranes, Biochim Biophys Acta, 649, 125, 10.1016\u002F0005-2736(81)90017-1\nJenkins, 1996, Actions of general anaesthetics on 5-HT3 receptors in N1E-115 neuroblastoma cells, Br J Pharmacol, 117, 1507, 10.1111\u002Fj.1476-5381.1996.tb15314.x\nJensen, 1994, Propofol induces changes in the cytosolic free calcium concentration and the cytoskeletal organization of cultured human glial cells and primary embryonic rat brain cells, Anesthesiology, 81, 1220, 10.1097\u002F00000542-199411000-00016\nJiang, 2004, Electron microscopic analysis of KvAP voltage-dependent K+ channels in an open conformation, Nature, 430, 806, 10.1038\u002Fnature02735\nKaech, 1999, Volatile anesthetics block actin-based motility in dendritic spines, Proc Natl Acad Sci U S A, 96, 10433, 10.1073\u002Fpnas.96.18.10433\nKatoh, 1998, Electroencephalographic derivatives as a tool for predicting the depth of sedation and anesthesia induced by sevoflurane, Anesthesiology, 88, 642, 10.1097\u002F00000542-199803000-00014\nKaufman, 1977, Biophysical mechanisms of anesthetic action: historical perspective and review of current concepts, Anesthesiology, 46, 49, 10.1097\u002F00000542-197701000-00010\nKauzmann, 1959, Some factors in the interpretation of protein denaturation, Adv Protein Chem, 14, 1, 10.1016\u002FS0065-3233(08)60608-7\nKawano, 2004, Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels, Anesthesiology, 100, 338, 10.1097\u002F00000542-200402000-00024\nKendig, 2002, In vitro networks: subcortical mechanisms of anaesthetic action, Br J Anaesth, 89, 91, 10.1093\u002Fbja\u002Faef158\nKhakh, 2001, International union of pharmacology: XXIV. Current Status of the nomenclature and properties of P2X receptors and their subunits, Pharmacol Rev, 53, 107\nKindler, 2003, Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5), J Pharmacol Exp Ther, 306, 84, 10.1124\u002Fjpet.103.049809\nKita, 1981, The partial molar volumes of anesthetics in lipid bilayers, Biochim Biophys Acta, 647, 130, 10.1016\u002F0005-2736(81)90301-1\nKoblin, 2000, Mechanisms of action, 48\nKoblin, 1998, Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics), Anesth Analg, 87, 419, 10.1097\u002F00000539-199808000-00035\nKochs, 1999, Middle latency auditory evoked responses and electroencephalographic derived variables do not predict movement to noxious stimulation during 1 minimum alveolar anesthetic concentration isoflurane\u002Fnitrous oxide anesthesia, Anesth Analg, 88, 1412, 10.1097\u002F00000539-199906000-00039\nKrasowski, 2000, The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations, Br J Pharmacol, 129, 731, 10.1038\u002Fsj.bjp.0703087\nKrasowski, 2001, General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABAA receptor but not with lipid solubility, J Pharmacol Exp Ther, 297, 338\nKurata, 2002, Functional magnetic resonance imaging reveals temporal dynamics of cerebral pain processing, 458\nKwok, 2004, Preconditioning of the myocardium by volatile anesthetics, Curr Med Chem Cardiovasc Hematol Agents, 2, 249, 10.2174\u002F1568016043356318\nLarrabee, 1952, Selective action of anesthetics on synapses and axons in mammalian sympathetic ganglia, J Neurophysiol, 15, 91, 10.1152\u002Fjn.1952.15.2.91\nLechleiter, 1986, Halothane-induced changes in acetylcholine receptor channel kinetics are attenuated by cholesterol, Biochim Biophys Acta, 856, 640, 10.1016\u002F0005-2736(86)90159-8\nLee, 1976, Model for action of local anaesthetics, Nature, 262, 545, 10.1038\u002F262545a0\nLee-Son, 1992, Stereoselective inhibition of neuronal sodium channels by local anesthetics, evidence for two sites of action?, Anesthesiology, 77, 324, 10.1097\u002F00000542-199208000-00016\nLeo, 1971, Partition coefficients and their uses, Chemical Reviews, 71, 525, 10.1021\u002Fcr60274a001\nLi, 2000, Effects of halothane on GABAA receptor kinetics: evidence for slowed agonist unbinding, J Neurosci, 20, 899, 10.1523\u002FJNEUROSCI.20-03-00899.2000\nLins, 1995, The hydrophobic effect in protein folding, FASEB J, 9, 535, 10.1096\u002Ffasebj.9.7.7737462\nLipnick, 1991\nLittle, 1996, How has molecular pharmacology contributed to our understanding of the mechanism(s) of general anesthesia?, Pharmacol Ther, 69, 37, 10.1016\u002F0163-7258(95)02030-6\nLiu, 1993, Is there a cutoff in anesthetic potency for the normal alkanes?, Anesth Analg, 77, 12, 10.1213\u002F00000539-199307000-00004\nLoop, 2002, Thiopental inhibits the activation of nuclear factor-B, 341\nLouis, 2001, Malignant hyperthermia: an inherited disorder of skeletal muscle Ca+ regulation, Biosci Rep, 21, 155, 10.1023\u002FA:1013644107519\nLu, 2002, The general anesthetic pentobarbital slows desensitization and deactivation of the glycine receptor in the rat spinal dorsal horn neurons, J Biol Chem, 277, 41369, 10.1074\u002Fjbc.M206768200\nLukas, 1999, International union of pharmacology: XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits, Pharmacol Rev, 51, 397\nMacDonald, 1991, Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones, J Physiol, 432, 483, 10.1113\u002Fjphysiol.1991.sp018396\nMachleidt, 1972, The hydrophobic expansion of erythrocyte membranes by the phenol anesthetics, Biochim Biophys Acta, 255, 178, 10.1016\u002F0005-2736(72)90020-X\nMachu, 1994, Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in xenopus laevis oocytes, J Pharmacol Exp Ther, 271, 898\nMacIver, 1991, Anesthetic effects on resting membrane potential are voltage-dependent and agent-specific, Anesthesiology, 74, 83, 10.1097\u002F00000542-199101000-00014\nMartin, 1993, The effect of local anaesthetics on the ryanodine receptor\u002FCa2+ release channel of brain microsomal membranes, FEBS Lett, 328, 77, 10.1016\u002F0014-5793(93)80969-2\nMasaki, 2004, Attenuation of gap-junction-mediated signaling facilitated anesthetic effect of sevoflurane in the central nervous system of rats, Anesth Analg, 98, 647, 10.1213\u002F01.ANE.0000103259.72635.72\nMascia, 1996, Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics, Br J Pharmacol, 119, 1331, 10.1111\u002Fj.1476-5381.1996.tb16042.x\nMashimo, 2005, Basic and systemic mechanisms of anesthesia\nMcLarnon, 1986, Mechanism of nicotinic channel blockade by anesthetics, 155\nMcGivern, 1990, General anaesthetics and field currents in unclamped, unmyelinated axons of rat olfactory cortex, Br J Pharmacol, 101, 217, 10.1111\u002Fj.1476-5381.1990.tb12116.x\nMetcalfe, 1968, The proton relaxation of benzyl alcohol in erythrocyte membranes, Mol Pharmacol, 4, 87\nMihic, 1996, Inhibition of Rho1 receptor GABAergic currents by alcohols and volatile anesthetics, J Pharmacol Exp Ther, 277, 411\nMihic, 1997, Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors, Nature, 389, 385, 10.1038\u002F38738\nMiller, 1985, The nature of the site of general anesthesia, Int Rev Neurobiol, 27, 1, 10.1016\u002FS0074-7742(08)60555-3\nMiller, 1999, Mechanisms of action\nMiller, 2000\nMiller, 2002, The nature of sites of general anaesthetic action, Br J Anaesth, 89, 17, 10.1093\u002Fbja\u002Faef167\nMiller, 1987, General anesthetic and specific effects of ethanol on acetylcholine receptors, Ann N Y Acad Sci, 492, 71, 10.1111\u002Fj.1749-6632.1987.tb48656.x\nMiller, 1972, Physicochemical approaches to the mode of action of general anesthetics, Anesthesiology, 36, 339, 10.1097\u002F00000542-197204000-00008\nMintun, 2002, In vivo molecular brain imaging: approaches with positron emission tomography, 459\nMiro, 1999, Effects of general anaesthetic procedures on mitochondrial function of human skeletal muscle, Eur J Clin Pharmacol, 55, 35, 10.1007\u002Fs002280050589\nMohammadi, 2001, Structural requirements of phenol derivatives for direct activation of chloride currents via GABAA receptors, Eur J Pharmacol, 421, 85, 10.1016\u002FS0014-2999(01)01033-0\nMoody, 1997, Distinct loci mediate the direct and indirect actions of the anesthetic etomidate at GABA(A) receptors, J Neurochem, 69, 1310, 10.1046\u002Fj.1471-4159.1997.69031310.x\nMoss, 1991, Modulation of the general anesthetic sensitivity of a protein: a transition between two forms of firefly luciferase, Proc Natl Acad Sci U S A, 88, 134, 10.1073\u002Fpnas.88.1.134\nMullins, 1954, Some physical mechanisms in narcosis, Chem Rev, 54, 289, 10.1021\u002Fcr60168a003\nMurat, 1991, The effects of volatile anesthetics on the calcium sensitivity of cardiac myofilaments, Adv Exp Med Biol, 301, 181, 10.1007\u002F978-1-4684-5979-1_16\nNagele, 2002, 262\nNakahiro, 1989, General anesthetics modulate GABA receptor channel complex in rat dorsal root ganglion neurons, FASEB J, 3, 1850, 10.1096\u002Ffasebj.3.7.2541038\nNakao, 1989, Effects of volatile anesthetics on cardiac calcium channels, Acta Anaesthesiol Scand, 33, 326, 10.1111\u002Fj.1399-6576.1989.tb02917.x\nNakazawa, 1991, Comparison of adenosine triphosphate- and nicotine-activated inward currents in rat phaeochromocytoma cells, J Physiol, 434, 647, 10.1113\u002Fjphysiol.1991.sp018491\nNash, 2002, In vivo genetics of anaesthetic action, Br J Anaesth, 89, 143, 10.1093\u002Fbja\u002Faef159\nNau, 1999, Stereoselectivity of bupivacaine in local anesthetic-sensitive ion channels of peripheral nerve, Anesthesiology, 91, 786, 10.1097\u002F00000542-199909000-00031\nNishikawa, 2003, The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits, Anesthesiology, 99, 678, 10.1097\u002F00000542-200309000-00024\nNishikawa, 2000, Excitatory synaptic transmission mediated by NMDA receptors is more sensitive to isoflurane than are non-NMDA receptor-mediated responses, Anesthesiology, 92, 228, 10.1097\u002F00000542-200001000-00035\nNishimura, 2002, General anesthesia supresses nocturnal melatonin secretion, 436\nNorth, 1997, Contrasting membrane localization and behavior of halogenated cyclobutanes that follow or violate the Meyer-Overton hypothesis of general anesthetic potency, Biophys J, 72, 1754, 10.1016\u002FS0006-3495(97)78821-0\nNunn, 1971, Arrest of mitosis by halothane, Br J Anaesth, 43, 524, 10.1093\u002Fbja\u002F43.6.524\nOlofsen, 1999, The dynamic relationship between end-tidal sevoflurane and isoflurane concentrations and bispectral index and spectral edge frequency of the electroencephalogram, Anesthesiology, 90, 1345, 10.1097\u002F00000542-199905000-00019\nO'Shea, 2004, Propofol restores the function of “Hyperekplexic” mutant glycine receptors in xenopus oocytes and mice, J Neurosci, 24, 2322, 10.1523\u002FJNEUROSCI.4675-03.2004\nOrser, 1994, Propofol-induced neuroexcitation and receptor desensitization, Can J Anaesth, 41, 366, 10.1007\u002FBF03009857\nOrser, 1997, Multiple mechanisms of ketamine blockade of N-methyl-d-aspartate receptors, Anesthesiology, 86, 903, 10.1097\u002F00000542-199704000-00021\nOrser, 1998, General anaesthetics and their effects on GABAA receptor desensitization, Toxicol Lett, 100–101, 217, 10.1016\u002FS0378-4274(98)00188-X\nOrser, 2002, Increased desensitization of ampa receptors may cause hypersensitivity to anesthetics in GluR2 null mutant mice, 311\nOscarsson, 2001, Reorganization of actin in neurons after propofol exposure, Acta Anaesthesiol Scand, 45, 1215, 10.1034\u002Fj.1399-6576.2001.451007.x\nOverton, 1901\nPatel, 2001, Anesthetic-sensitive 2P domain K+ channels, Anesthesiology, 95, 1013, 10.1097\u002F00000542-200110000-00034\nPatel, 2003, 2P domain K+ channels: novel pharmacological targets for volatile general anesthetics, Adv Exp Med Biol, 536, 9, 10.1007\u002F978-1-4419-9280-2_2\nPatel, 2003, The general anesthetic propofol increases brain N-arachidonylethanolamine (Anandamide) content and inhibits fatty acid amide hydrolase, Br J Pharmacol, 139, 1005, 10.1038\u002Fsj.bjp.0705334\nPaton, 1967, The margin of safety of neuromuscular transmission, J Physiol, 191, 59, 10.1113\u002Fjphysiol.1967.sp008237\nPentyala, 2002, Intravenous anesthetics reduce airway resistance by their action on plasma membrane calcium pump, 404\nPeoples, 2002, Inhibition of N-methyl-d-aspartate receptors by straight-chain diols: implications for the mechanism of the alcohol cutoff effect, Mol Pharmacol, 61, 169, 10.1124\u002Fmol.61.1.169\nPerlik, 1992, Somatosensory evoked potential surgical monitoring, observations during combined isoflurane-nitrous oxide anesthesia, Spine, 17, 273, 10.1097\u002F00007632-199203000-00005\nPistis, 1997, The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in xenopus laevis oocytes: a comparative study, Br J Pharmacol, 122, 1707, 10.1038\u002Fsj.bjp.0701563\nPlanells-Cases, 2000, Arginine-rich peptides are blockers of VR-1 channels with analgesic activity, FEBS Lett, 481, 131, 10.1016\u002FS0014-5793(00)01982-7\nPohorille, 1996, Interactions of anesthetics with the membrane–water interface, Chem Phys, 204, 337, 10.1016\u002F0301-0104(95)00292-8\nPope, 1982, The influence of N-alkanols and cholesterol on the duration and conductance of gramicidin single channels in monoolein bilayers, Biochim Biophys Acta, 688, 279, 10.1016\u002F0005-2736(82)90605-8\nPringle, 1981, Can the lipid theories of anesthesia account for the cutoff in anesthetic potency in homologous series of alcohols?, Mol Pharmacol, 19, 49\nRampil, 1998, A primer for EEG signal processing in anesthesia, Anesthesiology, 89, 980, 10.1097\u002F00000542-199810000-00023\nRebecchi, 2002, Anaesthetic actions on other targets: protein kinase, C. and guanine nucleotide-binding proteins, Br J Anaesth, 89, 62, 10.1093\u002Fbja\u002Faef160\nReeves, 2002, The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel, Mol Membr Biol, 19, 11, 10.1080\u002F09687680110110048\nRehberg, 1999, Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane, Anesthesiology, 91, 397, 10.1097\u002F00000542-199908000-00013\nRehberg, 1999, Suppression of central nervous system sodium channels by propofol, Anesthesiology, 91, 512, 10.1097\u002F00000542-199908000-00026\nRehberg, 1995, Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line, Mol Pharmacol, 48, 89\nRehberg, 1995, The membrane lipid cholesterol modulates anesthetic actions on a human brain ion channel, Anesthesiology, 82, 749, 10.1097\u002F00000542-199503000-00017\nRehberg, 1996, Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics, Anesthesiology, 84, 1223, 10.1097\u002F00000542-199605000-00025\nReves, 2000, Nonbarbiturate intravenous anesthetics, 228\nReyes, 1979, Effect of the anesthetics benzyl alcohol and chloroform on bilayers made from monolayers, Biophys J, 28, 259, 10.1016\u002FS0006-3495(79)85175-9\nRichards, 1980, The mechanisms of general anaesthesia, 1\nRichards, 2002, Anaesthetic modulation of synaptic transmission in the mammalian CNS, Br J Anaesth, 89, 79, 10.1093\u002Fbja\u002Faef162\nRichards, 1998\nRichards, 1978, Degenerate perturbations of protein structure as the mechanism of anaesthetic action, Nature, 276, 775, 10.1038\u002F276775a0\nRoth, 1986\nRoth, 1989, Actions of pentobarbital enantiomers on nicotinic cholinergic receptors, Mol Pharmacol, 36, 874\nRoth, 2002, Receptor-mediated excitatory effects of general anesthetics, 381\nRubin, 1991, Molecular and cellular mechanisms of alcohol and anesthetics, Ann N Y Acad Sci, 625, 1, 10.1111\u002Fj.1749-6632.1991.tb33825.x\nRudolph, 2004, Molecular and neuronal substrates for general anaesthetics, Nature Reviews Neuroscience, 5, 709, 10.1038\u002Fnrn1496\nSamain, 2002, Isoflurane alters angiotensin II-induced Ca2+ mobilization in aortic smooth muscle cells from hypertensive rats: implication of cytoskeleton, Anesthesiology, 97, 642, 10.1097\u002F00000542-200209000-00019\nSandorfy, 2002, Towards a comprehensive theory of general anesthesia, 66\nSandorfy, 2004, Weak intermolecular associations and anesthesia, Anesthesiology, 101, 1225, 10.1097\u002F00000542-200411000-00024\nSandorfy, 1974, On the biological importance of the hydrogen bond breaking potency of fluorocarbons, Chemical Physics Letters, 26, 466, 10.1016\u002F0009-2614(74)80392-1\nSanna, 1995, Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital, Mol Pharmacol, 47, 213\nSanna, 1995, Actions of the general anesthetic propofol on recombinant human GABAA receptors: influence of receptor subunits, J Pharmacol Exp Ther, 274, 353\nSasaki, 2002, Barbiturates accelerate the recovery from brief hypoxia in area CA1 of rat hippocampal slices, 387\nSaxon, 1988, Ryanodine in low concentrations is a Ca-release stimulator rather than inhibitor in rat myocardium, Gen Physiol Biophys, 7, 39\nSchapira, 2002, Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine, BMC Struct Biol, 2, 1, 10.1186\u002F1472-6807-2-1\nScheller, 1995, Enflurane blocks ion current through the nicotinic acetylcholine receptor, Anasthesiol Intensivmed Notfallmed Schmerzther, 30, 370, 10.1055\u002Fs-2007-996512\nScheller, 1996, Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state, Anesth Analg, 83, 830, 10.1097\u002F00000539-199610000-00031\nScheller, 1997, Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations, Anesthesiology, 86, 118, 10.1097\u002F00000542-199701000-00016\nScholz, 2002, Mechanisms of (Local) anaesthetics on voltage-gated sodium and other ion channels, Br J Anaesth, 89, 52, 10.1093\u002Fbja\u002Faef163\nSchüttler, 1990, Steuerung der totalen intravenösen Anästhesie, 72\nSchüttler, 1985, infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example, Eur J Anaesthesiol, 2, 133\nSchwarz, 2002, CNS effects of local anesthetics: novel lidocaine actions in the thalamus, 233\nSchwinn, 2000, Basic principles of pharmacology related to anesthesia, 15\nSeeman, 1972, The membrane actions of anesthetics and tranquilizers, Pharmacol Rev, 24, 583\nSeeman, 1972, General anesthetics expand cell membranes at surgical concentrations, Biochim Biophys Acta, 255, 171, 10.1016\u002F0005-2736(72)90019-3\nSinger, 1972, The fluid mosaic model of the structure of cell membranes, Science, 175, 720, 10.1126\u002Fscience.175.4023.720\nSlater, 1993, Inhibition of protein kinase C. by alcohols and anaesthetics, Nature, 364, 82, 10.1038\u002F364082a0\nSloan, 1998, Anesthetic effects on electrophysiologic recordings, J Clin Neurophysiol, 15, 217, 10.1097\u002F00004691-199805000-00005\nSmith, 1994, The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision, Anesthesiology, 81, 820, 10.1097\u002F00000542-199410000-00008\nSonner, 1998, Desflurane and the nonimmobilizer 1,2-dichlorohexafluorocyclobutane suppress learning by a mechanism independent of the level of unconditioned stimulation, Anesth Analg, 87, 200, 10.1097\u002F00000539-199807000-00041\nSonner, 2003, Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration, Anesth Analg, 97, 718, 10.1213\u002F01.ANE.0000081063.76651.33\nSpeers, 1971, General anesthetics: 2. Halogenated methyl isopropyl ethers, J Med Chem, 14, 593, 10.1021\u002Fjm00289a009\nStanski, 2000, Monitoring depth of anesthesia, 1087\nSteinbach, 2001, Modulation of GABAA receptor channel gating by pentobarbital, J Physiol, 537, 715, 10.1113\u002Fjphysiol.2001.012818\nStephenson, 1956, A modification of receptor theory, Br J Pharmacol, 11, 379\nStevens, 2005, Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors, Anesth Analg, 100, 1696, 10.1213\u002F01.ANE.0000151720.36988.09\nStoelting, 2001, Nonopiod intravenous anesthetics, 249\nStoelting, 1970, Minimum alveolar concentrations in man on awakening from methoxyflurane, halothane, ether and fluroxene anesthesia: MAC awake, Anesthesiology, 33, 5, 10.1097\u002F00000542-197007000-00004\nSuzuki, 2002, Biphasic effects of isoflurane on the cardiac action potential: an ionic basis for anesthetic-induced changes in cardiac electrophysiology, Anesthesiology, 97, 1209, 10.1097\u002F00000542-200211000-00026\nSuzuki, 2002, The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in xenopus oocytes, Anesthesiology, 96, 699, 10.1097\u002F00000542-200203000-00028\nSweetman, 1982, Effect of the general anaesthetics, alphaxalone, hexobarbitone and halothane on calcium uptake into rat brain mitochondria in vitro and in vivo, Methods Find Exp Clin Pharmacol, 4, 299\nTaheri, 1991, What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs?, Anesth Analg, 72, 627, 10.1213\u002F00000539-199105000-00010\nTaheri, 1993, Anesthesia by N-alkanes not consistent with the Meyer-Overton hypothesis: determinations of the solubilities of alkanes in saline and various lipids, Anesth Analg, 77, 7, 10.1213\u002F00000539-199307000-00003\nTanford, 1997, How protein chemists learned about the hydrophobic factor, Protein Sci, 6, 1358, 10.1002\u002Fpro.5560060627\nTang, 2002, Large-scale molecular dynamics simulations of general anesthetic effects on the ion channel in the fully hydrated membrane: the implication of molecular mechanisms of general anesthesia, Proc Natl Acad Sci U S A, 99, 16035, 10.1073\u002Fpnas.252522299\nTang, 2000, General anesthetic binding to gramicidin A: the structural requirements, Biophys J, 78, 1804, 10.1016\u002FS0006-3495(00)76730-0\nTang, 2002, Effects of volatile anesthetic on channel structure of gramicidin A, Biophys J, 83, 1413, 10.1016\u002FS0006-3495(02)73912-X\nTang, 1997, Different distribution of fluorinated anesthetics and nonanesthetics in model membrane: a 19F NMR study, Biophys J, 72, 1676, 10.1016\u002FS0006-3495(97)78813-1\nTelford, 1992, Fentanyl does not alter the “sleep” plasma concentration of thiopental, Anesth Analg, 75, 523, 10.1213\u002F00000539-199210000-00010\nTerrell, 1971, General Anesthetics: 1. Halogenated methyl ethyl ethers as anesthetic agents, J Med Chem, 14, 517, 10.1021\u002Fjm00288a014\nTerrell, 1972, General anesthetics: 3. Fluorinated methyl ethyl ethers as anesthetic agents, J Med Chem, 15, 604, 10.1021\u002Fjm00276a008\nTetko, 2002, Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program, J Chem Inf Comput Sci, 42, 1136, 10.1021\u002Fci025515j\nTetko, 2001, Prediction of N-octanol\u002Fwater partition coefficients from PHYSPROP database using artificial neural networks and E-state indices, J Chem Inf Comput Sci, 41, 1407, 10.1021\u002Fci010368v\nThompson, 2001, Locating an antagonist in the 5-HT3 receptor binding site: a modeling and radioligand binding study, J Biol Chem, 280, 20476, 10.1074\u002Fjbc.M413610200\nThornton, 1984, Effects of halothane or enflurane with controlled ventilation on auditory evoked potentials, Br J Anaesth, 56, 315, 10.1093\u002Fbja\u002F56.4.315\nThornton, 1989, Effect of propofol on the auditory evoked response and oesophageal contractility, Br J Anaesth, 63, 411, 10.1093\u002Fbja\u002F63.4.411\nTing, 2003, Neuronal network modelling of the effects of anaesthetic agents on somatosensory pathways, Biol Cybern, 88, 99, 10.1007\u002Fs00422-002-0346-x\nTodorovic, 1998, Pharmacological properties of T-Type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents, J Neurophysiol, 79, 240, 10.1152\u002Fjn.1998.79.1.240\nTodorovic, 2000, Anticonvulsants but not general anesthetics have differential blocking effects on different T-type current variants, Mol Pharmacol, 58, 98, 10.1124\u002Fmol.58.1.98\nTomioka, 2000, Propofol potentiates ATP-activated currents of recombinant P2X(4) receptor channels expressed in human embryonic kidney 293 cells, Neurosci Lett, 284, 167, 10.1016\u002FS0304-3940(00)01014-4\nTonner, 1992, The general anesthetic potency of propofol and its dependence on hydrostatic pressure, Anesthesiology, 77, 926, 10.1097\u002F00000542-199211000-00015\nTonner, 1997, Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in xenopus laevis, Anesthesiology, 87, 1479, 10.1097\u002F00000542-199712000-00027\nTonner, 1999, l-nitroargininemethylester (l-NAME), a nitric oxide synthase inhibitor, increases the anesthetic potency of etomidate, Anasthesiol Intensivmed Notfallmed Schmerzther, 34, 136, 10.1055\u002Fs-1999-8739\nTosteson, 1969\nTrudell, 1977, A unitary theory of anesthesia based on lateral phase separations in nerve membranes, Anesthesiology, 46, 5, 10.1097\u002F00000542-197701000-00003\nTrudell, 2002, Molecular modelling of specific and non-specific anaesthetic interactions, Br J Anaesth, 89, 32, 10.1093\u002Fbja\u002Faef157\nTsuchiya, 2001, Structure-specific membrane-fluidizing effect of propofol, Clin Exp Pharmacol Physiol, 28, 292, 10.1046\u002Fj.1440-1681.2001.03441.x\nTsuchiya, 1990, Halothane impairs the bioenergetic functions of isolated rat liver mitochondria, Toxicol Appl Pharmacol, 104, 466, 10.1016\u002F0041-008X(90)90168-T\nTsutsumi, 2001, Propofol activates vanilloid receptor channels expressed in human embryonic kidney 293 cells, Neurosci Lett, 312, 45, 10.1016\u002FS0304-3940(01)02185-1\nUeda, 1976, Molecular mechanism of inhibition of firefly luminescence by local anesthetics, Proc Natl Acad Sci U S A, 73, 481, 10.1073\u002Fpnas.73.2.481\nUeda, 1986, Do anesthetics fluidize membranes?, Anesthesiology, 64, 67, 10.1097\u002F00000542-198601000-00010\nUnwin, 2005, Refined structure of the nicotinic acetylcholine receptor at 4A resolution, J Mol Biol, 346, 967, 10.1016\u002Fj.jmb.2004.12.031\nUrban, 1993, Differential effects of gaseous and volatile anaesthetics on sodium and potassium channels, Br J Anaesth, 71, 25, 10.1093\u002Fbja\u002F71.1.25\nUrban, 2002, Current assessment of targets and theories of anaesthesia, Br J Anaesth, 89, 167, 10.1093\u002Fbja\u002Faef165\nUrban, 2002\nUrban, 2002, Concepts and correlations relevant to general anaesthesia, Br J Anaesth, 89, 3, 10.1093\u002Fbja\u002Faef164\nUrban, 1987, The actions of halogenated ethers on the ionic currents of the squid giant axon, Proc R Soc Lond B Biol Sci, 231, 13, 10.1098\u002Frspb.1987.0032\nUrban, 1991, Molecular models of anesthetic action on sodium channels, including those from human brain, Ann N Y Acad Sci, 625, 327, 10.1111\u002Fj.1749-6632.1991.tb33861.x\nVahle-Hinz, 2002, What can in vivo electrophysiology in animal models tell us about mechanisms of anaesthesia?, Br J Anaesth, 89, 123, 10.1093\u002Fbja\u002Faef166\nValenzuela, 1995, Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers, Biophysical Journal, 69, 418, 10.1016\u002FS0006-3495(95)79914-3\nVanderkooi, 1977, Interaction of general anesthetics with phospholipid vesicles and biological membranes, Biochim Biophys Acta, 464, 1, 10.1016\u002F0005-2736(77)90366-2\nVeselis, 2002, Novel insights into drug-memory interactions using functional neuroimaging (FNI) techniques, 447\nViolet, 1997, Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics, Anesthesiology, 86, 866, 10.1097\u002F00000542-199704000-00017\nWaizer, 1973, A method for determining minimum alveolar concentration of anesthetic in the rat, Anesthesiology, 39, 394, 10.1097\u002F00000542-197310000-00009\nWakamori, 1991, Effects of two volatile anesthetics and a volatile convulsant on the excitatory and inhibitory amino acid responses in dissociated CNS neurons of the rat, J Neurophysiol, 66, 2014, 10.1152\u002Fjn.1991.66.6.2014\nWeigl, 2002, G protein gated inwardly rectifying potassium channels are targets for volatile anesthetics, 195\nWhite, 1980, Pharmacology of ketamine isomers in surgical patients, Anesthesiology, 52, 231, 10.1097\u002F00000542-198003000-00008\nWittmann, 2002, Thiopentone and propofol inhibit the expression of FMLP receptors in human neutrophils in vitro, 273\nYaksh, 1998\nYamakura, 2000, Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels, comparison with isoflurane and ethanol, Anesthesiology, 93, 1095, 10.1097\u002F00000542-200010000-00034\nYamakura, 1995, Effects of propofol on various AMPA-, kainate- and NMDA-selective glutamate receptor channels expressed in xenopus oocytes, Neurosci Lett, 188, 187, 10.1016\u002F0304-3940(95)11431-U\nYost, 1999, Potassium channels: basic aspects, functional roles, and medical significance, Anesthesiology, 90, 1186, 10.1097\u002F00000542-199904000-00035\nYost, 2003, Update on tandem pore (2P) domain K+ channels, Curr Drug Targets, 4, 347, 10.2174\u002F1389450033491091\nYost, 2002, Tandem pore (2P) domain K+ channels as anesthetic targets, 203\nZhang, 1997, Volatile general anaesthetic actions on recombinant nACh alpha 7, 5-HT3 and chimeric nACh alpha 7-5-HT3 receptors expressed in xenopus oocytes, Br J Pharmacol, 120, 353, 10.1038\u002Fsj.bjp.0700934\nZhou, 1996, Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells, J Pharmacol Exp Ther, 278, 732\nZimmerman, 1994, Potentiation of gamma-aminobutyric acida receptor Cl- current correlates with in vivo anesthetic potency, J Pharmacol Exp Ther, 270, 987\nZink, 2002, Modulation of intracellular calcium homeostasis by tetracaine in skinned skeletal muscle fibres—reasons for its moderate myotoxicity?, 330\nZink, 2002, Differential effects of bupivacaine on intracellular Ca2+ regulation: potential mechanisms of its myotoxicity, Anesthesiology, 97, 710, 10.1097\u002F00000542-200209000-00026\nZuo, 2001, Dual action of N-alcohols on neuronal nicotinic acetylcholine receptors, Mol Pharmacol, 60, 700\nZuo, 2002, Alcohol modulation of neuronal nicotinic acetylcholine receptors is alpha subunit dependent, Alcohol Clin Exp Res, 26, 779",{"EN":771},"Interactions of anesthetics with their targets: Non-specific, specific or both?",{"VOID":773},"10.1016\u002Fj.pharmthera.2005.12.005","2024-12-13T23:57:19.942+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725806000027",[777,792,804],{"id":778,"sortIndex":19,"researcher":18,"roles":779,"affiliations":780,"properties":789},"41055243-6756-4781-9632-3f4d269acfd6",[126],[781],{"id":18,"sortIndex":19,"affiliation":782,"properties":18},{"id":783,"createTime":784,"updateTime":784,"relativeEntities":785,"slug":18,"properties":786,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"91368e18-321b-461e-8ed2-ee4af64bb7e9","2024-01-16T07:52:01.959+00:00",[],{"title":787},{"VI":788},"Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Bonn, Sigmund-Freud-Straße 25, D-53127 Bonn, Germany",{"title":790},{"VI":791},"Bernd W. Urban",{"id":793,"sortIndex":282,"researcher":18,"roles":794,"affiliations":795,"properties":801},"1eb926a9-d7f0-4b17-98b5-5e87867f4786",[126],[796],{"id":18,"sortIndex":19,"affiliation":797,"properties":18},{"id":783,"createTime":784,"updateTime":784,"relativeEntities":798,"slug":18,"properties":799,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":800},{"VI":788},{"title":802},{"VI":803},"Martin Barann",{"id":805,"sortIndex":141,"researcher":18,"roles":806,"affiliations":807,"properties":813},"539dda43-14b4-4947-80f5-4e7de65a4d50",[126],[808],{"id":18,"sortIndex":19,"affiliation":809,"properties":18},{"id":783,"createTime":784,"updateTime":784,"relativeEntities":810,"slug":18,"properties":811,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":812},{"VI":788},{"title":814},{"VI":815},"Markus Bleckwenn",{"url":775,"publisher":817,"properties":839},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":818,"slug":10,"properties":819,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":822,"manageAffiliations":823,"indexDatabases":824,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":820,"title":821},{"VOID":13},{"EN":15},[],[],[825,832],{"id":83,"indexDatabase":826,"url":98,"indexYears":18,"academicFieldIds":831,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":827,"label":828,"description":829,"key":94,"publicationTags":830,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":833,"url":76,"indexYears":77,"academicFieldIds":838,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":834,"label":835,"description":836,"key":73,"publicationTags":837,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":840,"pages":842},{"VOID":841},"111",{"VOID":843},"729-770","2006-09-01",2006,{"id":847,"createTime":848,"updateTime":849,"relativeEntities":850,"slug":851,"properties":852,"entityType":118,"verifyStatus":119,"verifyTime":849,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":859,"fullTextUrl":18,"authors":860,"publicationType":155,"publisherRelationship":876,"citationCount":18,"citationInfo":18,"publishDate":245,"publishYear":246,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"770b669f-0abc-4d29-866f-9eabe1bee541","2024-01-17T01:57:25.782+00:00","2024-12-10T23:56:56.833+00:00",[],"Intermediate-trapping-and-laue-X-ray-diffraction-Potential-for-enzyme-mechanism-dynamics-and-inhibitor-screening",{"references":853,"title":855,"doi":857},{"VOID":854},"Alber, 1976, Crystal structure of elastase-substrate complex at −55 °C, Nature, 263, 297, 10.1038\u002F263297a0\nAppelt, 1991, Design of enzyme inhibitors using iterative protein crystallographic analysis, J. Med. Chem., 34, 1925, 10.1021\u002Fjm00111a001\nBennett, 1980, Structure of a complex between yeast hexokinase A and glucose, J. Mol. Biol., 140, 211, 10.1016\u002F0022-2836(80)90103-5\nBolduc, 1995, Mutagenesis and laue structures of enzyme intermediates: isocitrate dehydrogenase, Science, 268, 1312, 10.1126\u002Fscience.7761851\nBrubaker, 1996, Synthesis, kinetics, and structural studies of a photolabile caged isocitrate: a catalytic trigger for isocitrate dehydrogenase, Biochemistry, 10.1021\u002Fbi951105v\nCampbell, 1986, Laue diffraction, Inf. Q. Protein Cryst., Daresbury Lab, 18, 23\nCampbell, 1990, Calcium binding sites in tomato bushy stunt virus visualized by Laue crystallography, J. Mol. Biol., 214, 627, 10.1016\u002F0022-2836(90)90278-T\nChen, 1992, Inhibition of b-lactamase by clavulanate: trapped intermediates in cryocrystallographic studies, J. Mol. Biol., 224, 1103, 10.1016\u002F0022-2836(92)90472-V\nCherfils, 1991, Protein-protein recognition analyzed by docking simulation, Proteins Struc. Funct. Genet., 11, 271, 10.1002\u002Fprot.340110406\nChristianson, 1986, X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature, 83, 7568\nCleland, 1979, Statistical analysis of enzyme kinetic data, Methods Enzymol., 63, 103, 10.1016\u002F0076-6879(79)63008-2\nCorrie, 1992, The development and application of photosensitive caged compounds to aid time-resolved structure determination of macromolecules, 65\nCruikshank, 1987, Multiplicity distribution of reflections in Laue diffraction, Acta Crystallogr., A 43, 656, 10.1107\u002FS0108767387098763\nCruickshank, 1991, Angular distribution of reflections in Laue diffraction, Acta Crystallogr., A 47, 352, 10.1107\u002FS0108767391000703\nDing, 1994, Direct structural observation of an acyl-enzyme intermediate in the hydrolysis of an ester substrate by elastase, Biochemistry, 33, 9285, 10.1021\u002Fbi00197a032\nDuke, 1994, Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals, Protein Sci., 3, 1178, 10.1002\u002Fpro.5560030804\nFarber, 1995, It's show time, Curr. Biol., 5, 1088, 10.1016\u002FS0960-9822(95)00217-X\nFarber, 1988, X-ray laue diffraction from crystals of xylose isomerase, 85, 112\nFauman, 1994, Water-mediated substrate\u002Fproduct discrimination: the product complex of thymidylate synthase at 1.83 Å, Biochemistry, 33, 1502, 10.1021\u002Fbi00172a029\nFerre-D'Amare, 1994, Use of dynamic light scattering to assess crystallizability of macromolecules and macromolecular assemblies, Structure, 2, 357, 10.1016\u002FS0969-2126(00)00037-X\nFiner-Moore, 1993, Refined structures of substratebound and phosphate-bound thymidylate synthase from Lactobacillus casei, J. Mol. Biol., 232, 1101, 10.1006\u002Fjmbi.1993.1463\nFink, 1981, X-ray cryoenzymology, Adv. Enzymol., 52, 177\nFleischer, 1993, Antifolate analogs: mechanism of action, analytical methodology, and clinical efficacy, Ther. Drug Monit., 15, 521, 10.1097\u002F00007691-199312000-00012\nFletterick, 1975, The structure of a yeast hexokinase monomer and its complexes with substrates at 2.7 Å resolution, 72, 38\nFriedrich, 1912, Interferenzerscheinungen bei Rontgenstrahlen, 303\nFulop, 1994, Laue diffraction study on the structure of cytochrome c peroxidase compound I, Structure, 2, 201, 10.1016\u002FS0969-2126(00)00021-6\nGerstein, 1994, Structural mechanisms for domain movements in proteins, Biochemistry, 33, 6739, 10.1021\u002Fbi00188a001\nGoodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021\u002Fjm00145a002\nGoodsell, 1986, Isohelical analysis of DNA groove-binding drugs, J. Med. Chem., 29, 727, 10.1021\u002Fjm00155a023\nGoodsell, 1990, Automated docking of substrates to proteins by simulated annealing, Proteins Struc. Funct. Genet., 8, 195, 10.1002\u002Fprot.340080302\nGrissom, 1988, Isotope effect studies of the chemical mechanism of pig heart NADP isocitrate dehydrogenase, Biochemistry, 27, 2934, 10.1021\u002Fbi00408a040\nHadfield, 1993, A fast and portable microspectrophotometer for protein crystallography, J. Appl. Crystallogr., 26, 839, 10.1107\u002FS0021889893005552\nHajdu, 1990, Progress with Laue diffraction studies on protein and virus crystals, Biochemistry, 29, 1669, 10.1021\u002Fbi00459a001\nHajdu, 1986, Time-resolved structural studies on catalysis in the crystal with glycogen phosphorylase, Biochem. Soc. Trans., 14, 538, 10.1042\u002Fbst0140538\nHajdu, 1987, Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b, EMBO J., 6, 539, 10.1002\u002Fj.1460-2075.1987.tb04786.x\nHajdu, 1987, Millisecond x-ray diffraction and the first electron density map from Laue photographs of a protein crystal, Nature, 329, 115, 10.1038\u002F329178a0\nHajdu, 1991, On the limitations of the laue method when applied to crystals of macromolecules, 29\nHardy, 1987, Atomic structure of thymidylate synthase: target for rational drug design, Science, 235, 448, 10.1126\u002Fscience.3099389\nHedman, 1985, Protein microcrystal diffraction and the effects of radiation damage with ultra-high flux synchrotron radiation, 82, 7604\nHelliwell, 1984, Synchrotron x-radiation protein crystallography-instrumentation, methods, and applications, Rep. Prog. Phys., 47, 1403, 10.1088\u002F0034-4885\u002F47\u002F11\u002F001\nHelliwell, 1985, Protein crystallography with synchrotron radiation, J. Mol. Struct., 130, 63, 10.1016\u002F0022-2860(85)85023-7\nHelliwell, 1992\nHelliwell, 1989, The recording and analysis of synchrotron x-radiation Laue diffraction photographs, J. Appl. Crystallogr., 22, 483, 10.1107\u002FS0021889889006564\nHowell, 1992, Activity of crystalline turkey egg white lysozyme, Proteins Struc. Funct. Genet., 12, 91, 10.1002\u002Fprot.340120111\nHurley, 1989, Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase, 86, 8635\nHurley, 1990, Regulation of an enzyme by phosphorylation at the active site, Science, 249, 1012, 10.1126\u002Fscience.2204109\nHurley, 1990, Regulation of isocitrate dehydrogenase by phosphorylation involves no long-range conformational change in the free enzyme, J. Biol. Chem., 265, 3599, 10.1016\u002FS0021-9258(19)39632-2\nHurley, 1991, Catalytic mechanism of NADP-dependent isocitrate dehydrogenase: implications from the structures of magnesium-isocitrate and NADP complexes, Biochemistry, 30, 8671, 10.1021\u002Fbi00099a026\nJoseph, 1990, Anatomy of a conformational change: hinged ‘Lid’ motion of the triosephosphate isomerase loop, Science, 249, 1425, 10.1126\u002Fscience.2402636\nKalman, 1979, Derivation of integrated reflected energy formulas, Acta Crystallogr., A 35, 634, 10.1107\u002FS0567739479001480\nKamb, 1992, Cofactor triggers the conformational change in thymidylate synthase: implications for an ordered binding mechanism, Biochemistry, 31, 12876, 10.1021\u002Fbi00166a024\nKirkpatrick, 1983, Optimization by simulated annealing, Science, 220, 671, 10.1126\u002Fscience.220.4598.671\nKuntz, 1992, Structure-based strategies for drug design and discovery, Science, 257, 1078, 10.1126\u002Fscience.257.5073.1078\nKuntz, 1982, A geometric approach to macromolecule-ligand interactions, J. Biol. Chem., 161, 269\nLaskowski, 1993, PROCHECK: a program to check the stereochemical quality of protein structures, J. Appl. Cryst., 26, 283, 10.1107\u002FS0021889892009944\nLaue, 1912, Eine quantitative prufung der theorie fur the interferenzerscheinungen bei Rontgenstrahlen, 363\nLolis, 1990, Structure of yeast triosephosphate isomerase at 1.9-Å resolution, Biochemistry, 29, 6609, 10.1021\u002Fbi00480a009\nMakinen, 1977, Reactivity and cryoenzymology of enzymes in the crystalline state, Annu. Rev. Biophys. Bioeng., 6, 301, 10.1146\u002Fannurev.bb.06.060177.001505\nMargaritondo, 1988\nMatthews, 1968, Solvent content of protein crystals, J. Mol. Biol., 33, 491, 10.1016\u002F0022-2836(68)90205-2\nMatthews, 1990, Crystal structure of Escherichia coli thymidylate synthase containing bound 5-fluoro-2′-deoxyuridylate and 10-propargyl-5,8-dideazafolate, J. Mol. Biol., 214, 923, 10.1016\u002F0022-2836(90)90346-N\nMatthews, 1990, Stereochemical mechanism of action for thymidylate synthase based on the x-ray structure of the covalent inhibitor ternary complex with 5-fluoro-2′-deoxyuridylate and 5,10-methylenetetrahydrofolate, J. Mol. Biol., 214, 937, 10.1016\u002F0022-2836(90)90347-O\nMeng, 1992, Automated docking with grid-based energy evaluation, J. Comp. Chem., 13, 505, 10.1002\u002Fjcc.540130412\nMoffat, 1989, Time-resolved macromolecular crystallography, Annu. Rev. Biophys. Biophys. Chem., 18, 309, 10.1146\u002Fannurev.bb.18.060189.001521\nMoffat, 1984, X-ray laue diffraction from protein crystals, Science, 223, 1423, 10.1126\u002Fscience.223.4643.1423\nMoffat, 1986, Laue diffraction from biological samples, Nucl. Instrum. Methods, A246, 627, 10.1016\u002F0168-9002(86)90164-6\nMontfort, 1990, Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate, Biochemistry, 29, 6964, 10.1021\u002Fbi00482a004\nMorris, 1993, The genetic toxicology of 5-fluoropyrimidines and 5-chlorouracil, Mutat. Res., 297, 39, 10.1016\u002F0165-1110(93)90006-9\nO'Hara, 1995, Direct measurement of diffusion rates in enzyme crystals by video absorbance spectroscopy, J. Appl. Crystallogr., 28, 829, 10.1107\u002FS0021889895007722\nPerry, 1990, Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases, Proteins, 8, 315, 10.1002\u002Fprot.340080406\nRasmussen, 1992, Crystalline ribonuclease A loses function below the dynamic transition at 220K, Nature, 357, 423, 10.1038\u002F357423a0\nReynolds, 1988, Preliminary study of a phasetransformation in insulin crystals using synchrotron radiation Laue diffraction, Acta Crystallogr., B 44, 512, 10.1107\u002FS0108768188005956\nRodgers, 1994, Cryocrystallography, Structure, 2, 1135, 10.1016\u002FS0969-2126(94)00116-2\nRöntgen, 1898, Abdruck der 1. und 2. Originalmitteilung von 1895, uber eine neue art von strahlen, und der 3. Mitteilung von 1897, weitere beobachtungen uber die eigenschaften der x-strahlen, Ann. Phys. Chem., 64, 1, 10.1002\u002Fandp.18983000102\nSchlichting, 1989, Biochemical and crystallogaphic characterization of a complex of c-Ha-ras p21 and caged GTP with flash photolysis, 86, 7687\nSchlichting, 1990, Time-resolved x-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis, Nature, 345, 309, 10.1038\u002F345309a0\nSchlichting, 1994, Crystal structure of photolyzed carbonmonoxymyoglobin, Nature, 371, 808, 10.1038\u002F371808a0\nShoichet, 1991, Protein docking and complementarity, J. Mol. Biol., 221, 327, 10.1016\u002F0022-2836(91)80222-G\nShoichet, 1993, Structure-based discovery of inhibitors of thymidylate synthase, Science, 259, 1445, 10.1126\u002Fscience.8451640\nSinger, 1992, The hydrolytic water molecule in trypsin, revealed by timeresolved Laue crystallography, Science, 259, 669, 10.1126\u002Fscience.8430314\nStoddard, 1995, Direct measurement of reactivity in the protein crystal by steady-state kinetic studies, Structure, 3, 991, 10.1016\u002FS0969-2126(01)00235-0\nStoddard, 1992, Prediction of the structure of a receptor-protein complex using a binary docking method, Nature, 358, 774, 10.1038\u002F358774a0\nStoddard, 1990, Photolysis and deacylation of inhibited chymotrypsin, Biochemistry, 29, 8042, 10.1021\u002Fbi00487a008\nStoddard, 1990, Structure and activity of two photoreversible cinnamates bound to chymotrypsin, Biochemistry, 29, 4871, 10.1021\u002Fbi00472a017\nStoddard, 1991, Observation of the light-triggered binding of pyrone to chymotrypsin by Laue x-ray crystallography, 88, 5503\nSzebenyi, 1988, Quantitative analysis of Laue diffraction patterns recorded with a 120 picosecond exposure from an x-ray undulator, Trans. Am. Crystallogr. Assoc., 24, 167\nTeng, 1994, Photolysis-induced structural changes in single crystals of carbonmonoxymyoglobin at 40K, Nature Struct. Biol., 1, 701, 10.1038\u002Fnsb1094-701\nTilton, 1992, Effects of temperature on protein structure and dynamics: x-ray crystallographic studies of the protein ribonuclease A at nine different temperatures from 98 to 320 °K, Biochemistry, 31, 2469, 10.1021\u002Fbi00124a006\nVarney, 1992, Crystal-structure-based design and synthesis of benz-[cd]indole-containing inhibitors of thymidylate synthase, J. Med. Chem., 35, 663, 10.1021\u002Fjm00082a006\nWeichsel, 1995, Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancer drug 1843U89, Nature Struct. Biol., 2, 1095, 10.1038\u002Fnsb1295-1095\nWodak, 1978, Computer analysis of proteinprotein interaction, J. Mol. Biol., 124, 323, 10.1016\u002F0022-2836(78)90302-9\nWyckoff, 1967, Design of a diffractometer and flow cell system for x-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease S, J. Mol. Biol., 27, 563, 10.1016\u002F0022-2836(67)90059-9\nWyckoff, 1967, Design of a diffractometer and flow cell system for X-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease-S, J. Mol. Biol., 27, 563, 10.1016\u002F0022-2836(67)90059-9\nYennewar, 1994, X-ray crystal structure of γ-chymotrypsin in hexane, Biochemistry, 33, 7326, 10.1021\u002Fbi00189a038\nYennewar, 1995, A structural explanation for enzyme memory in nonaqueous solvents, J. Am. Chem. Soc., 117, 577, 10.1021\u002Fja00107a001",{"EN":856},"Intermediate trapping and laue X-ray diffraction: Potential for enzyme mechanism, dynamics, and inhibitor screening",{"VOID":858},"10.1016\u002F0163-7258(96)00058-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0163725896000587",[861],{"id":862,"sortIndex":19,"researcher":18,"roles":863,"affiliations":864,"properties":873},"42e134eb-ea60-4e64-a6d0-bf123c3e2305",[126],[865],{"id":18,"sortIndex":19,"affiliation":866,"properties":18},{"id":867,"createTime":868,"updateTime":868,"relativeEntities":869,"slug":18,"properties":870,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"3acb632d-9153-45a5-92e3-ad879c64501a","2024-01-17T01:57:25.794+00:00",[],{"title":871},{"VI":872},"Program in Structural Biology, Division of Basic Sciences, Fred Hutchinson Cancer Research Center A3-023, 1124 Columbia Street, Seattle, WA 98104, USA",{"title":874},{"VI":875},"Barry L. Stoddard",{"url":859,"publisher":877,"properties":899},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":878,"slug":10,"properties":879,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":882,"manageAffiliations":883,"indexDatabases":884,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":880,"title":881},{"VOID":13},{"EN":15},[],[],[885,892],{"id":83,"indexDatabase":886,"url":98,"indexYears":18,"academicFieldIds":891,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":887,"label":888,"description":889,"key":94,"publicationTags":890,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":893,"url":76,"indexYears":77,"academicFieldIds":898,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":894,"label":895,"description":896,"key":73,"publicationTags":897,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":900,"pages":902},{"VOID":901},"70",{"VOID":903},"215-256",{"id":905,"createTime":906,"updateTime":907,"relativeEntities":908,"slug":909,"properties":910,"entityType":118,"verifyStatus":119,"verifyTime":907,"verifyNote":120,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":915,"fullTextUrl":18,"authors":916,"publicationType":155,"publisherRelationship":998,"citationCount":18,"citationInfo":18,"publishDate":1026,"publishYear":1027,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":186},"1e8f3872-60a2-41a7-8f74-71c4c71b8f0c","2023-12-31T03:59:35.915+00:00","2024-12-25T23:56:50.818+00:00",[],"Dopamine-receptors%C3%A2-physiological-understanding-to-therapeutic-intervention-potential",{"title":911,"doi":913},{"EN":912},"Dopamine receptors—physiological understanding to therapeutic intervention potential",{"VOID":914},"10.1016\u002Fs0163-7258(99)00029-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0163725899000297",[917,934,949,971,983],{"id":918,"sortIndex":401,"researcher":18,"roles":919,"affiliations":920,"properties":931},"ae83d86e-2c3e-475a-8984-17ada3cfd517",[126],[921],{"id":18,"sortIndex":19,"affiliation":922,"properties":18},{"id":923,"createTime":924,"updateTime":925,"relativeEntities":926,"slug":927,"properties":928,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"1ace23e4-ba92-4a11-95e1-87d9bec8ebc9","2024-01-10T19:20:09.476+00:00","2024-09-22T23:02:27.864+00:00",[],"Department-of-Pharmacology-University-of-Oxford-Oxford-OX1-3QT-UK",{"title":929},{"VI":930},"Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK",{"title":932},{"VI":933},"Stephanie Cragg",{"id":935,"sortIndex":282,"researcher":18,"roles":936,"affiliations":937,"properties":946},"130c0ba7-1622-462b-be02-d0ac64026d4a",[126],[938],{"id":18,"sortIndex":19,"affiliation":939,"properties":18},{"id":940,"createTime":941,"updateTime":941,"relativeEntities":942,"slug":18,"properties":943,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"d33b9b7a-87a2-4fe6-a3f4-1d284ba85f38","2023-12-31T03:59:35.938+00:00",[],{"title":944},{"VI":945},"Laboratory of Pharmacology, Université Catholique de Louvain, Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium",{"title":947},{"VI":948},"Muriel Geurts",{"id":950,"sortIndex":141,"researcher":18,"roles":951,"affiliations":952,"properties":968},"94be0cec-fd12-4eee-a4e5-76b337a67431",[126],[953,963],{"id":954,"sortIndex":141,"affiliation":955,"properties":962},"93c8d898-8e49-4b0f-b20c-4cb7e84785c5",{"id":956,"createTime":957,"updateTime":957,"relativeEntities":958,"slug":18,"properties":959,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"fe750ab8-b8eb-4f5f-82fc-c850216bbf3f","2023-12-31T03:59:35.943+00:00",[],{"title":960},{"VI":961},"Department of Neurology, Université Catholique de Louvain, Cliniques Universitaires Saint Luc , B-1200 Brussels, Belgium",{},{"id":18,"sortIndex":19,"affiliation":964,"properties":18},{"id":940,"createTime":941,"updateTime":941,"relativeEntities":965,"slug":18,"properties":966,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":967},{"VI":945},{"title":969},{"VI":970},"Jean-Marie Maloteaux",{"id":972,"sortIndex":19,"researcher":18,"roles":973,"affiliations":974,"properties":980},"b70a8f42-2622-42ea-8a99-0c3f3fb9112e",[126],[975],{"id":18,"sortIndex":19,"affiliation":976,"properties":18},{"id":940,"createTime":941,"updateTime":941,"relativeEntities":977,"slug":18,"properties":978,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":979},{"VI":945},{"title":981},{"VI":982},"Gérard Emilien",{"id":984,"sortIndex":337,"researcher":18,"roles":985,"affiliations":986,"properties":995},"420641ab-5c50-45fd-ac38-b368fa5abd74",[126],[987],{"id":18,"sortIndex":19,"affiliation":988,"properties":18},{"id":989,"createTime":990,"updateTime":990,"relativeEntities":991,"slug":18,"properties":992,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"efcd2de8-ca97-433c-9d82-7c2943a97ab8","2023-12-31T03:59:35.967+00:00",[],{"title":993},{"VI":994},"Department of Internal Medicine, Divisions of Endocrinology and Diabetes, State University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands",{"title":996},{"VI":997},"Klaas Hoogenberg",{"url":915,"publisher":999,"properties":1021},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1000,"slug":10,"properties":1001,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1004,"manageAffiliations":1005,"indexDatabases":1006,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1002,"title":1003},{"VOID":13},{"EN":15},[],[],[1007,1014],{"id":83,"indexDatabase":1008,"url":98,"indexYears":18,"academicFieldIds":1013,"indexDatabaseRanking":18},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":1009,"label":1010,"description":1011,"key":94,"publicationTags":1012,"standard":18},[],{"EN":90,"VI":90},{"VI":92,"EN":93},[96,97],[100],{"id":63,"indexDatabase":1015,"url":76,"indexYears":77,"academicFieldIds":1020,"indexDatabaseRanking":81},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":1016,"label":1017,"description":1018,"key":73,"publicationTags":1019,"standard":18},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79,80],{"volume":1022,"pages":1024},{"VOID":1023},"84",{"VOID":1025},"133-156","1999-11-01",1999]